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The Gram positive and obligate anaerobe bacterium Clostridioides difficile can be found 
ubiquitously in our environment. Simultaneously, C. difficile infections (CDI) are the most 
common cause of hospital-acquired, antibiotic-induced diarrhea. CDI leads to severe 
diarrhea, colon inflammation and eventually to life-threatening colon perforation. Antibiotic 
resistance of C. difficile and increasingly poor response to treatment are associated with 
increasing numbers of cases in hospitals in industrialized countries. These circumstances 
justify the desperate search for innovative treatment options that do not rely on traditional 
broadband antibiotic dosages to alleviate CDI infection courses. Within the last years, 
C. difficile attracted increasing attention from multi-disciplinary research, creating a steady 
fundament for a better understanding. However, C. difficile still raises exciting questions 
that need to be answered urgently. 
C. difficile gains its ability to overgrow and dominate compromised intestinal flora by 
several specialized metabolic pathways. One of such is known as the Stickland 
fermentation. Here, amino acids are used in a coupled reaction as source of carbon and 
energy. Oxidative reactions include deamination and decarboxylation of various amino 
acids under generation of ATP and NADH. Reductive reactions occur specifically and 
mainly on proline and glycine. Metabolic investigations showed that proline is the preferred 
substrate for NAD+ regeneration and the proline reductase has been shown to play 
important roles in manifold metabolic regulations. An intact proline reductase has been 
proven to be a requirement for C. difficile growth and sporulation. Further, toxin production 
is regulated by PrdR, the regulator of the proline reductase operon. This σ54-dependent 
regulator constitutes a direct link of proline availability and therefore the metabolic state of 
the pathogen and induction of toxin production. 
The proline reductase itself was described to consist of three subunits, PrdAβ, PrdAα and 
the selenocystein containging PrdB. The β and α subunits mature by a rare 
selenocysteinolysis from the PrdA-proprotein. The complex was confirmed to be soluble, 
but previous studies also showed an association to the bacterial membrane, presumably 
indicating interactions to membrane proteins. The single subunits have molecular weights 
(MW) of 45, 23 and 25 kDa, respectively, and were found to assemble into a large 
supercomplex of more than 800 kDa. However, due to its exclusiveness for Clostridia and 
prevailing poor accessibility of the proteins, detailed molecular understanding for structure 
Summary 
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and function of the proline reductase supercomplex remains elusive. Comprehensive and 
detailed knowledge of the assembly, the architecture and molecular functionality can 
potentially contribute to identification of alternative approaches for CDI treatment.  
The most important prerequisite for biochemical and structural characterization is a valid 
and robust protein isolation procedure. Existing purification protocols for the proline 
reductase supercomplex were revised and refined to obtain a sample of the highest 
possible quality, in order to meet the requirements for structural elucidation by negative 
stain TEM. The proline reductase supercomplex was isolated directly from C. difficile to 
ensure correct folding and complex assembly. Biophysical investigations by SAXS, MALS, 
negative stain TEM, as well as sequence-based analyses allowed describing the proline 
reductase supercomplex as a metastable triacontameric complex of 930 kDa, exhibiting a 
large extent of intrinsic flexibility. Results from limited proteolysis suggested that an 
N-terminal stretch of PrdAβ is responsible for pentamerization of hexamers. The remaining 
parts of PrdAβ and PrdAα comprise an interaction scaffold for PrdB. Together, the 
hexamer PrdAβ2α2PrdB2 constitutes a rather rigid catalytically active domain, which is 
congruously represented with five copies in the full supercomplex. For both, truncated but 
unmatured PrdA-proprotein and PrdB, recombinant isolation procedures were established. 
These strategies allowed generation of preliminary cryo-EM data that will likely lead to a 
high-resolution structure of the truncated, hexameric subcomplex in the near future.  
Besides C. difficiles’s proline reductase, another focus was put on the phospholipases 
originating from Legionella pneumophila. This Gram-negative bacterium naturally occurs 
in cold fresh-water reservoirs, where it is able to replicate inside amoebae by modulation 
of host cell functions and vesicle trafficking. This ability arises from a highly complex 
secretome, a large number of modulators that are injected into the host cell or the 
Legionella containing vacuole (LCV). The same mechanisms enable L. pneumophila to 
infect human lung macrophages upon inhalation of contaminated aerosols, causing heavy 
pneumonia, described as the so-called Legionnaires disease. 
Important examples of L. pneumophila’s secretome and dominant virulence factors are 
phospholipases. These enzymes attack host cell membranes and thereby alter membrane 
integrity and release toxic second messengers. In order to protect itself from noxious 
activity, the phospholipases are subjected to strict regulation mechanisms.  
The phospholipase PlaA is secreted from L. pneumophila and activated in the LCV lumen 
by proteolytic maturation. A backbone cleavage is conducted by ProA, a secreted and 
rather unspecific protease, also acting as a virulence factor. Structural determination of 
pre-mature PlaA was achieved by X-ray crystallography. It unveiled that the lid domain, 
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framed and stabilized by a disulfide bond, shields the active site from the solvent. The 
proteolysis site was found at an exposed location in the lid domain. Hence, the maturation 
event is expected to increase lid flexibility. At the same time, the disulfide bond maintains 
the enzyme’s structural integrity despite backbone cleavage. This way, the active site is 
unshielded and the triggering of phospholipase activity can be explained.  
Another sophisticated principle of enzymatic regulation for protection from self-inflicted 
lysis was revealed by characterization of the highly potent virulence factor PlaB. The 
tetrameric structure obtained from X-ray crystallography allowed the generation of 
structure-guided mutants that were studied by a combination of sub-cellular localization 
experiments and activity assays. Together, these data suggest that PlaB activity is 
inhibited intracellularly by a novel mechanism of NAD(H)-mediated dimer-of-dimer 
formation. Upon NAD(H) detachment, the dimer/dimer interface becomes unstable. The 
monomer/monomer interface within the dimer, however, is built from an almost 30 amino 
acid long stretch at the C-terminus of PlaB. This hook-like structure establishes a stable 
interaction between both monomers and is essential for enzymatic activity due to 
hydrolase-fold complementation. An unknown export mechanism transfers the enzyme to 
the bacterial surface, where non-canonical structural elements facilitate membrane 
association of PlaB dimers. These dimers represent the active form of PlaB that exhibit 









1.1 Topic I: The proline reductase from Clostridioides 
difficile 
The proline reductase (PR) of Clostridioides difficile is a central metabolic enzyme with 
massive influence on many functions. Studies have shown necessity for growth, clear 
participation in toxin regulation and tight connection to sporulation. Thus, all three major 
topics in C. difficile research are touched by this entity, highlighting the importance for the 
organism. 
1.1.1 Clostridioides difficile, an overview on an exceptional 
bacterium 
Clostridioides difficile, formerly known as Clostridium difficile, is an obligate anaerobe, 
Gram-positive, rod-shaped and spore forming bacterium (for microscopic image, see 
figure 1.1). It was initially identified from the intestinal flora of newborns as Bacillus difficilis. 
The designation was inspired by troublesome cultivation behavior under anaerobic 
conditions (Hall et al., 1935). For historical reasons, the class of Clostridia is divided in 14 
clusters, covering highly divergent anaerobes. For a long time, 16 sRNA ribotyping 
provided a basis for classification of Clostridia (Gurtler, 1993). However, strains classified 
to be closely related did not necessarily show the same phenotypes and exhibited large 
differences in pathogenicity. At the same time, highly divergent strains showed similar 
results for ribotyping (Sirard et al., 2011). Consequently, a set of miscellaneous methods 
for classification of Clostridia were developed. As sequencing capacities increased, the 
most comprehensive classification by whole genome analysis arose , which is the latest 
standard in Clostridia classification (Moore et al., 2019). C. difficile significantly differs from 
the classical Clostridia (Cluster I) with its well-known representative C. botulinum. Listed 
in Cluster XI, it is more closely related but still distinct from a number of bacteria 
summarized as Peptoclostridia, with the representatives Paeniclostridium sordellii or 
Acetoanaerobium sticklandii among them (Collins et al., 1994; Monot et al., 2011).  
Interestingly, C. difficile shows a so-called plastic, or mobile, genome, describing 
enhanced levels of chromosomal rearrangements. This is leading to an impressive number 
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of several hundred different strains, divided in at least 6 clades (Sebaihia et al., 2006; 
Knight et al., 2015). The plastic genome manifests itself in a broad range of genome sizes 
and is possibly driven by adaption to environmental pressure. It is achieved by acquisition 
of mobile genetic elements such as plasmids, transposons or phages (He et al., 2010; 
Knetsch et al., 2012; Moore et al., 2019).  
 
Figure 1.1: Morphology of C. difficile. A) C. difficile colonies on a blood agar plate. B) Phase-contrast microscopy 
image of a C. difficile culture. Vegetative cells are visible as elongated rods. Spores are seen as ellipsoids, 
highlighted by phase contrast. Gram stain shows positive results. C) C. difficile spores visualized by scanning 
electron micrography. D) Endoscopic picture of pseudomembranous colitis caused by C. difficile. Healthy colon 
tissue appears pink, damaged tissue is yellow. Image and caption taken from Smits et al, 2016 (Smits et al., 
2016). 
 
C. difficile naturally occurs in human infants (Hall et al., 1935) but is ubiquitously present 
in our environment. Especially soil and water samples in proximity to animal husbandry 
show conspicuous contamination and an alarming overlap to virulent strains found in 
hospitals (Weese, 2010). Particularly, cattle and swine pose a substantial risk, as 
increasing demand for food enhances concrete danger for regional waves of infections by 
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large-scale farming and environmental contamination (Rodriguez-Palacios et al., 2006, 
2007; Yaeger et al., 2007; Hammitt et al., 2008).  
Within recent years, C. difficile came into focus of research, as 2,824 severe cases of 
C. difficile infections (CDI) were recorded in Germany in 2018, of which 24% were lethal 
and 31% contributed to death. Severe CDI showed the second highest portion of 
deceased, only excelled by seasonal influenza (Robert Koch-Institut, 2019). Moreover, an 
alarming increase of antibiotic resistances was monitored in the recent past, making 
C. difficile to an evident risk for public health issues (Kawata et al., 1984; Barkin et al., 
2017; Ong et al., 2017). 
1.1.2 Pathogenesis and treatment of Clostridioides difficile 
Several studies elaborated a clear relationship between antibiotic treatment and a 
generally increased susceptibility for infectious diseases (Lupp et al., 2007; Kamada et al., 
2012; Peterfreund et al., 2012). Unsurprisingly, this relationship also applies to CDI, since 
it was shown that the risk for CDI increases with application of broad-spectrum antibiotics, 
such as clindamycin, cephalosporin or ampicillin (Bartlett, 2002; Reeves et al., 2011).  
Currently, there is evidence that more than 20% of antibiotic-associated diarrhea (AAD) in 
humans are verifiably caused by CDI (Bartlett, 1979, 2002; Kelly et al., 1994). Severity of 
clinical courses of CDI vary, dependent on C. difficile strains, patients microbiota, diet and 
possibly further unrevealed factors (Kelly et al., 1994). The courses are classified as mild, 
severe or fulminant. Mild courses are characterized by diarrhea and can be treated by oral 
application of 500 mg metronidazole or 125 mg vancomycin for up to two weeks (Surawicz 
et al., 2013). Occurrence of fever and strong abdominal pain is observed for severe forms 
of CDI. Here, vancomycin treatment doses are raised to 500 mg and the application can 
be rectal (Cohen et al., 2010). In case of poor response, oral dosage of 200 mg 
fidaxomycin can be considered (Cornely et al., 2014). A fulminant course cannot be 
precluded in certain cases. It is characterized by severe pain, strong diarrhea and potential 
development of a toxic megacolon and colon perforation with concrete life-threatening 
consequences (McDonald et al., 2018). Ultimately, a colectomy can be considered, in 
which irrecoverable colon sections are removed (Lamontagne et al., 2007).  
Interestingly, the occurrence of severe forms of CDI coincidently increased with the 
identification of a so-called hyper-virulent strain of C. difficile, toxinotype III NAP1/027. This 
strain exhibited an enormously increased level of toxin production compared to other 
C. difficile strains (Warny et al., 2005). Most prominent toxins of C. difficile (Tcd) are TcdA 
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and TcdB (Voth et al., 2005; Carter et al., 2012; Awad et al., 2014). Both toxins are 
encoded in the pathogenicity locus (PaLoc) and represent monoglycosyltransferases that 
glycosylate Rho-GTPases, leading to disintegration of the cytoskeleton, subsequent cell-
rounding, the loosening of tight junctions and finally to cell death in the colon (Voth et al., 
2005; Steele et al., 2013). Further, it has been observed that TcdA and TcdB also induce 
levels of proinflammatory cytokines such as TNF-α or IL-8 (Shen, 2012). In addition, the 
binary toxin, which is encoded by the genes cdtA and cdtB and is present in some virulent 
strains, adds another level of virulence (Perelle et al., 1997). Although only a small portion 
of virulent strains of C. difficile carry cdtA/cdtB, clinically relevant strains were identified 
that were TcdA/TcdB-negative and gained their virulence from the binary toxin (Florin et 
al., 1991). Some hyper-virulent strains, including toxinotype III NAP1/027, show a mutation 
in the gene tcdC, a putative down-regulator of TcdA/TcdB production located in the PaLoc, 
possibly explaining their increased virulence (Mani et al., 2001; Matamouros et al., 2007).  
Exact regulation mechanisms for toxin production remain elusive, but researchers have 
identified a link to the environment of the microbe. In this regard, comparison of low and 
high-protein diets showed that higher intestinal amino acid content increased the risk of a 
severe CDI due to higher levels of toxin production. At the same time, a C. difficile mutant 
unable to utilize proline was ineffective to infect mice (Battaglioli et al., 2018).  
One important component of C. difficile’s central metabolism is the Stickland fermentation, 
which will be described in the following section.  
1.1.3 Stickland fermentation as a central key-player in the 
metabolism of Clostridioides difficile 
Stickland fermentation was described in 1934 by Leonhard Huber Stickland as a 
fermentation of amino acids, coupling oxidative and reductive reactions (Stickland, 1934). 
It enables proteolytic clostridia to use amino acids as sole source of carbon and energy. 
The reaction can be divided in an oxidative and a reductive arm, which are coupled by a 
NAD+/NADH-flux. In more detail, the oxidative reactions are restricted to leucin, isoleucine 
and alanine as electron donors and comprise oxidative deamination and decarboxylation, 
both reactions generate NADH. Substrates for the reductive arm are mainly restricted to 
glycine and, more importantly, proline, which act as electron acceptors. Both reductive 
deamination of glycine and reductive ring cleavage of proline regenerate NAD+. Although 
the product of proline reduction, 5-aminovalerate, is subsequently secreted and is no 
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longer accessible for the metabolism, proline is highly preferred over glycine as electron 
acceptor and absolutely necessary for growth (Bouillaut et al., 2013). 
In general, an upregulation of toxin production is connected to a lack of nutrients and an 
entry to the stationary growth phase, highlighting the importance for a better understanding 
of the central metabolism of C. difficile (Dupuy et al., 1998). A schematic overview of the 
proline dependent Stickland fermentation and its role in toxin production is shown in figure 
1.2. 
 
Figure 1.2: Stickland fermentation in its metabolic context. L-proline inhibits TcdA/TcdB production via PrdR. It 
is transferred to D-proline by PrdF and enters the reductive Stickland fermentation. The proline reductase 
complex reduces D-proline to 5-aminovalerate under consumption of ATP and NH4+. The oxidized proline 
reductase complex is regenerated by reduced NADH-binding PrdC. Reducing equivalents NAD+ and NADH 
couple the reductive arm of the Stickland fermentation to the oxidative arm, where amino acids are oxidatively 
deaminated and decarboxylated. The NAD+/NADH-ratio is sensed by the redox-sensing regulator (Rex), which 
inhibits the glycine reductase and alternative reducing pathways, if proline is present. Alternative reducing 
pathways would result in accumulation of butyrate, which would again induce TcdA/TcdB production. 
Conclusively, the presence of proline represses toxin production.  
 
The enzyme fulfilling proline reduction is the proline reductase (PR) (Kabisch et al., 1999). 
This protein complex was found to be associated with the proton motive force (PMF), 
possibly explaining the observed preference of its substrate over glycine (Lovitt et al., 
1986). Interestingly, there is a notable similarity of the nucleotide-binding PrdC, necessary 
for regeneration of the PR to its reduced state, to RnfC (Fonknechten et al., 2010 a; 
Poehlein et al., 2014). RnfC is one subunit of the Rnf complex, essential for generation of 
a proton gradient and ATP-synthesis, emphasizing the central role of the PR in C. difficile’s 
metabolism (Tremblay et al., 2012). C. difficile was shown to be thoroughly adapted to the 
intestinal environment, where typically low concentrations of glucose prevail. It has been 
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shown that C. difficile is independent of the consumption of sugars when amino acids are 
present in the culture media (Ferraris et al., 1990; Jackson et al., 2006). Genomic analysis 
of closely related species revealed the presence of 12 proteases and 38 peptidases, 
emphasizing the importance of accessible amino acids during C. difficile growth 
(Fonknechten et al., 2010 b). Recent research discovered and verified a clear link between 
amino acid availability, the metabolic state of C. difficile and toxin production (Martin-
Verstraete et al., 2016). In more detail, toxin production is effectively repressed when 
certain amino acids, such as proline, are available for fermentation (Karisson et al., 1999). 
When C. difficile enters the stationary growth phase, toxin production starts (Dupuy et al., 
1998). As long as proline is available, the σ54-factor PrdR stimulates PR expression and 
is thought to be one responsible factor for toxin repression (Bouillaut et al., 2015). 
Simultaneously, the redox-sensing system Rex monitors the NAD+/NADH-ratio in the 
organism, which is also an indicator for the metabolic state, and represses toxin production 
(Bouillaut et al., 2019). While the dependencies of metabolic state and nutrient availability 
on toxin production have been investigated to some extent, the exact relationships and 
pathways remain unclear and need further, direct detection of proteinogenic interactions. 
Yet another context remains enigmatic: surprisingly, it was found that several proline- 
deficient mutant strains of C. difficile were unable to sporulate (Dembek et al., 2015). 
Indisputably, metabolic fitness and ability for sporulation seem to be closely related. 
However, no causalities were identified so far.  
Therefore, PR must be considered as a central metabolic key-player, essential for growth, 
with obvious cross-play to TcdA/TcdB regulation and ultimately with a connection to 
sporulation. Consequently, a profound understanding of PR and its interaction partners 
will be of immense use in the progress of alternative treatment development. 
1.1.4 The proline reductase as a target for structural biology 
As mentioned before, the PR is a particularly interesting target of research, as the 
importance on cellular and metabolic levels has been shown. It reductively cleaves D-
proline to 5-aminovalerate (Seto, 1978; Kabisch et al., 1999). However, due to poor 
accessibility of protein material for research and the small number of homologs, structural 
information is not available and hence, detailed and valid information about its architecture 
and mode of action at atomic resolution is missing.  
As far as known, the PR complex assembles from the gene products of prdA and prdB, 
both located in the PR operon. PrdA matures to PrdAα and PrdAβ by a serino- or 
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cysteinolysis, inducing a backbone rupture at amino acid position 421 (Bednarski et al., 
2001). The N-terminal PrdAβ closes with a regular C-terminus, while the C-Terminal PrdAα 
carries a pyruvoyl moiety at its N-terminus, which is necessary for substrate binding. This 
maturation does not occur spontaneously but seems to require a chaperone or an 
appropriate electron donor (Kabisch et al., 1999). The mature PrdAαβ complex forms a 
complex with PrdB, which is a small protein of 25 kDa and carries a selenocysteine at 
position 151 (Jackson et al., 2006). PrdAαβ and PrdB form a higher MW complex with yet 
unknown subunit ratios. Dependent on purification and determination strategies, the 
described MW of the PR complex varies from 280 kDa (Seto et al., 1976; Jackson et al., 
2006) to 870 kDa (Kabisch et al., s1999). Until now, the importance of oligomerization, 
mechanisms leading to assembly and the involvement of possible interaction partners of 
PR are unknown. Some results also point towards membrane association of the PR 
complex (Seto et al., 1976). So far, the PR complex has only been purified from Clostridia 
cell cultures, limiting the amount of pure protein for experimentation.  
As the PR complex cannot be structurally predicted by sequence-based methods, 
experimental structure elucidation is urgently needed to completely understand the mode 
of oligomerization, interaction and activity. Such findings will enhance the understanding 




1.2 Topic II: Phospholipases from Legionella pneumophila 
A number of phospholipases have been found to act as important and highly potent 
virulence factors of Legionella pneumophila. As uncontrolled phospholipase activity is of 
potential danger for L. pneumophila itself, the bacterium has evolved sophisticated 
mechanisms for export, regulation, inhibition and activation in order to prevent self-inflicted 
lysis.  
1.2.1 Legionella pneumophila as pathogen 
More than 50 species have been identified in the genus Legionella, of which at least 24 
are associated to human disease (Newton et al., 2010).  
 
Figure 1.3: Intracellular life cycle of L. pneumophila. L. pneumophila is taken up by the eukaryotic host cell 
(amoeba or alveolar macrophage) by phagocytosis (1). Fusion of the Legionella‐containing vacuole (LCV) with 
the endocytic pathway (2) and the delivery to lysosomes (3) is prevented by secretion of effector proteins.  
Recruitment of ER‐derived vesicles trafficking to the Golgi fuse with the LCV (3). A replicative vacuole 
surrounded with ribosomes is formed (4).  Inside the LCV, L. pneumophila replicates and becomes flagellated 
(5). Escape from the host cell induces a new start in the infection cycle in neighbouring cells (6). Figure and 




They naturally occur ubiquitously in fresh water (Fliermans et al., 1981) and replicate 
intracellularly in amobae and nematodes (Hales et al., 1999; Swanson et al., 2000). Here 
L. pneumophila modulates its environment and forms a comfortable niche by secretion of 
effector proteins (Isberg et al., 2009; Hilbi et al., 2011). In a similar manner L. pneumophila 
can also adopt to replication in human lung macrophages upon inhalation of contaminated 
aerosols (Newton et al., 2010). L. pneumophila is the causative organism of Legionnaires’ 
disease, a severe pneumonia, with a number of about 1500 registered cases in Germany 
in 2018 (Robert Koch-Institut, 2019). The number of infections is continuously increasing 
since several years, putatively due to changes in the environment. Secreted effector 
proteins are large in number and some even carry Rho- and Rab-GTPase domains, a 
unique observation in prokaryotes (Gomez-Valero et al., 2019). Their role in vesicle 
transport systems shows how Legionella manipulate membrane trafficking (Novick et al., 
1997). Among secreted effector proteins are also a number of phospholipases, which 
disturb membrane integrity and produce second-messengers (Schmiel et al., 1999).  
1.2.2 Phospholipases as virulence factors  
The phospholipases from L. pneumophila are of crucial importance for pathogenesis, as 
they participate in modulation of host cells (Flores-Díaz et al., 2016). Phospholipases can 
be divided in phospholipases A (PLAs) and lysophospholipases A (LPLA), which hydrolyze 
the carboxyl ester bonds at sn-1 or sn-2 position in phospholipids and lysophospholipids, 
respectively (Schmiel et al., 1999). At least 15 genes encoding PLA/LPLAs belonging to 
three families are found in L. pneumophila. Many of these are secreted into the LCV lumen, 
injected into the host cell or are surface-exposed in order to interact with the host cell 
(Flores-Díaz et al., 2016; Hilbi set al., 2011; Lang, Hiller, & Flieger, 2017; W. C. Winn & 
Myerowitz, 1981). Secretion systems are known for many phospholipases and mostly 
comprise type-2 secretion into the extracellular space for PlaA and PlaC or type-4 injection 
into the host cell, as exemplified by PatA. For PlaB however, the situation is different. The 
secretion path used for PlaB is still unclear (Banerji et al., 2008). Most phospholipases are 
classified as GDSL hydrolases, as they have the GDSL amino acid motif in their active site 
(Akoh et al., 2004). However, PlaB has a THSTG amino acid motif in its active site and is 
therefore classified as a THSTG hydrolase (Flieger et al., 2004). A deeper understanding 
of phospholipase mode of activation and action will hopefully help to define new targets 
for specific treatment of the Legionnaires disease.  
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1.2.3 The phospholipase PlaA 
PlaA is a 34 kDa phospholipase, which is expressed with a N-terminal secretion signal and 
has a common α/β-hydrolase fold (ABH-fold) based on sequence-based predictions. It was 
found to be secreted from L. pneumophila by type-2 secretion into the extracellular lumen, 
were it is activated by ProA-mediated proteolytic cleavage (Flieger et al., 2002; Lang et 
al., 2017). Interestingly, the enzymatic activity of PlaA changes upon maturation. As a 
proprotein, PlaA catalyzes a propionylization of cholesterol. Mature PlaA, on the other 
hand, detoxifies lysophosphocholine (Lang et al., 2012, 2017). It is still a question of 
current research how PlaA influences the host cell. At present, a role of PlaA in membrane 
destabilization has been reported (Creasey et al., 2012). A crystal structure of PlaA could 
potentially increase our understanding of substrate specificity and possibly could enhance 
the knowledge of the exact biological role of PlaA in L. pneumophila pathogenesis. Special 
attention should be paid to surface-exposed substrate binding sites, the lid domain as an 
important element for substrate recognition, and closer investigation of the location of the 
proteolytic cleavage site. Therefore, a crystallographic approach was addressed. 
1.2.4 The phospholipase PlaB 
The phospholipase PlaB is an essential virulence factor for lung colonization, tissue 
destruction and intracellular replication of L. pneumophila. It localizes to the bacterial 
surface and shows an extraordinary activation mechanism by deoligomerization. PlaB 
possesses PLA, LPLA and hemolytic activities essential for intracellular replication in 
mouse macrophages (Flieger et al., 2004; Bender et al., 2009; Kuhle et al., 2014). PlaB is 
also crucial for lung colonization and tissue destruction in guinea pig infections (Schunder 
et al., 2010). It is the only characterized member of a novel PLA family, and homologs are 
found in several water-associated bacteria including the opportunistic pathogen 
Pseudomonas aeruginosa (Flieger et al., 2004; Bender et al., 2009). Previous work 
suggested that PlaB is organized in two domains, an N-terminal phospholipase (amino 
acids 1-~300) connected to a C-terminal domain of unknown function (amino acids ~301-
474) that is essential for activity as well (Bender et al., 2009). The catalytic triad Ser85-
Asp203-His251 of the N-terminal domain is embedded in an uncommon THSTG consensus 
motive (Bender et al., 2009). The C-terminal domain does not show any similarity to known 
proteins, but it has been shown that the last 15 amino acids of PlaB are essential for activity 
although their exact role remains unclear (Bender et al., 2009; Kuhle et al., 2014). PlaB is 
exported from L. pneumophila and associated to the outer membrane of the pathogen, 
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where it is exposed on the surface. However, PlaB lacks export signals as well as lipid 
anchors or transmembrane helices. Therefore, knowledge of the export mode through 
inner and outer bacterial membranes is unclear (Flieger et al., 2004; Schunder et al., 
2010). PlaB provides the most prominent PLA/LPLA activity in L. pneumophila, affecting 
many different lipids including phosphatidylglycerol and phosphatidylcholine, which is also 
present in the bacterial membrane. Therefore, enzyme regulation is crucial to prevent 
cytotoxicity for the pathogen itself (Finnerty et al., 1979; Flieger et al., 2004; Conover et 
al., 2008). Indeed, PlaB shows a rare activation mechanism that requires protein 
deoligomerization. It was found that concentrations above 0.1 μM promote inactivation by 
tetramerization, whereas deoligomerization occurs at nanomolecular concentration and 
below, where PlaB shows highest activities (Kuhle et al., 2014). However, the detailed 
mechanism how dissociation of the oligomers mechanistically leads to enzyme activation 
and the role of the C-terminal domain remains unclear. Detailed molecular understanding 
could raise opportunities for an early intracellular activation of PlaB, which would induce 
self-toxicity as a novel treatment option. First crystallographic studies (data not published) 
showed easy crystal formation, however, the crystals obtained in this earlier work showed 
poor quality and structure elucidation was impossible. Extensive additive screening and 
further crystallographic refinement strategies were planned to be applied.  
1.3 Principles of integrative structural biology 
The term “structural biology” describes all kind of investigations that address the 
architecture and coupled functionality of biomolecules. Proteins are the most studied 
examples of research, but also DNA and mixed structures are targeted by structural 
biology. After the discovery of X-rays in 1895 by Wilhelm Conrad Röntgen, one of many 
basics for structural biology was set. It took 65 years until the first crystal structure of a 
protein was published: in 1960, Max Ferdinand Perutz solved the structure of hemoglobin 
by X-ray crystallography after he solved the phase problem by soaking the crystals with 
mercury (Perutz et al., 1960). Thenceforth, the newly discovered technique developed 
rapidly, only in 1990 more than 100 structures were submitted to the Protein Data Bank 
(PDB), four years later there were 1000 per year already. Until today (spring 2020), more 
than 140.000 X-ray structures have been deposited to the PDB and thanks to recent 
approaches such as serial crystallography and fragment screening, the number continues 
to grow constantly. However, further techniques were developed to determine atomic 
coordinates in biomolecules. In 1946, magnetic resonance was discovered by Felix Bloch 
(Bloch, 1946) and the first NMR structure of a protein was determined in 1985 (Williamson 
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et al., 1985). Due to the complexity of the molecules and broad peaks in spectra, the size 
of the target was limited to approximately 5 kDa (Widmer et al., 1989). The peptide or 
protein size still matters in NMR spectroscopy, although resolution was pushed by stronger 
magnets and hence improved significantly. In order to detect carbon and nitrogen in NMR 
spectroscopy, the atoms need to be substituted by isotopes that have a spin unequal to 
zero, which makes sample production costly. The application is still limited to proteins 
smaller than 30 kDa today. However, advantages of the NMR technique are the direct 
detection of interactions of other atoms or molecules with the labelled target and needs of 
crystallization are omitted. In respect of molecule size, X-ray crystallography has its upper 
limits between 150 and 200 kDa per molecule. Structures of (homo)oligomers of higher 
total MW were successfully determined, but their number is comparably low, as well. Here, 
another technique stands in that is capable to capture supercomplexes. Electron 
microscopy (EM) was developed in 1931 (Ruska, 1987) and first images of vitrified 
samples at cryo-conditions were collected in 1987 (Dubochet et al., 1987). Since its 
development, limitations in EM are found in very small specimens. An important 
breakthrough was achieved by the determination of the hepatitis B protein core complex 
with 5 MDa to a resolution of 7.4 Å (Böttcher et al., 1997). Until recently, the resolution of 
this complex was pushed to 2.66 Å (Böttcher et al., 2018). Currently, the highest resolution 
was achieved for the hexameric glutamate dehydrogenase with 1.8 Å (Merk et al., 2016) 
and also molecule size decreases continuously, filling existent gaps between 
crystallography and cryo-EM. Due to chronical advance and accessible infrastructure, X-
ray crystallography is still the dominant technique in structural biology, contributing to 
almost 90% to the PDB, as shown in figure 1.4 (Berman et al., 2000).  
 
Figure 1.4: Macromolecular structure data 
of the Protein Data Bank (PDB). The diagram 
shows the portions of structures solved by 
different experimental methods (X-ray 
crystallography, NMR spectroscopy, 
electron microscopy and other methods). X-
ray crystallography is the most prominent 
technique, represented by almost 90% of all 
deposited structures. NMR spectroscopy 
follows with a larger subset of 8%. Since 
recently, the number of EM structures 
increased tremendously, currently 




Overcoming size limitations, further aspects hinder certain biological macromolecules from 
being structurally described. Membrane proteins are in general hard to access, as the 
biological membrane needs to be reconstituted for sample stability. However, development 
of nanodiscs enables EM to visualize membrane proteins as single particles (Hauer et al. 
2015; Denisov and Sligar 2016; Sun and Gennis 2019).  
As a complementary method, SAXS still seems to be underestimated. The sample 
requirements are comparably low and despite the existing ambiguity in the well-known 
visualization of the results, SAXS can provide precious and precise information on 
molecular weight, particle size distribution and hence is suited to prove biomolecular 
complex formation.  
The term “integrative structural biology” describes the combination of all techniques 
mentioned above. Integrative structural biology generates synergistic effects by 
circumventing weaknesses and exploits strengths of NMR, X-ray crystallography, EM and 
SAXS. In the following section, the different methods are briefly introduced. 
1.3.1 X-ray crystallography 
Protein crystals show properties that are highly advantageous for high resolution data 
collection. In a crystal, the molecules pack in a large number into a three-dimensional 
arrangement, established by repetitive molecular contacts on the protein surface as 
indicated in figure 1.5. Therefore, compared to a single molecule, the signal to noise ratio 
for scattered light is much higher.  
 
Figure 1.5: The crystallographic unit cells. A crystal 
packs an arbitrary number of unit cells in a repetitive 
manner to form two-dimensional crystal plates and 
three-dimensional crystals. The cell is defined by the 




The diffraction itself results from destructive and constructive interferences, caused by the 
interaction of the X-ray beam with a repetitive pattern of molecules in crystals and is 
detectable to high diffraction angles, consequently leading to potential atomic resolution 
(Rupp, 2009). At the same time, crystallization itself causes one of the major restraints of 
this technique. A protein that gains its biological function from its flexibility is fixed in a solid 
state. Not every conformation is equally likely to crystallize and some conformations might 
not be depicted at all. Hence, a crystal structure is always a snapshot of a certain protein 
conformation. However, structural information is of high value in protein sciences and 
subsequent soaking experiments, structure guided mutagenesis and other experiments 
enable scientist to decipher molecular reaction mechanisms (Buck, 2003).  
Crystal growth is most commonly achieved in a vapor diffusion experiment. Here, small 
volumes of a protein solution are mixed with equal volumes of a precipitation solution. 
Common precipitants are high concentrations of salt, alcohol or polymers such as 
polyethylene glycol (PEG) that decrease protein solubility. In many cases, the pH of the 
precipitation formula is kept constant by the addition of an organic buffer compound. 
Certain reagents that can be essential in small amounts for crystallization are referred to 
as additives. The mixed droplet is placed in a sitting well, next to a reservoir well that holds 
the precipitation solution in a large excess. The whole entity is sealed and vapor diffusion 
occurs, meaning that water evaporates from the droplet and condenses in the reservoir, 
due to dilution of the precipitant in the crystallization droplet. This behavior increases 
protein and precipitant concentration slowly but gradually. In case of matching conditions, 
eventually protein crystals may grow from the solution as solubility limit of the protein is 














Figure 1.6: Bragg’s Law. Diffraction of X-rays by a crystal. A) The crystallographic unit cell generates a reciprocal 
lattice which generates lattice planes (red, blue and green triangles). B) Lattice planes are exemplified by (hkl) 
equals (111), (222) and (333). The distance d between lattice plains correlates with achievable resolution from 
crystal diffraction. C) Two identical X-rays (orange wave) diffracted by reciprocal lattice planes (black). The travel 
distance difference is defined by 2dsin(ϴ) and generates a phase shift between the X-rays. When 2dsin(ϴ) is an 
integer of λ, Bragg’s Law is fulfilled and constructive interference of the waves occurs, resulting in a detectable 
diffraction spot. The scattering vector S (blue) is defined by the vector difference of s and s0 (red). 
 
As finding the correct crystallization condition is a unique procedure for every protein and 
may be elaborate, protein crystallization is usually performed in a 3 x 96-well format and 
with machine support.  
Crystals are flash frozen in liquid nitrogen (LN2) after addition of cryo-protectants that 
promote vitrification. Data collection is performed by X-ray exposure. The crystal is rotated 
in the beam to project all reflections possible on a detector. Diffraction occurs when 





Figure 1.7: Ewald’s sphere. The illustration shows how the Ewald’s sphere is defined by a radius of 1/λ. With its 
origin in (000) it illustrates that diffraction occurs when reciprocal lattice points meet the shell of the sphere. 
Such events are highlighted with red circles. Scattering of the incident beam s0 results in scattered vectors s 
(red). The vector difference S (blue) is unique for each reflection, captured on a detector. The detector collects 
position and intensity of each individual spot by rotation of the crystal in the X-ray beam.  
 
Rotating the crystal in the beam during data collection, causes temporary and angle 
dependent reflection detection. The occurrence of reflections can be understood by the 
implementation of the Ewald’s sphere with a radius of 1/λ and an origin in the crystal center. 
When a lattice point of the reciprocal lattice touches the Ewald’s sphere, a reflection is 
observed (see figure 1.7).  
The collected data is then forwarded to data processing. In a first step, the data is indexed. 
Here, the diffraction angles and relative positions of reflections to each other are 
determined. From mirror symmetries in the diffraction pattern, the rotational symmetry in 
the crystal and hence the space group can be determined. The distance of diffraction spots 
in h/k/l-directions corresponds to the inverse of the unit cell lengths a/b/c. Therefore, 
reflections that lie close together in h-direction correspond to a long unit cell axis in a-
direction. This way, the unit cell parameters a/b/c and α/β/γ are determined. Systematic 
absences of reflections, where the structure factor is zero, indicate the presence of a screw 
axis, a combination of rotation and translation, projecting two molecules on each other.  
The subsequent integration step determines spot intensities I(hkl), necessary for structure 
determination. I(hkl) is proportional to |F(hkl)|2. However, the phase information iφ(hkl) cannot 
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be recorded. This leads to the so-called crystallographic phase problem, which describes 
that the electron density in real space ρ(xyz) cannot be determined by the structure factor 
equation (x), as the phase and the density are two variables that are missing. 
𝜌(𝑥𝑦𝑧) =  
1
𝑉
∑ ∑ ∑ |𝐹(ℎ𝑘𝑙)|
𝑙𝑘ℎ
𝑒𝑥𝑝[−2𝜋𝑖(ℎ𝑥 + 𝑘𝑦 + 𝑙𝑧) + 𝑖𝜑(ℎ𝑘𝑙)] 
(3) 
Transformation of waves with phase and amplitude information are converted to the 
complex number system. Here, the wave amplitude is represented by the absolute value 
and the phase is given as the angle of a vector. This procedure makes wave addition 
easier and intuitively possible by vector addition. The structure factor F(hkl) is a complex 
number and can therefore be simplified by illustration in an Argand diagram, as shown in 
figure 1.8 (Rupp, 2009).  
𝐹(ℎ𝑘𝑙) = 𝐴 + 𝑖𝐵 (4) 
where the measured value |F| is 
|𝐹| = √𝐴2 + 𝐵2 (5) 
and 
𝐴 = |𝐹|𝑐𝑜𝑠𝛷 (6) 
and 
𝐵 = |𝐹|𝑠𝑖𝑛𝛷 (7) 
 
 
Figure 1.8: Argand-diagram. Complex numbers can be 
illustrated as a vector with an amplitude and a rotation 
angle. In X-ray crystallography, the amplitude 
correlates with measured spot intensity. The rotation 
angle represents the phase. 
 
The aim is to determine Φ(hkl), which can be achieved by molecular replacement (MR) or 
experimental phasing. For MR a homologous structure must be available. By rotational 
and translational functions, model molecules will be fit in the asymmetric unit (ASU) in an 
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estimated number. When experimental and theoretical structure factors converge, phases 
from the model can be used (Rupp, 2009). 
If MR fails, due to a missing model or other crystallographic issues, experimental phasing 
offers another option to determine crystallographic phases. Here, anomalous scatterers, 
such as heavy metals, are incorporated into the crystal and a dataset is recorded exploiting 
scattering differences for phase determination as shown in figure 1.9 (Rupp, 2009). 
 
 
Figure 1.9: Structure factors. In native data collection 
the structure factor amplitudes for protein (P) are 
symmetrical. Therefore, the values for FP+ and FP- are 
equal (Friedel pairs). Upon incorporation of heavy 
metal scatterers (H), the symmetrical, native structure 
factor amplitudes for FP+ and FP- are modified by the 
anomalous atomic scattering factors f’ and Δf’’. This 
results in structure factor amplitudes FPH+ and FPH-, 
which are unequal in value. The structure factor 
difference can be used to determine phases 
experimentally. 
 
Once initial phases for a dataset are obtained, model refinement aims at lowering the 
difference for observed structure factors to model-based calculated structure factors. 
Evaluation includes electron density interpretation, peptide bond angles for structural 
elements or rotamer conformations, among others.  
1.3.2 NMR spectroscopy 
NMR spectroscopy is another technique of structural biology with its own strengths and 
weaknesses. In a static magnetic field, NMR sensitive nuclei find preferred z-orientation. 
This behavior is called the Zeeman effect. When a second magnetic field is applied with 
an oscillation equal to the nuclei’s Larmor frequency and perpendicularly to the static field, 
a reorientation to the x,y-plane is enforced. This magnetic field is applied in pulses of 
varying lengths. When the pulse is switched off, the nuclei fall back to their initial state and 
the emitted signal, which depends on the chemical environment of each single atom, can 
be recorded by the free induction decay (FID). To be NMR-sensitive, the quantum spin 
number of the atom may not equal zero, which is dependent on the number of protons and 
neutrons in the atomic core. The most relevant examples for the spin number in proteins 




Table 1.1: Selection of elements and their accessibility for NMR spectroscopy.  
 
 Isotope Spin I Natural abundance (%)  
 1H ½ 99.98  
 2H 1 0.016  
 12C 0 98.9  
 13C ½ 1.108  
 14N 1 99.63  
 15N ½ 0.37  
 
The Nuclear Overhauser Effect (NOE) arises from inter-atomic interactions and is 
detectable for atoms with an average distance of up to 5 - 6 Å (Markwick et al., 2008). The 
chemical shift for an atom depends on its environment, which is why, for example, a 
differentiation between backbone protons of helices and sheets becomes possible (Case, 
1998; Wishart et al., 2002). Unlike crystallography, each chemical shift signal contains 
information on only one nucleus, making this technique meaningful for direct interaction 
studies. Visual comparison of apo- and holo-spectra enables identification of residues that 
show a chemical shift upon interaction with another molecule or a change in the 
environment. NMR spectroscopy is usually performed in solution, minimizing preparation 
time and costs.  
A 1D 1H NMR spectroscopy, performed as shown in figure 1.10, depicts a quick validation 
of sample quality, giving information on protein size, oligomerization and protein stability.  
 
Figure 1.10: Pulse sequence for 1D proton NMR 
spectroscopy measurement. After a recycle delay, a 
90° pulse is applied. The detector senses maximal 
signal during the FID.  
Due to the large number of coupling protons in a protein, a simple 1D proton spectrum 
results in an extremely complex spectrum where single signals cannot be assigned to their 
originating protons. However, this experiment is an essential component of NMR studies 
and is typically performed in an early stage of a project, as the peak width already provides 
precious information on the sample quality and the protein oligomerization state. 
A more comprehensive method is multidimensional NMR spectroscopy. Typical 2D 
experiments show a more complex pulse-sequence, shown in figure 1.11. Usually, they 
consist of a first preparation pulse, followed by an evolution time t1 and a second mixing 
pulse, followed by data acquisition time t2. Correlated spectroscopy (COSY), nuclear 
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Overhauser enhancement spectroscopy (NOESY) and total correlation spectroscopy 
(TOCSY) are typical 2D experiments that do not require heteronuclear labelling. HSQC, 
the so-called protein fingerprint, requires 15N-labelling.  
 
Figure 1.11: Pulse sequence for 2D 
HSQC NMR spectroscopy 
measurement. 1H and 15N 
experiments are performed 
iteratively.  
The globally optimized alternating phase rectangular pulse (GARP) is used for efficient 
decoupling of certain nuclei. Therewith, spectra complexity is drastically reduced and the 
results become interpretable. Successful data collection allows signal assignment to 
individual residues, a non-trivial task. However, automated assignment and structure 
determination was developed during recent years, potentially enhancing the availability of 
NMR spectroscopy to a broader range of researchers (Meiler et al., 2003).  
Besides costly and time-consuming 15N or 13C labelling procedures, one main difficulty in 
NMR-based structural biology is the size limitations to smaller molecules. The relaxation, 
base for signal detection, occurs with enhanced speed by increasing size of the molecule. 
This shortens the acquisition time and leads to broader and more overlapping signals. 
However, increasing magnetic strength widens the capable spectrum of protein size and 
until recently, useful data on proteins as big as 70 kDa could successfully be recorded (Xu 
et al., 2006; Purslow et al., 2020). 
Data acquisition is usually performed between 20°C and 30°C in a liquid environment. This 
enables NMR spectroscopy to study molecular dynamics, folding or unfolding of a sample 
and the direct interaction of target proteins to ligands. Further, circumventing poor 
crystallization behavior of a high number of disordered or flexible proteins fully justifies 
costly and laborious sample preparation.  
1.3.3 Small angle X-ray scattering 
Small angle X-ray scattering (SAXS) provides a relatively easily accessible method to 
determine a trustworthy value for the MW of a protein in both, batch mode and online mode 
when coupled to a SEC system.  
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SAXS is the measurement of scattering differences between the target solubilized in buffer 
and the buffer itself. Scattering angles and intensities are low, as the interaction of light 
and matter is not constructively enhanced like in crystallography. Thus, the background 
scattering should be kept at a low level to yield a reliable scattering profile for the target 
after data subtraction. High concentrations of additives such as PEG or glycerol should be 
avoided, just as high concentrations of salt. The background buffer must match the sample 
buffer down to the smallest detail, which is why sample dialysis must be performed after a 
protein concentration step for a batch measurement. In SEC-SAXS, a section from the 
scattering profile before elution of any material is adducted for background subtraction. 
The experimental setup is shown in figure 1.12. An X-ray beam passes a sample in a flow 
cell. A light scattering detector is placed behind the flow cell. Due to small scattering 
angles, the distance from the cell to the detector is much larger, compared to a 
crystallographic diffraction experiment. As the molecules are randomly oriented in solution, 
the scattering intensity over the scattering angle is recorded. Distinct diffraction spots 
cannot be observed, as a crystallographic lattice and therefore wave interference is 
missing. 
 
Figure 1.12: Experimental setup SAXS experiments. The incident X-ray beam is scattered by passing the sample. 
Angle-dependent scattering intensities are detected. The scattering curve is further processed.  
 
The averaged and subtracted scattering curve provides information of particle size and 
shape. The size of a scattering particle is determined from the Guinier analysis. In analogy 
to MALS, described in chapter 3.6.5, the radius of gyration Rg is determined from the 
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intensity of scattered light at low scattering angles. In SAXS, the number of data points is 
much larger than in MALS, due to usage of a detector plate, for example the PILATUS3 X 
2M (Dectris, Baden-Daettwil, Switzerland), a hybrid photon counting detector with almost 
2.5 megapixels, which collects intensities over a wide range of small X-ray scattering 
angles. When presenting the data as a Guinier plot with ln(Is) over s2, where s is the 
scattering vector, dependent on the scattering angle 2ϴ and the wavelength λ, 





a linear range in the low angle scattering region is suitable for interpolation of the intensity 
of the scattered beam at an angle equal zero, I0.  











The distance distribution describes the probability p of finding a point, for example. an 
atom, with a distance r to any other point in the system, dependent on the intensity I and 
the scattering vector s. 








Plotting p(r) over r provides the pair distance distribution function (PDDF) allows 





Figure 1.13: SAXS profile and pair distance distribution function. Both diagram depend on the scatterers size 
and shape (adopted from Svergun & Koch, 2003). 
 
The r-value at the point at which the PDDF converges to zero is used to determine the 
maximal diameter Dmax of the scatterer. Dmax depicts an important value for validation of 
complementary experiments and is also used for MW estimations. Further, the PDDF 
serves for the generation of a 3D bead model, where the beads represent hypothetical 
single scattering points. The model results in a low-resolution envelope, which is generated 
to fit the experimental data as closely as possible. This envelop can give precious 
information on shape, oligomerization state and complex assembly of proteins which are 
inaccessible for crystallization or other structural biology techniques, especially when 
partial substructures are available (Pauw, 2013).  
Untrustworthy data can quickly lead to misleading interpretations when collected on 
samples of poor quality. Therefore, it is of crucial importance to prepare samples carefully 
and to pay attention to measurement requirements. Inhomogeneous particle size 
distribution due to agglomeration, degradation or a dynamic oligomerization equilibrium 
will result in signal overlap and an averaged scattering profile, making a useful data 
interpretation impossible. Hence, a high homogeneity and protein stability is required for 
batch measurements. Targets that show agglomeration upon thawing, a dynamic 
oligomerization equilibrium or other peculiarities, should be considered to be tested in a 
more time consuming SEC-SAXS mode (Pauw, 2013).  
1.3.4 Electron microscopy 
Hans Busch was the first to use electromagnetic lenses to influence a beam of electrons. 
With this knowledge, electron microscopy (EM) was developed more than 80 years ago 
by Ernst Ruska (Ruska, 1987). Since then, the technique developed rapidly and generated 
a set of variations, like transmission EM, electron tomography or electron scattering. Within 
the last years this field was opened to structural biologists, offering new perspectives on 
proteins that could not be studied in their structure before. EM is the only method in 
structural biology that delivers direct images of the sample. 
A suitable source produces electrons that are accelerated in an electromagnetic field and 
used to display an image of a specimen. As electrons cannot be redirected by classical 
lenses like optical light, solenoids are used that generate tunable electromagnetic fields, 
suitable to take influence on the electrons speed and course. When the electrons hit the 
specimen, they are scattered elastically and inelastically. Solenoids will refocus the 
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scattered electrons that will be detected by a CCD or CMOS camera, whose development 
mainly contributed to the generation of sharper images. 
Confining on proteinogenic samples, transmission EM (TEM) is widely used, where the 
electrons pass through the specimen. Conventional negative stain TEM is used to achieve 
low resolution information, typically limited to around 20 Å for decent sample quality. Here, 
the proteins are blotted on a grid and embedded in a layer of heavy metal salts, such as 
uranyl acetate, ammonium molybdate or phosphotungstate to enhance the contrast 
between background and protein. The specimen must be dried, as residual water would 
evaporate in the vacuum and destroy the specimen. The main drawbacks of negative stain 
TEM are rooted in the sample preparation itself. Heavy metal ions are prone to react with 
proteinogenic side chains such as cysteines and may cause denaturation. Further, water 
withdrawal and the prevailing low pH that is necessary for the most common negative stain 
reagents must be tolerated by the sample. Hence, sample stability depicts the major issue 
in negative stain TEM. On the other hand, the high contrast enables data acquisition at 
smaller and cheaper instruments compared to cryo-EM and sample preparation and 
storage is kept at an economical level. Occasionally, negative stain TEM data serves as a 
proof of principle and a pre-stage of cryo-EM. 
The idea of embedding a target in a layer of vitrified ice is as old as EM itself and is referred 
to as cryo-EM (Dubochet et al., 1985, 1987). Referring to proteinogenic targets, the clear 
advantage in comparison to negative stain TEM lies in the presence of vitrified water. This 
way the protein can be kept in a native-like environment with optimized buffer conditions 
and the hydration shell is preserved, stabilizing the sample. While advantageous for 
protein stability, the very same procedure causes extremely low contrast, as the electron 
density for proteins and surrounding buffer differ only slightly. Hence, cryo-EM can only be 
performed with large microscopes with 200 or 300 keV acceleration voltage and sensitive 
cameras.  
Within the last years, the MW limit of addressable proteins was lowered continuously from 
the megadalton size range down to a few hundred kilodalton. Simultaneously, achieved 
resolutions improved quickly. Mostly, these improvements are based on the development 
of direct single electron detectors, providing smaller pixel size and higher sensitivity. Also, 
processing algorithms improved, exploiting eventual symmetries or differentiating between 
several conformational states. The vast development in cryo-EM map quality is referred to 
as the “resolution revolution” (Kühlbrandt, 2014).  
However, trustworthy resolution determination in EM remains difficult. Most commonly the 
Fourier Space Correlation (FSC) is used, comparing two individually refined maps from 
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the same dataset. Applied thresholds for resolution determination have encountered 
various changes. While in early studies, an FCS value of 0.143 was considered to 
determine the resolution, its value had been raised to 0.5 in more recent studies (Afonine 
et al., 2018). 
The biggest strength of cryo-EM lies in the possibility to encounter large protein complexes 
which are highly unlikely to crystallize. Intrinsic flexibility does not hinder reconstructions 
per se, however final resolution may suffer. In the nearer future, cryo-EM could potentially 
be used to circumvent difficult crystallization of medium-sized proteins, classified as non-
crystallizable. The development of nanodiscs even enabled the visualization of membrane-
incorporated proteins (Hauer et al., 2015). However, specimen preparation can be time 
consuming and costly and even exceed laboratory efforts required for crystallization. 
The most prominent hurdle in cryo-EM is described by a poor reproducibility of blotting 
procedures, despite sophisticated automatization techniques. The ice thickness has a 
strong influence on sample quality. Thicker ice causes higher background and lower 
contrast, impeding successful data acquisition. On the other hand, a layer too thin leads 
to protein denaturation at the air-water-interface. At the same time, particles should not 
overlap and be distributed equally in randomized orientations (Drulyte et al., 2018). A 
common cause of reduced data quality is a preferred sample orientation, presumably due 
to interactions at the air-water-interface. Preferred particle orientations can be addressed 
by tilting the specimen or supplementation of detergents (Zi Tan et al., 2017).  
Initial particle picking is performed manually and hence may introduce a bias. It clearly 
requires scientific experience. Subsequent automated particle picking results typically in 
several hundred thousand or million single particles, which are averaged and used for a 
3D reconstruction. However, a large number of particles may be excluded from 
calculations, if not fitting to averaged classes. Still, all particles present in the sample 
potentially present relevant biological conformations. Experimental approaches are used 
frequently to favor certain conformations in order to reduce computing efforts. Typically, 
small molecules known to interact with the target or their derivatives are added to capture 
different states of the target (Scheres, 2016). Beside additive screening, flexibility and 
stability of the target can further be decreased by introducing crosslinks prior to or during 
an additional separation step (Stark, 2010; Adamus et al., 2019). However, data 
interpretation of crosslinked samples must be taken with caution, as the created complex 
may be artificial and the biological relevance may not be given. 
The immense efforts, on the other side, are countered by implementation of automated 
processes. Those are realized in the laboratory routines by automated blotting procedures 
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or support data analysis, for example by e pluribus unum (EPU) workflows. In general, 
data acquisition covers a range of defoci for higher contrast and images that are corrected 




2 Research Objectives 
In the recent past, a spirit of optimism has emerged in almost all fields of biology. Many 
developments in the field of cryo-EM have opened new perspectives for the study of large 
protein complexes and cellular machineries, recalling their long-known but nevertheless 
neglected importance in biological studies. The study of new emerging infectious diseases 
demands an integrative approach in structural biology, which includes techniques such as 
NMR spectroscopy, X-ray crystallography, SAXS and cryo-EM combined with biochemical 
characterization. This has helped to generate synergy in experimental outcomes for the 
most pertinent questions in infection biology, some of which being: How do pathogens 
infect humans? How to mitigate different courses of disease? Can science offer 
contemporary agents against emerging antibiotic resistances? 
Within a rapidly changing world, novel threats for human health emerge. Especially in 
developed countries, where antibiotic doses are prescribed recklessly and personal 
responsibility of patients is low, antibiotic resistances are a common issue. Of particular 
importance are nosocomial infections caused by opportunistic pathogens turning into a 
dangerous complication for patients with a compromised immune system, as it occurs after 
surgeries or application of broad-spectrum antibiotics. One important example is the 
opportunistic pathogen Clostridioides difficile. This microbe has the exceptional ability to 
adapt and annihilate microbial gut flora in humans. Its ability to overgrow and dominate 
the intestinal microbiota is mainly linked to the clostridia-specific Stickland fermentation 
and the main cause of antibiotic associated diarrhea and severe colon inflammation. This 
pathway uses amino acids as a source of carbon and energy and is an important regulatory 
mechanism for sporulation and toxin production. It is therefore of immense importance for 
C. difficile and its toxicity, but has been insufficiently investigated until now. An 
indispensable component of this pathway is the proline reductase complex, which forms a 
high molecular weight complex assembled from smaller subunits (PrdAα, PrdAβ and 
PrdB). This attribute makes it an attractive target for an integrative structural biology 
approach. A deeper understanding of the structural composition of the proline reductase 
complex can potentially provide innovative targets for treatment of C. difficile infection. 
Thus, the subunits PrdAα, PrdAβ and PrdB of C. difficile proline reductase were 
investigated using a broad spectrum of structural biology techniques, such as negative 
stain TEM and cryo-EM. 
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Apart from hospital-acquired infections, new modes of airborne infections occurred within 
the last decades that are spread by man-made facilities. A pathogen causing such 
infections is pneumonia-causing Legionella pneumophila, which gained notoriety since its 
first recorded outbreak in 1976. Since then, yearly numbers have increased slowly but 
steadily. Climate change and increasing use of air conditioners seem to be the main 
possible reasons for yearly spikes in such infections. L. pneumophila adapts to a 
replicative state inside human lung macrophages by modulating their immediate 
microenvironment. Among other factors, this is enabled by a number of phospholipases, 
depicting highly potent virulence factors that affect host cell membrane integrity and 
release secondary messengers. 
One example of such a phospholipase expressed and secreted in L. pneumophila during 
its infection cycle is PlaA. While its exact role in the pathogen’s lifecycle remains unclear, 
it has been shown that PlaA must undergo proteolytic maturation, carried out by another, 
also secreted, effector protein, ProA. Thus, it is an important event and protein X-ray 
crystallography was used in this study to investigate the influence of the maturation of PlaA 
on the protein structure and the role of a disulfide bond in its enzymatic activity.  
Another phospholipase, exhibiting the most prominent PLA activity, is PlaB, which shows 
interesting properties in terms of its localization, oligomerization and regulation. The origin 
for PlaB’s unusual properties is thought to be encoded in its uncharacterized C-terminal 
domain. In this thesis, the structural characterization of PlaB was addressed by X-ray 
crystallography, paired with biochemical characterization and structure-guided 
mutagenesis with the aim to increase understanding of its unique properties in regulation 
and its role in L. pneumophila pathogenicity. 
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3 Material & Methods 
All chemicals, unless stated differently, were ordered in their highest purity from Abcam 
(Cambridge, UK), Agilent (Santa Clara, California, USA), Beckman Coulter (Brea, 
California, USA), Bio-Rad Laboratories (Hercules, California, USA), Biozym Scientific 
(Hessisch Oldendorf, Germany), Carl Roth (Karlsruhe, Germany), Macherey-Nagel 
(Düren, Germany), Merck KGaA (Darmstadt, Germany), New England Biolabs (Ipswich, 
Massachusetts, USA), Omnilab (Bremen, Germany), Promega (Madison, Wisconsin, 
USA), Qiagen (Venlo, The Netherlands), Sigma Aldrich (St. Louis, Missouri, USA), Thermo 
Fisher Scientific (Waltham, Massachusetts, USA), Th. Geyer (Höxter, Germany) or VWR 
International (Radnor, Pennsylvania, USA). 
3.1 Buffers & Solutions 
Unless stated differently, solutions were prepared with ultra-pure water. Solubilized 
antibiotics were sterile filtered (0.22 µM) unless dissolved in ethanol. Cell culture media 
were autoclaved or sterile filtered (0.22 µM) if heat labile compounds were present. Protein 
buffers were filtered (0.45 µM) and degassed, buffers for MALS experiments and heat 
labile compounds were sterile filtered (0.22 µM). 
Antibiotics (1000X) 
    Ampicillin 100 mg/mL 
    Chloramphenicol 34 mg/mL in 70% EtOH 
    Kanamycin 30 mg/mL 
Special cell culture media 
CDMM Stock solutions (for 1 l) Final concentration 
 100 mL of 10X Salt mix  
 50 g/L Na2HPO4 
20 g/L NaH2PO4 
9 g/L KH2PO4 
9 g/L NaCl 
pH 7.0 
35.2 mM Na2HPO4 
16.7 mM NaH2PO4 
6.6 mM KH2PO4 
15.4 mM NaCl 
pH 7.0 
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 200 mL of 5X Casamino acid mix 
 50 g/L Casamino acids 
2.5 g/L L-L-cystein 
0.5 g/L L-tryptophane 
0.5 g/L L-proline 
5 g/L Casamino acids 
2.0 mM L-L-cystein 
0.2 mM L-tryptophane 
0.4 mM L-proline 
sterile filtered 
   
 10 mL of 100X Trace elements 
 4 g/L (NH4)2SO4 
2.6 g/L CaCl2 – 2 H2O 
2 g/L MgCl2 - 6 H2O 
1 g/L MnCl2 - 4 H2O 
0.1 g/L CoCl2 - 6 H2O 
0.015 g/L NaHSeO3 
3.0 mM (NH4)2SO4 
2.0 mM CaCl2 – 2 H2O 
1.0 mM MgCl2 - 6 H2O 
0.5 mM MnCl2 - 4 H2O 
42 µM CoCl2 - 6 H2O 
9.9 µM NaHSeO3 
   
 2 mL of 500X Ironsulfate  
 2 g/L FeSO4 – 7 H2O 0.7 mM FeSO4 – 7 H2O 
   
 5 mL of 200X Vitamins  
 0.06 g/L D-biotin 
0.2 g/L Ca-D-pantothenate 
0.2 g/L pyridoxin 
245 µM D-biotin 
91 µM Ca-D-pantothenate 
118 µM pyridoxin 
sterile filtered  
   
 10 mL of 20% Glucose  
 200 g/L glucose 11.1 mM (0.2%) glucose, sterile 
filtered 
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M9MM Stock solutions (for 1 l) Final concentration 
 100 mL 10X M9 Salt 
Solution 
 
 75.2 g/L Na2HPO4 – 2 H2O 
30 g/L KH2PO4 
5 g/L NaCl 
pH 7.2 
4.21 mMol/L Na2HPO4-2 H2O 
22.04 mMol/L KH2PO4 
8.55 mMol/L NaCl 
pH 7.2 
   
 10 mL 100X Trace Elements  
 5 g/L EDTA 
0.83 g/L FeCl3 - 6 H2O 
84 mg/L ZnCl2 
13 mg/L CuCl2 – 2 H2O 
10 mg/L CoCl2 – 6 H2O 
10 mg/L H3BO3 
1.6 mg/L MnCl2 – 4 H2O 
pH 7.5 
0.134 mM EDTA 
0.031 mM FeCl3 – 6 H2O 
6.2 μM ZnCl2 
0.76 μM CuCl2 – 2 H2O 
0.42 μM CoCl2 – 6 H2O 
1.62 μM H3BO3 
0.081 μM MnCl2 – 4 H2O 
pH 7.5 
 Additives  
 1 g NH4Cl 1 g/L NH4Cl, sterile filtered 
 20 mL 20% Glucose 22.2 mM (0.4%) Glucose, sterile 
filtered 
 0.5 mL 2M MgSO4 1 mM MgSO4 
 0.3 mL 1M CaCl2 0.3 mM CaCl2 
 1.0 mL 1 mg/mL biotin 1 mg/L biotin, sterile filtered 
 1.0 mL 1 mg/mL thiamin 1 mg/L thiamin, sterile filtered 
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Common cell culture media 
LB medium 10 g/L tryptone, 5 g/L yeast extract, 7 g/L NaCl 
LB agar 10 g/L tryptone, 5 g/L yeast extract. 7 g/L NaCl, 16 g/L agar 
SOB medium 20 g/L tryptone, 5 g/L yeast extract, 0.5 g/L NaCl, 2.5 mM KCl, 
10 mM MgCl2, adjust with NaOH to pH 7.5 
SOC medium 20 g/L tryptone, 5 g/L yeast extract, 0.5 g/L NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 20 mM glucose, adjust with NaOH to pH 7.5 
TB medium 12 g/L tryptone, 24 g/L yeast extract, 4 % (v/v) glycerol 
10X TB buffer 23.13 g/L KH2PO4, 125.41 g/L K2HPO4 
IPTG stock  1 M IPTG 
 
Protein purification buffers 
DNase stock solution 1 mg/mL DNase I 
PrdA lysis buffer 50 mM HEPES pH 8, 500 mM NaCl, 10 mM Imidazole, 
5 mM BME, DNase I, cOmplete™ EDTA-free Protease 
Inhibitor Cocktail 
PrdA wash buffer 50 mM HEPES pH 8, 200 mM NaCl, 10 mM imidazole, 
5 mM BME 
PrdA Ni-NTA elution 
buffer 
50 mM HEPES pH 8, 200 mM NaCl, 5 mM BME, 
300 mM imidazole 
PrdA SEC buffer 20 mM HEPES pH 8, 200 mM NaCl, 1 mM DTT 
PrdB lysis buffer DNase I, cOmplete™ EDTA-free Protease Inhibitor Cocktail 
PrdB wash buffer 50 mM HEPES pH 8, 200 mM NaCl, 5 mM BME 
PrdB Ni-NTA elution 
buffer 
50 mM HEPES pH 8, 200 mM NaCl, 5 mM BME, 300 mM 
imidazole 
PrdB Strep elution buffer 20 mM HEPES pH 8, 200 mM NaCl, 1 mM DTT, 8 mM 
d-desthiobiotin 
PrdB storage buffer 20 mM KH2PO4/K2HPO4 pH 8, 100 mM NaCl 
PR lysis buffer 50 mM HEPES pH 8.0, 1 mM DTT, 1 mg/mL lysozyme, 
DNase I, cOmplete™ EDTA-free Protease Inhibitor Cocktail 
PR precipitation buffer 50 mM HEPES pH 8.0, 1 mM DTT, 2 M (NH4)2SO4 
PR HIC buffer A 50 mM HEPES pH 8.0, 1 mM DTT, 5% (v/v) ethyleneglycol 
PR HIC buffer B 50 mM HEPES pH 8.0, 1 mM DTT, 1 M (NH4)2SO4 
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PR IEX buffer A 50 mM HEPES pH 8.0, 1 mM DTT 
PR IEX buffer B 50 mM HEPES pH 8.0, 1 mM DTT, 1 M KCl 
PR SEC-MALS buffer 50 mM HEPES pH 8.0, 1 mM DTT, 150 mM KCl 
PlaA SEC buffer 20 mM Tris pH 8, 150 mM NaCl, 1 mM DTT 
PlaB lysis buffer 50 mM HEPES pH 8, 200 mM NaCl, 1 mM DTT, DNase I, 
cOmplete™ EDTA-free Protease Inhibitor Cocktail 
PlaB wash buffer 50 mM HEPES pH 8, 200 mM NaCl, 1 mM DTT 
PlaB Strep elution buffer 50 mM HEPES pH 8, 200 mM NaCl, 1 mM DTT, 
8 mM d-desthiobiotin 
PlaB SEC buffer 20 mM HEPES pH 8, 150 mM NaCl, 1 mM DTT 
 
Bioanalytical application buffers 
Western Blot buffer 25 mM TRIS pH 8.3, 152 mM glycine, 15 % (v/v) MeOH 
8X SDS PAGE loading 
buffer, reducing 
10 mM Tris/HCl pH 6.8, 3 mM bromophenol blue, 7 % (v/v) 
SDS, 20 % (v/v) glycerol, 3.5 % (v/v) β-mercaptoethanol 
50X TAE buffer 2 M Tris/base, 1 M acetic acid, 50 mM EDTA, adjust to 
pH 8.5 
TEV storage buffer 50 mM Tris/HCl, pH 7.5, 1 mM EDTA, 5 mM DTT, 
50% (v/v) glycerol 
TFB1 30 mM K-acetate, 100 mM RbCl2, 10 mM CaCl2, 50 mM 
MnCl2, 15 % (v/v) glycerol, pH 5.8 
TFB2 10 mM MOPS, 75 mM CaCl2, 10 mM RbCl2, 15% (v/v) 
glycerol, pH 6.5 
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3.2 Bacterial strains 
All E. coli strains were stored as glycerol stocks at -80°C. Clostridiodes difficile 630Δerm 
was cultured at the BRICS, TU Braunschweig.  
Table 3.1: E. coli strains used in this thesis. The different strains were used for DNA production (marked with *) 
or protein expression (marked with **) 
 
E. coli strain Genotype Reference 
DH5α *  F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG purB20 φ80dlacZΔM15 
Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ– 
(Grant et al., 1990) 
BL21(DE3) ** E. coli str. B F– ompT gal dcm lon 
hsdSB(rB-mB-) λ(DE3 [lacI lacUV5-T7p07 
ind1 sam7 nin5]) [malB+]K-12(λS) 
(Studier et al., 1986) 
BL21(DE3) pLysS ** F–, ompT, hsdSB (rB–, mB–), dcm, gal, 
λ(DE3), pLysS, Cmr. 
(Davanloo et al., 
1984) 
Top10 * F– mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15ΔlacX74 recA1 araD139 
Δ(ara leu) 7697 galU galKrpsL (StrR) 
endA1 nupG  
(Durfee et al., 2008) 
XL21 blue * F´ proAB lacIqZΔM15 Tn10 Tetr/ recA1 





OmniMAX2 * F´ {proAB lacIq lacZΔM15 Tn10(TetR ) 
Δ(ccdAB)} mcrA Δ(mrr hsdRMS-mcrBC) 
Φ80(lacZ)ΔM15 Δ(lacZYA-argF)U169 
endA1 recA1 supE44 thi-1 gyrA96 relA1 
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3.3 Kits and Screens 
Kits for molecular biology purposes, listed below, were used following the corresponding 
manual. 
Limited proteolysis Hampton Research, Aliso Viejo, California, USA 
QIAprep MiniPrep QIAGEN, Venlo, The Netherlands 
QIAquick PCR Purification 
Kit 
QIAGEN, Venlo, The Netherlands 
QIAquick Gel Extraction Kit QIAGEN, Venlo, The Netherlands 
RUBIC additive screen Molecular Dimensions Limited, Sheffield, Great Britain 
Limited, Sheffield, Great Britain 
Single conditions from crystallization screens were mixed 1:1 with protein solution in a 
sitting drop vapor diffusion experiment. Additive screens were mixed in a 1:10 ratio with a 
stock of a prepared reservoir solution prior to mixing with protein solution. Detailed 
description of protein crystallization is given in chapter 3.7.1. Crystallization screens used 
in the presented projects are listed below.  
Additive Screen HT  Hampton Research, Aliso Viejo, California, USA  
ComPAS  QIAGEN, Venlo, The Netherlands  
Index HT  Hampton Research, Aliso Viejo, California, USA  
JCSG Core Suite I - IV QIAGEN, Venlo, The Netherlands  
JCSG+  QIAGEN, Venlo, The Netherlands  
Mb Class II  QIAGEN, Venlo, The Netherlands  
MIDAS™ HT-96  Molecular Dimensions Limited, Sheffield, Great Britain  
Morpheus® HT-96  Molecular Dimensions Limited, Sheffield, Great Britain  
Morpheus® II  Molecular Dimensions Limited, Sheffield, Great Britain  
PACT Suite  QIAGEN, Venlo, The Netherlands  
PGA-LM HT-96  Molecular Dimensions Limited, Sheffield, Great Britain  
Protein Complex Suite  QIAGEN, Venlo, The Netherlands  
Silver Bullets  Hampton Research, Aliso Viejo, California, USA  
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3.4 General Methods in Molecular Biology 
Genes were cloned from Clostridioides diffcile 630Δerm genomic DNA (gDNA) provided 
by Dr. Meina Neumann-Schaal from the DSMZ.  
Antibiotics used in culture media or agarose plates were Ampicillin (Amp) at 100 µg/mL, 
Kanamycin (Kan) at 30 µg/mL, and Chloramphenicol (Cm) at 34 µg/mL. 
3.4.1 Generation of chemically competent E. coli cells 
Rubidium-competent cells were generated in 250 mL batches. Therefore, 250 mL of LB 
medium was inoculated with the E. coli strain desired and grown at 37°C and 130 rpm to 
an OD600 = 0.5. After reaching the OD, the culture was cooled down on ice for 10 minutes 
and spun down at 4°C, 3000 rpm for 5 minutes. Pelleted cells were resuspended in 100 mL 
of cold TFB1 and chilled on ice for 5 minutes. Cells were spun down at 4°C, 3000 rpm for 
5 minutes and resuspended in 10 mL of cold TFB2. The cell suspension was aliquoted to 
50 µL in pre-cooled reaction tubes and immediately flash frozen in LN2. Aliquots were 
stored at -80°C until further use. 
3.4.2 Agarose gel electrophoresis 
In order to verify PCR amplification, a DNA agarose gel electrophoreses was carried out. 
In detail, 2.4 g of agarose were added to 300 mL of 1X TAE buffer, pH 8 and heated until 
the agarose was dissolved to yield a 0.8% agarose TAE solution. The solution was cooled 
down to approximately 60°C. For DNA detection 10 µL Roti®-Safe GelStain (Carl Roth 
GmbH + Co.KG, Karlsruhe, Germany) was spread drop-wisely in the mini-gel caster (Bio-
Rad Laboratories, Hercules, California, USA) and the warm agarose TAE solution was 
added to the caster to a height of approximately 0.7 cm while Roti®-Safe GelStain was 
distributed equally in the gel. After letting the gel cool down, it was transferred to a Mini-
Sub Cell GT Horizontal Electrophoresis System, 7 x 7 cm (Bio-Rad Laboratories, Hercules, 
California, USA) and covered with TAE buffer. The comb was removed and up to 50 µL of 
sample could be applied. DNA markers used were SmartLadder (Eurogentec, Lüttich, 
Belgium) and GeneRuler™ DNA Ladder Mix (Thermo Fisher Scientific, Waltham, 
Massachusetts, USA), both applied with 5 µL. The gel was run for 30 minutes, applying 
100 V. 
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3.4.3 Primer Design and PCR 
Primer design was performed following a manual approach. Forward primers were 
determined by 5’ gene boundaries of interest. Melting temperature was adjusted by 
summing up AT pairs with 2°C and GC pairs with 4°C per base up to 66°C - 68°C for the 
coding area of the primer. A palindromic cleavage sequence was added at the 5’ end of 
the sequence depending on the desired restriction enzyme, together with an overhang to 
enhance cleavage efficiency. Reverse primers were generated equivalently, but cleavage 
site and overhang were added at the 3’ end before transforming the sequence to the 
reverse complement. Primers used during the project are listed in table S1. For PCR 
reactions, the single components were mixed and transferred to a PCR reaction tube as 
shown in table 3.2. 
Table 3.2: PCR ingredients. The PCR gene amplification was performed applying the shown pipetting scheme.  
 
 Volume for  





2X Phusion® High-Fidelity PCR Master Mix 12.5 µL 25 µL  
10 µM Primer fw 1.0 µL 2.0 µL 0.4 µM 
10 µL Primer rv 1.0 µL 2.0 µL 0.4 µM 
DNA template variable variable variable 
ddH2O ad 25 µL ad 50 µL  
 
PCR reactions for gDNA templates needed to be optimized with respect to the amount of 
introduced gDNA. Best results were achieved by using 1 µL of a gDNA stock with 10 ng/µL 
for a 25 µL reaction (final concentration 0.4 ng/µL). For plasmid DNA the final 
concentration varied between 28 ng/µL and 8 ng/µL. The PCR reaction was carried out 
with a PEQSTAR 2x / Gradient thermocycler (PEQLAB Biotechnologie GmbH, Munich, 
Germany) with settings shown in table 3.3. 
Site directed mutagenesis was performed by polymerase incomplete primer extension 
(PIPE) cloning, as described in the literature (Ho et al., 1989) 
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Table 3.3: PCR protocol. Standard protocol for gene amplification from gDNA and plasmids.  
 
Command Temperature Time 
 Heat lid to 110°C  
 Initial melting 95°C 3 min 
Open cycle   
35x 
   Denaturation 95°C 30 sec 
   Annealing 52°C 30 sec 
   Elongation 72°C 1 min 30 sec 
Close cycle   
 Complementation 72°C 10 min 
 Storage 4°C forever 
 
Certain PCR reactions like polymerase incomplete primer extension (PIPE) cloning, site-
directed mutagenesis or those reactions that did not lead to a single amplicon were 
repeated following a touch-down protocol adopted from the protocol given in table 3.2. 
Here, the annealing temperature was decreased from 65°C to 53°C within 7 cycles with 
an increment of 2°C per cycle. Subsequently, 25 cycles with an annealing temperature of 
52°C were queued before complementation.  
DNA amplicons were either purified by agarose gel electrophoresis as described in chapter 
3.4.1 and subsequent gel extraction using the QIAquick Gel Extraction Kit (QIAGEN, 
Venlo, Netherlands) or were isolated using QIAquick PCR Purification Kit (QIAGEN, Venlo, 
Netherlands) if PCR performance for a certain reaction was confirmed before. Purified 
DNA was stored at -20°C until further use. 
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3.4.4 DNA digestion 
Purified DNA was mixed with CutSmart® buffer (New England Biolabs, Ipswich, 
Massachusetts, USA) and restriction enzymes as shown in table 3.4. 
 
Table 3.4: DNA digestion protocol. DNA digestion was carried out applying the presented pipetting scheme.  
 
Component Volume cfinal 
10X CutSmart® buffer 5 µL 1X 
purified DNA variable 20 ng/µL 
Restriction enzyme 1 2.5 µL variable 
Restriction enzyme 2 2.5 µL variable 
ddH2O ad 50 µL  
 
The reaction mixture was incubated at room temperature (RT) for 1 hour. If the digested 
DNA was plasmid DNA, 1 µL of Antarctic Phosphatase (New England Biolabs, Ipswich, 
Massachusetts, USA) was added and the reaction was continued at 37°C for 30 minutes. 
After restriction and eventual dephosphorylation was completed, the reaction mix was heat 
inactivated at 95°C for 5 minutes. 10 µL of 6X DNA Gel Loading Dye (Thermo Fisher 
Scientific, Waltham, Massachusetts, USA) was added to the reaction mixture and the 
sample was analyzed and purified by agarose gel electrophoresis as described in chapter 
3.4.1. 
3.4.5 DNA ligation 
For DNA ligation, the digested insert (i) was added to a digested and dephosphorylated 
plasmid (p) in 3-fold molar excess. The amount of insert was calculated by formula (1): 
 
𝑉𝑖 = 3 ∗





The ligation reaction mix was completed with T4 DNA Ligase reaction buffer and T4 DNA 
Ligase (New England Biolabs, Ipswich, Massachusetts, USA), as shown in table 3.5. 
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Table 3.5: DNA ligation.  Ligation of digested DNA was carried out applying the presented pipetting scheme. 
 
Component Volume cfinal 
10X T4 DNA Ligase reaction buffer  2.0 µL 1X 
insert DNA, digested, purified variable variable 
plasmid DNA, digested, dephosphorylated, purified variable variable 
T4 DNA ligase 1.0 µL 400 units 
ddH2O ad 20 µL  
 
The reaction was carried out for 1 hour at RT. Then, 10 µL were used to start a 
transformation with competent E. coli cells. The remaining reaction mix was transferred to 
4°C and stored o/n. 
3.4.6 Transformation of DNA to competent E. coli cells 
To transform DNA into E. coli cells, a 50 µL aliquot of chemically competent E. coli cells 
was slowly thawed on ice. 1 to 10 µL of the desired DNA solution was added carefully to 
the cell suspension, which was incubated on ice for 5 minutes. Subsequently, a heat shock 
was performed by heating the cells to 42°C for 90 seconds. Afterwards, the cells were 
incubated on ice for another 5 minutes. Then the cell suspension was supplemented with 
1 mL of preconditioned SOC medium and incubated in a Thermomixer® R (Eppendorf, 
Hamburg, Germany) at 37°C with 800 rpm for 30 – 60 minutes. If plasmid DNA was 
transformed, 50 µL of the cell suspension were spread on an agar plate containing the 
desired antibiotics. In case of a transformed ligation batch, the cells were spun down for 3 
minutes with 5000 rpm and 20°C, resuspended in 50 µL of SOC medium and spread on 
an agar plate containing the desired antibiotics. The inoculated plates were incubated o/n 
at 37°C.  
3.4.7 Colony PCR and sequencing 
Clones arising from a ligation batch were checked for correct gene insertion by colony 
PCR and sequencing. To run a colony PCR, the Red-Taq DNA-Polymerase-MasterMix 
(VWR®, Radnor, Pennsylvania, USA) was prepared together with the primers necessary 
for gene amplification. Usually, primers annealing to the T7 promotor and terminator were 
used.  
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Table 3.6: Colony-PCR ingredients. A colony-PCR was prepared applying the shown pipetting scheme.  
 
 Volume for  
Component 10 * 50 µL reactions cfinal 
2X Red-Taq DNA-Polymerase-Mastermix 250 µL 1X 
Primer fw 10 µL 0.02 pmol/µL 
Primer rv 10 µL 0.02 pmol/µL 
ddH2O 230 µL  
 
The PCR reaction mix was transferred to PCR reaction tubes as 50 µL aliquots. Single 
colonies from o/n agar plates were picked with a sterile toothpick and used for introducing 
the DNA template to the PCR reaction mix. Further, the toothpick was used to inoculate 
5 mL of LB medium supplemented with desired antibiotics, which was then incubated o/n 
at 37°C and 130 rpm.  
The PCR was performed following the protocol described in chapter 3.4.3 and the size of 
the amplified DNA was documented by agarose gel electrophoresis as described in 
chapter 3.4.2. 
Cultures which showed a correct insert size were harvested and plasmid DNA was isolated 
using the QIAprep Miniprep-Kit (Venlo, The Netherlands). The isolated DNA was sent for 
sequencing (Eurofins, Luxemburg). Once the correct gene insertion was confirmed, DNA 
was transformed to different E. coli strains as described in chapter 3.4.6 and after o/n 
culture, glycerol stocks were generated by mixing 500 µL of culture with 500 µL of 
86 % (v/v) glycerol in a cryovial. The cryo-protected suspension was flash frozen in LN2 
and stored at -80°C. A small amount of this material was transferred into fresh medium to 
inoculate another culture. 
Material & Methods 
42 
 
3.5 Protein Production and Purification 
During the working process, protein samples were generally kept on ice or at 4°C. If not 
used in the near future, purified protein solutions were aliquoted to ≤ 100 µL and were 
flash frozen in LN2.  
3.5.1 Recombinant protein production in E. coli 
After a plasmid had been successfully transformed into an E. coli expression strain as 
described in chapter 3.4.6, a pre-culture was incubated o/n in corresponding medium with 
added antibiotics. The OD600 was determined using the WPA Biowave CO8000 Cell 
Density Meter. For the main culture, the desired volume of corresponding medium with 
added antibiotics was inoculated with the pre-culture to an OD600 = 0.05. The culture was 
incubated at 37°C and stirred with 130 rpm, until an OD600 = 0.5 was reached. In the 
following the temperature was lowered to 20°C and expression was induced by addition 
of 50 – 1000 μM IPTG. Protein production carried out o/n and the cells were pelleted using 
a Sorvall™ RC6+ Centrifuge (Thermo Fisher, Waltham, Massachusetts, USA) at 4°C with 
6000 rpm for 15 minutes. Subsequently, the cells were transferred into a 50 mL centrifuge 
tube and flash frozen in LN2. The cells were stored at -20°C until used. 
3.5.2 Expression test 
To test optimal conditions for expression of certain recombinant proteins, the parameters 
temperature, IPTG concentration and time were varied to identify their influence on protein 
expression. To do so, a 200 mL culture of desired medium with antibiotics was inoculated 
with an OD600 = 0.05 from an o/n culture. This main culture was incubated at 37°C and 
130 rpm, until the OD600 reached a value of 0.5. Then the main culture was split into four 
50 mL cultures. Two of the cultures were induced by the addition of 50 µM IPTG, the other 
two were induced by the addition of 500 µM IPTG from a 1 M IPTG stock solution. From 
both series, one flask each was transferred to 20°C, the remaining flasks were kept at 
37°C. To check on expression of soluble protein, 10 mL of culture were taken from each 
flask after 3 hours and after o/n expression and were transferred to 15 mL centrifuge tubes. 
The cells were pelleted by centrifugation at 4°C, 4000 rpm for 10 minutes and the 
supernatant was discarded. Pelleted cells were flash frozen in LN2.  
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For protein expression analysis, cell pellets were thawed and resuspended in 1 mL cold 
standard lysis buffer. The cells were disrupted by sonication with three 30 seconds cycles 
with a Bandelin Sonopuls, equipped with a MS73 sonotrode, set to 50% cycles and 70% 
amplitude. In between the sonication steps, the sample was cooled on ice. After lysis the 
suspension was transferred to a 1.5 mL reaction tube and cell debris was removed by 
centrifugation at 4°C, 16.000 rpm for 30 minutes. The supernatant was transferred to a 
fresh reaction tube and affinity beads were added. Depending on the affinity tag fused to 
the recombinant target protein, certain volumina of 50% bead suspensions were added to 
the crude lysate. For Strep-tagged protein, 5 µL Strep-Tactin®XT high-capacity beads 
(IBA Lifescinces, Göttingen, Germany), for His6-tagged protein 7 µL Ni Sepharose 6 Fast 
Flow (Thermo Fisher Scientific, Waltham, Massachusetts, USA) or for MBP-tagged protein 
5 µL Amylose Resin (New England Biolabs, Ipswich, Massachusetts, USA) were added. 
The mixtures of lysate and affinity beads were incubated at 4°C on a rotating mixer for 1 
hour. Afterwards, the resins were pelleted by gentle centrifugation at 4°C, 500 rpm for 
1 minute and the supernatant was carefully removed. The remaining beads were washed 
with fresh standard lysis buffer and spun down three times. Finally, 10 µL of 8X SDS-
PAGE loading buffer were added to the bead material. To check for insoluble expression 
products, a tip of pelleted cell debris was transferred to 50 µL of standard lysis buffer and 
10 µL 8X SDS-PAGE loading buffer. The total content of soluble protein was addressed 
by adding 10 µL 8X SDS-PAGE loading buffer to 50 µL of crude lysate. All SDS-PAGE 
samples were analyzed by SDS-PAGE as described in chapter 3.5.9.  
The gels were inspected with respect to the amount of purified, soluble protein that was 
present in the bead fraction for each expression condition. The identified condition for 
highest productivity was upscaled to 1 L batches. 
3.5.3 Selenomethionine derivatization 
As described in chapter 1.3.1., selenomehtionine (SeMet) labelling of recombinant protein 
can become necessary if experimental phasing is required to solve a protein structure from 
an X-ray crystallography experiment. To achieve a high incorporation rate with sufficient 
amount of protein yield, the production of the target protein in an M9MM, supplemented 
with SeMet, was optimized. The E. coli strain transformed with the plasmid of the target 
protein was cultured in an o/n pre-culture at 37°C and 130 rpm. Two times 1 L TB medium, 
supplemented with TB buffer and necessary antibiotics were inoculated with an 
OD600 = 0.05 and also incubated at 37°C and 130 rpm in another o/n culture. This culture 
was spun down at RT, 6.000 rpm for 15 minutes. The resulting cell pellet was resuspended 
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in 500 mL M9MM and again spun down at RT, 6.000 rpm for 15 minutes to remove 
residual components of TB medium. The washed cell pellet was then resuspended in two 
times 1 L M9MM, conditioned to 20°C and was incubated at 20°C, at 130 rpm for 
15 minutes. After that adaption time, SeMet was added to a final concentration of 50 mg/L 
and after another 15 minutes, the protein expression was induced by addition of the 
desired amount of IPTG. The expression was carried out at 20°C and 130 rpm o/n. Cells 
were harvested by centrifugation at 4°C, 6.000 rpm for 15 minutes and the cell pellet was 
transferred to a 50 mL centrifuge tube. Cells were frozen in LN2 and stored at -20°C until 
further use. 
3.5.4 15N labelling of recombinant proteins 
To be able to generate a “protein finger print” by an HSQC-experiment, the target protein 
needs to be labelled by 15N. The expression needed to be performed in the smallest 
volume and at highest cell densities possible, due to the high costly incorporation of 15N. 
Therefore, expression as a 2 L fermenter batch was addressed. To achieve a good yield 
and high incorporation yield, the expression protocol was optimized together with Daniela 
Gebauer and Dr. Joop van den Heuvel, both working at RPEX at the HZI.  
The Labfors 5 fermenter (Infors HT, Germany) was filled with the heat stable components 
of the M9MM (100 mL 10X M9 salt solution, 0.5 mL 2M MgSO4, 0.3 mL 1M CaCl2, 10 mL 
100X trace elements and water) and was autoclaved fully assembled. After the fermenter 
cooled down to RT, heat labile compounds were added through a 0.22 µM sterile filter 
(5 mL 200 mg/mL 15NH4Cl, 20 mL 20% glucose, 1 mL 1 mg/mL biotin and 1 mL 1 mg/mL 
thiamin). The temperature was adjusted to 20°C and the oxygen probe was calibrated. For 
inoculation, an o/n culture was grown in TB medium, supplemented with TB puffer and 
desired antibiotics. The cells were pelleted at RT and 6.000 rpm for 15 minutes and 
resuspended in 500 mL M9MM (without 15N) to remove residual components of the TB 
medium. The cells were pelleted again and resuspended in 200 mL of M9MM (without 15N) 
and the OD600 was determined. With this inoculum the fermenter was inoculated with an 
OD600 = 2.0 and cells were allowed to adapt for 30 minutes. After adaption, protein 
expression was started by addition of 1 mM IPTG. During expression, the pH was 
monitored, anti-foam was applied and oxygen was regulated by stirring speed. 
After expression, cells were harvested and spun down at 4°C, 6.000 rpm for 15 minutes. 
Cell pellets were distributed on 50 mL centrifuge tubes and flash frozen in LN2. The frozen 
cells were stored at -20°C until processed further.  
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3.5.5 Cell lysis by homogenization 
A cell pellet harvested from a 1 L o/n culture as described in chapter 3.5.1, was 
resuspended in an appropriate volume of cold lysis buffer. The suspension was stirred 
vigorously in a beaker at 4°C for 10 minutes and afterwards passed through two sheets of 
filter paper. The cell suspension was then transferred to the inlet vessel of the pre-
equilibrated EmulsiFlex-C3 (Avestin Europe GmbH, Mannheim, Germany). The 
suspension was passed through the homogenizer twice with a pressure of 16.000 psi and 
was collected in centrifuge tubes. Lysed cells were pelleted by centrifugation at 4°C, 
16.000 rpm for 1 hour. The lysate was subjected to downstream processing.  
3.5.6 Recombinant protein affinity chromatography techniques 
Lysates from recombinant protein expression generated as described in chapters 3.5.1, 
3.5.3, 3.5.4 and 3.5.5 were further addressed by the appropriate affinity chromatography 
technique as a first step of purification. Lysate that was planned to be subjected to Strep-
Tactin® material was additionally cleared at 4°C, 100.000 x g for 1 hour.  
The affinity columns were attached to ÄKTA™ systems (GE Healthcare, Chicago, Illinois, 
USA) and equilibrated with desired buffer (for an overview of buffers used, see chapter 
4.1). Subsequently the lysate was passed through the column using a super loop or a 
sample pump, the flow through was collected. Unspecifically bound proteins were removed 
by washing until UV absorption of eluting solvent reached a constant level. Elution was 
initiated by addition of competitive compounds, such as imidazole for the Ni-NTA and 
d-desthiobiotin for the Strep-Tactin® purification. Running conditions for HisTrap™ HP and 
columns packed with Strep-Tactin® Superflow® high capacity are listed in table 3.7. 
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Table 3.7: Affinity chromatography columns. Recombinant proteins were tagged either with a His6- or a Strep-
tag. Accordingly, the following materials were used. 
 
 His6-tag Strep-tag 
Column 5 mL HisTrap™ HP  8 mL Strep-Tactin® 
Superflow®  
Flow rate 3 mL/min 2 mL/min 
Pressure limit 0.5 MPa 0.5 MPa 
Elution 0 – 300 mM gradient imidazole 7 mM d-desthiobiotin 
Avoided substances DTT, EDTA SDS, Guanidine/HCl 
 
Eluting material was collected and fractionated. The purification success was monitored 
by SDS-PAGE with cell pellet, crude lysate, flow through and elution samples. An SDS-
PAGE was performed as described in chapter 3.5.9. If applicable, eluted protein was mixed 
with recombinant TEV protease in a gravimetric ratio of 1:100 (Invitrogen, Carlsbad, 
California, USA) and dialyzed o/n to remove the affinity tag. TEV digestion control was 
performed by SDS-PAGE and the cleaved protein was collected and concentrated for 
further processing. If the protein was not used immediately, it was flash frozen as ≤ 100 µL 
aliquots in LN2 and stored at -80°C. 
3.5.7 Cultivation of Clostridioides difficile 
Cultivation of C. difficile was performed at the BRICS, TU Braunschweig with the help of 
Dr. Meina Neumann-Schaal and Dr. Julia Hofmann. All cultures were grown at 37°C in a 
water bath. Medium used was anaerobic CDMM. To achieve high chances of germination, 
several pre-cultures of 50 mL were inoculated from a spore stock and incubated o/n. A 
second pre-culture of two times 100 mL was inoculated with an OD600 = 0.05 and 
incubated o/n. The main culture consisted of eight times 0.8 L CDMM supplemented with 
0.1 g/L proline, which were inoculated with an OD600 = 0.05 and incubated until the OD600 
reached a value of 0.4. This density marks the end of the exponential growth phase, where 
the highest amount of proline reductase complex was assumed, as described in chapter 
1.1.3.. The cells were then harvested by centrifugation at 4°C, 4.000 rpm for 20 minutes. 
Four pellets were collected, each from 1.6 L culture, and transferred to four 50 mL 
centrifuge tubes. The pellets were flash frozen in LN2 and stored at -80°C until further use. 
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3.5.8 Native purification techniques 
The purification protocol for isolation of native proline reductase complex from C. difficile 
was adopted from Kabisch et al. (Kabisch et al., 1999) and iteratively optimized until the 
sample quality was sufficient for reliable biophysical characterization. Decisions towards 
variations were made based on a reduction of required purification steps, higher selectivity 
of the affinity material towards the proline reductase complex and improved thermostability 
of the purified protein and resulted in the following protocol.  
One cell pellet from 1.6 L C. difficile culture, generated as described in chapter3.5.7, was 
resuspended in C. difficile lysis buffer (see chapter 4.1) to a total volume of 40 mL. The 
suspension was transferred to a cylindrical Schlenk flask, which was aerosol-tightly 
attached to a sonicator (Bandelin Sonopuls, equipped with a MS73 sonotrode). The flask 
was placed in a beaker filled with an ice/water mixture. Sonication was carried out on ice 
with cycles set to 10% and amplitude to 50% for 30 minutes. The suspension was then 
transferred to a measuring cylinder and 40 mL of C. difficile precipitation buffer (see 
chapter 4.1) were added slowly while stirring. The suspension was stirred for 5 minutes, 
transferred to two high performance centrifuge tubes and centrifuged at 4°C with 
100.000 xg for 1 hour. Equipment used during cell lysis and precipitation was covered with 
a sporozide (Incidin™ Active, ECOLAB Healthcare, Mohnheim am Rhein, Germany) for at 
least 1 hour and autoclaved (except high performance centrifuge tubes).  
For identification of most suitable HIC material, the HIC selection kit was used. Equal 
amounts of crude lysate were applied on 1 mL columns and washed. The elution gradient 
of KCl was set to 330 mM within 5 mL and the concentration was kept there for 20 mL to 
remove impurities. Subsequently, the proline reductase complex elution was initiated by 
increasing the KCL concentration to 400 mM within 10 mL. This gradient could be set even 
steeper to avoid unnecessary sample dilution. The concentration was kept for 20 mL and 
fractions were collected. Remaining bound material was eluted by increasing the KCL 
concentration to 1 M. 
When the HiTrap Butyl HP HIC column was identified to be most suited, the supernatant 
was decanted carefully and applied on 5 mL column material (GE Healthcare, Chicago, 
Illinois, USA), pre-equilibrated with C. difficile HIC buffer B (for C. difficile HIC buffer A and 
B see chapter 4.1). The flow-through was collected. The column was washed with 
C. difficile HIC buffer B and elution of bound material was achieved by application of a 
negative linear gradient from 100% C. difficile HIC buffer B to 0% over 24 mL. The elution 
volume was collected and fractionated in 1 mL samples, which were analyzed by 
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SDS-PAGE as described in chapter 3.5.9. The gel was inspected for the distinctive pattern 
of the proline reductase complex subunits PrdAβ (45 kDa) and the double band for PrdAα 
(22 kDa) and PrdB (25 kDa). Fractions containing this pattern were pooled, despite 
remaining impurities.  
The pooled fractions were applied on an 8 mL MonoQ IEX column (GE Healthcare, 
Chicago, Illinois, USA), pre-equilibrated with C. difficile IEX buffer (5% C. difficile IEX buffer 
B. For C. difficile IEX buffer A and B see chapter 4.1). The flow-through was collected and 
the column was washed with C. difficile IEX buffer (5% C. difficile IEX buffer B). Elution of 
bound material was performed by gradually increasing the KCl concentration, as shown in 
table 3.8.  
Table 3.8: IEX MonoQ elution gradient. The purification of HIC-purified proline reductase was performed with 
the shown gradient. The column was equilibrated with 5% buffer B. IEX buffer A was gradually replaced by IEX 
buffer B.  
 
 from %B to %B Volume [mL] 
Gradient 5 35 16 
Plateau 35 35 8 
Gradient 35 50 2 
Plateau 50 50 10 
Gradient  50 100 2 
 
Samples were fractionated in 1 mL and analyzed on SDS-PAGE as described in chapter 
3.5.9. Again, the gel was inspected for appearance of the distinctive pattern for the proline 
reductase subunits. The proline reductase complex eluted between 350 and 500 mM KCl 
and was collected. The solution was either aliquoted to 100 µL and flash frozen in LN2 or 
immediately concentrated with a 2 mL protein concentrator with 10 kDa MWCO (Thermo 
Fisher Scientific, Waltham, Massachusetts, USA). The solution was concentrated to 
approximately 500 µL and applied to a Superose6 10/30 increase column (GE Healthcare, 
Chicago, Illinois, USA), pre-equilibrated with C. difficile SEC-MALS buffer (see chapter 
4.1) and attached to a SEC-MALS system (Wyatt/Agilent). Fractions were analyzed by 
SDS-PAGE as described in chapter 3.5.9., pooled and concentrated to 10 mg/mL. If 
subsequent TEM was addressed, the proline reductase complex was crosslinked by the 
addition of DSSO, dissolved in DMSO, at a maximum concentration of 15 mM. The 
reactions were carried out for 30 minutes in the dark at RT and were stopped by the 
addition of 2 M Tris buffer at pH 8.0. Pipetting schemes are provided in table 3.9.  
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Table 3.9: Proline Reductase DSSO crosslinking protocol. Crosslinking of the purified proline reductase complex 
was achieved by adding DSSO to the protein solution. The pipetting scheme for different final concentrations is 
shown. Protein solution was present at 10 mg/mL. DSSO was dissolved in DMSO with a stock concentration of 
50 mM.  
 
Vprotein [µl] VDSSO [µl] Vbuffer [µl] VTris [µl] cDSSO [mM] 
32.7 0.7 - 5.0 1 
15.0 1.6 23.4 10.0 2 
15.0 2.4 21.8 10.0 3 
15.0 3.2 20.2 10.0 4 
15.0 6.4 18.6 10.0 8 
15.0 8.0 17.0 10.0 10 
15.0 12.0 13.0 10.0 15 
 
The crosslinked protein complex was applied to SEC-MALS, once again, and fractions 
were collected for further analysis. The proline reductase complex containing fractions 
were pooled and either immediately used or flash frozen as 100 µL aliquots in LN2.  
3.5.9 SDS-PAGE 
For SDS-PAGE, a desired volume of sample was mixed with 8X SDS PAGE loading buffer 
and heated to 95°C for 5 minutes. A Mini-PROTEAN® Tetra System (Bio-Rad 
Laboratories, Hercules, California, USA) was assembled with Mini-PROTEAN® TGX Gels 
(Bio-Rad Laboratories, Hercules, California, USA) and filled with Rotiphorese® SDS-
PAGE buffer at 1X concentration (Carl Roth, Karlsruhe, Germany). As protein standard, 
5 µL Unstained Protein Molecular Weight Marker (Fermentas, Waltham, Massachusetts, 
USA) were applied to one chamber. The volume of sample varied between 2 and 15 µL. 
Running conditions were 200 V for 30 minutes. The finished gel was removed from the 
chamber and rinsed with water. Staining was performed with InstantBlue™ (Merck KGaA, 
Darmstadt, Germany) for 30 minutes. Afterwards the gel was transferred to water to 
reduce background staining.  
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3.5.10 Blue native PAGE 
Blue native page was carried out using a XCell SureLock™ Electrophoresis Cell and a 
NativePAGE™ 4-16% BisTris Gel. As anode buffer 20X Native PAGE™ Running Buffer 
was diluted to 1X concentration and filled into the outer electrophoresis chamber. For the 
cathode buffer, 1.5 µL of NativePAGE™ Cathode Buffer Additive was added to 300 µL of 
1X anode buffer, which was then filled to the inner electrophoresis chamber. 
The marker was constituted by dissolving the content of one vial HMW calibration kit for 
electrophoresis (Amersham, GE Healthcare, Chicago, Illinois, USA) in 100 µL of 
NativePAGE™ Sample Buffer and 5 µL of that marker were applied onto the gel. Also 
12 µL of sample were mixed with 4 µL NativePAGE™ Sample Buffer and 15 µL of the 
sample were loaded into the gel chambers. The voltage for electrophoresis was set to 10 V 
for 30 minutes and was subsequently increased to 100 V for 3 hours. The finished gel was 
removed from the chamber and rinsed with water. Staining was performed with 
InstantBlue™ (Merck KGaA, Darmstadt, Germany) for 30 minutes. Afterwards the gel was 
transferred to water to reduce background staining (all products of Invitrogen/Life 
Technologies, Carlsbad, California, USA).  
3.5.11 Limited Proteolysis 
To identify protease-resistance domains, 12 x 175 µg of PrdA were each mixed with 14 µL 
of 1:100 diluted proteases provided by the ProtiAce-Kit and ProtiAce-Kit2 (Hampton 
Research, Aliso Viejo, California, USA). The mixtures were incubated at 37°C and samples 
were taken at different time points. 8x SDS loading buffer was added and samples were 
heated to stop proteolysis. The effect of each protease was monitored by applying the 
samples on SDS-PAGE. The proteases were compared in their specific digestion behavior 
on PrdA by visual interpretation of the band pattern generated on the SDS-PAGE. 
3.5.12 Semi-dry Western blot for N-terminal sequencing 
For Semi Dry Western Blots, an SDS-PAGE was prepared as described in chapter 3.5.9, 
but PageRuler™ Prestained Protein Ladder (Thermo Fisher, Waltham, Massachusetts, 
USA) was used as marker and as a positive transfer control. The sample pattern was 
loaded twice. The stacking gel was removed and the piece for western blotting was cut in 
size. The double sample pattern was split in two halves, wherefrom one was immediately 
stained with InstantBlue™ (Merck KGaA, Darmstadt, Germany) for control purposes. Four 
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pieces of Whatman filter paper and PVDF membrane were cut to pieces with sizes 
according to the gel. The filter paper was soaked with Western Blot buffer. The PVDF 
membrane was first activated in MeOH and then transferred to water for two minutes. Then 
it was equilibrated in Western Blot buffer for 5 minutes and placed on top of two layers of 
filter papers on the anode of the Trans-Blot Turbo System (Bio-Rad Laboratories, 
Hercules, California, USA). The gel was positioned on the membrane and covered with 
two further sheets of soaked filter papers. Any air bubbles were removed. The cathode 
was put on top of the stack and closed such that the cassette was transferable to the 
blotting system. The voltage was set to 25 V and the blotting time was set to 30 minutes. 
The blotting efficiency could be estimated by the transfer of the pre-stained protein marker. 
The SDS-PAGE was further stained with InstantBlue™ (Merck KGaA, Darmstadt, 
Germany) to check for non-transferred proteins. For isolation of membrane parts that carry 
the unstained target protein, the stained SDS-PAGE that was separated and stained 
before served as a template and corresponding spots were cut from the membrane. The 
pieces of membrane were washed in ethanol/acetic acid and subjected to N-terminal 
sequencing.  
3.5.13 N-terminal sequencing 
N-terminal sequencing was performed by Beate Jaschok-Kentner at the Helmholtz Centre 
for Infection Research (Braunschweig, Germany). Protein samples were immobilized on a 
PVDF membrane by Western blotting. The PVDF membrane was carefully washed in 
ethanol/acetic acid. The cut-out bands were analyzed using an ABI 494 protein sequencer. 
The N-terminal residues were derivatized with PITC in a basic environment and cleaved 
after a pH-shift to acidic environment. Cleaved N-terminal residues were then analyzed 
using a reverse phase chromatography. The derivatization and cleavage steps were 
repeated 10 to 15 times. Identification of separated amino acids was achieved by 
comparison of the elution volume with standards.  
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3.6 Biophysical methods, principles and procedures 
The following section provides basic explanations of biophysical principles and 
experimental procedures for the set of biophysical methods that have been used in this 
thesis. 
3.6.1 Microscale Thermophoresis 
The physical phenomenon of thermophoresis describes the movement of a molecule in a 
medium due to a local temperature gradient. Most often molecules move from a higher 
temperature towards a lower temperature. The physical principles of this phenomenon are 
not fully understood yet, but its application on proteins has been developed into method to 
monitor interactions. Depending on the detection system, proteins either need to be 
labelled with a fluorophore or can be detected using the intrinsic fluorescence of 
tryptophane residues. An IR laser induces a sharp locally and temporally defined 
temperature gradient in a capillary filled with protein solution. This gradient induces 
thermophoresis of the protein molecules and within seconds the formerly equally 
distributed protein molecules will find a new distribution state with less molecules in the 
heat center, which leads to a lower detection signal. Turning off the IR laser lets the 
capillary cool down in a defined speed, which leads to molecular motion back to an equal 
distribution and to the initial signal intensity. During the whole experiment, speed and end 
states of the new equilibrium depend on many factors, mainly the hydration shell, protein 
charge, size and shape among others. Applying this technique to a constant concentration 
of a molecule with increasing concentration of a ligand, the affinity of both molecules to 
each other can be determined (Jerabek-Willemsen et al., 2014).  
Experimentally, the protein was labelled with a Cy5-NHS reagent, active against lysines, 
by the addition of 30 µM dye to 10 µM protein solution in an amine free buffer in a total 
volume of 200 µL. The reaction was carried out in the dark at RT for 30 minutes. Removal 
of aggregated sample material and free label was performed by a buffer exchange with a 
NAP-5 column (GE Healthcare, Chicago, Illinois, USA), equilibrated with protein buffer. 
Eluting material was collected, fractionated and checked by UV-Vis-spectrometry for 
protein content. First tests for an MST setup included capillary pre-tests in which ideal 
intensity curves and sufficient protein concentrations were targeted. Improvements can be 
achieved by choosing appropriate coating (standard, hydrophobic or premium coating), 
adjusting the LED power for excitation or dilution of the sample. The ideal signal has 200 
to 5000 counts and does not show any shoulders. Once those pre-tests were 
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accomplished, a 1:1 dilution series with 16 concentrations of the ligand in the 
corresponding protein buffer was set up. For each concentration, 10 µL of protein and 
10 µL of ligand were mixed and incubated for 10 minutes. Capillaries were filled with the 
samples and measured with the Monolith™ NT.115 (Nanotemper, Munich, Germany). A 
cap-scan was collected for verification of equal sample distribution and signal intensity, 
which was followed by the thermophoresis experiment (Jerabek-Willemsen et al., 2014). 
3.6.2 Thermal shift assay 
In a thermal shift assay, the melting temperature of a purified protein sample is determined. 
This is achieved by adding SYPRO® orange protein stain to the protein in a screen of 
different buffers or additives and by gradually heating the sample from 4 to 95°C in a real-
time PCR cycle system. Upon denaturation, hydrophobic moieties of the protein core will 
become solvent accessible. This leads to an interaction of the added dye with the protein, 
enhancing the fluorescence signal. Generating the first derivative of dF/dT allows 
determination of the melting temperature (Wienken et al., 2010; Jerabek-Willemsen et al., 
2014).  
This technique is useful for proteins that have a low stability. Buffer parameters such as 
pH and salt concentration were generally checked for any protein purified. Further, additive 
screening allows identification of compounds that stabilize the target due to binding or 
shielding actions. In addition, these results can potentially give more information with 
respect to domain architecture or oligomerization if double-peaks or non-symmetric peaks 
occur (Boivin et al., 2013; Chari et al., 2015).  
It has been shown that an increased melting temperature and melting behavior correlates 
with enhanced target crystallization (Boivin et al., 2013; Chari et al., 2015). This link can 
be explained by reduction of entropy upon binding between a protein and its ligand. 
Usually, interaction sites are flexible regions that take a defined and stiffer shape than 
before when a ligand is bound to this specific area. As a result, the protein-ligand complex 
has reduced flexibility and higher rigidity and it is more likely to be crystallized successfully. 
The same principles can be applied to any other technique in the field of structural biology.  
The experiments were performed in a 96-well format. First, a suitable protein concentration 
was determined, usually between 0.5 mg/mL and 2 mg/mL (0.05 mg/mL to 0.2 mg/mL final 
concentration). A screen was set up by mixing 5 µL protein solution, 5 µL SYPRO® orange 
protein stain and 40 µL buffer. Alternatively, the buffer fraction was spilt to 25 µL of an 
additive screen and 25 µL 2X buffer. A qPCR cycler (Bio-Rad Laboratories Hercules, 
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California, USA) was used to gradually heat the samples and to detect the fluorescence 
signal.  
3.6.3 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy can provide information on secondary structure (SS) 
elements in proteins, as circularly polarized light gives distinct signals for α-helices and 
β-sheets. Circularly polarized light is defined as wave of light with a rotating amplitude 
vector when the wave is projected on a plain. It can be described as a superimposition of 
two linearly polarized light waves with the same amplitude heights that lie perpendicular to 
each other and have a phase shift of 90°. Circularly polarized light changes its polarization 
upon interaction with chiral molecules. Those molecules absorb linearly polarized light in 
dependency of the angle of the incoming wave, relative to the orientation of the sample. 
As a result, the circularly polarized light is more strongly weakened in the amplitude of one 
linearly polarized wave component than in the other, and the superimposed wave is then 
elliptically polarized. The ellipticity is observed and monitored over a range of energies. 
SS elements of proteins generate distinct minima in this spectrum in the range of 
190 – 240 nm. At 208 and 220 nm, α-helices generate characteristic double minima. 
β-strands are identified by a minimum at 215 nm. The range of 240 – 320 nm can give 
information on aromatic residues. The aromatic side chains are not chiral by themselves, 
but will be detectable by CD spectroscopy as soon as they are embedded in chiral 
environment such as a protein core (Greenfield, 2009). 
The measurements reported here were performed with a Jasco-815 CD Spectrometer 
(Jasco Deutschland GmbH, Pfungstadt, Germany). The protein sample was dialyzed o/n 
against a 20 mM potassium phosphate buffer with a KCl concentration as low as possible. 
Cuvettes were washed at least five times with MilliQ water and dried. The blank 
measurement was performed with 200 µL of dialysis buffer. The protein concentration was 
adjusted with dialysis buffer. Then the protein sample was measured with the same 
settings as the blank. SS estimation was performed by the online tool K2D3 (Louis-Jeune 
et al., 2012).  
3.6.4 In-situ dynamic light scattering 
An in-situ dynamic light scattering (DLS) experiment was performed together with Dr. Arne 
Meyer and the company Xtal-concepts (Hamburg, Germany). The SpectroLight 600 
spectrometer provides the possibility to detect time-resolved light scattering in a protein 
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solution with volumes as small as 100 nL in a 96-well format. A coherent and 
monochromatic laser is used to generate Rayleigh-scattering from the particles in solution. 
The scattered light waves interfere with each other and show fluctuation, caused by 
molecular movement of the particles in solution. From this interference pattern, the 
movement velocity can be determined, which is dependent on the hydrodynamic radius of 
a particle. This enables a direct measurement of particle size distribution as a high 
throughput screening paired with very little sample consumption.  
The protein solution was mixed in a PCR reaction tube with buffers and additives and 
placed as a 1 µL droplet under oil.  
3.6.5 Multi angle light scattering 
Multi angle light scattering (MALS) is used for the accurate determination of MW and 
particle size. Both values arise from specific scattering events (Patel et al., 2018).  
First, the overall intensity of scattered light Is depends on a constant, specific for the 
experimental setup and the sample, its concentration c and its molar mass M.  
𝐼𝑠 =  𝑐𝑜𝑛𝑠𝑡.  ∗ 𝑐 ∗ 𝑀 (11) 
The setup specific constant can be explained in more detail by 
𝐼𝑠 =   𝐾 ∗  𝐼𝑖 ∗  
𝑉𝑠
𝑙2
 ∗ 𝑐 ∗ 𝑀 
(12) 
where K is the scattering constant, Ii is the intensity of the incoming laser, Vs is the 
scattering volume and l the distance between scattering sample and the detector. In this 
equation, except for K all parameters are known. K can be resolved as 








where n0 provides the refractive index of the solvent, dn/dc is the refractive index (RI), NA 
the Avogadro number and λ the wavelength of incoming light. For regular proteins, the RI 
is considered as a fixed value of 0.185 mL/g. The value for RI of the sample is directly 
proportional to its concentration. Therefore, measuring the RI with a differential 
refractometer provides a robust method to determine a protein concentration. As dn/dc is 
known and the concentration is determined, the scatter intensity is directly proportional to 
the MW of the protein (Wyatt, 1998).  
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On the other hand, the principle of size determination is based on the anisotropic 
scattering, which occurs as soon as the scattering particle exceeds a radius of 10 to 15 nm, 
which is true for many biomolecules. For particles larger than 15 nm, anisotropic scattering 
occurs, which can be detected with a multi angle detector setup. The measured intensity 
of low angle scattered light correlates to Rg.  
The measurements were performed on an Agilent chromatography system, equipped with 
WYATT detection systems (Optilab® T-rEX refractometer, MiniDawn TREOS II MALS 
detector). 
The samples were purified by affinity chromatography and were tested for stability and 
solubility beforehand. Stable and soluble samples of sufficient purity were concentrated. 
The sample volume may not exceed 100 µL. The amount of material needed for a reliable 
measurement varies with protein size. For smaller proteins a minimum mass of 200 µg 
was aspired. The amount needed decreases with increasing protein size. A SEC column 
was chosen with respect to its separation range and was equilibrated with running buffer 
with at least 2 column volumes (CV). Then the experiment was queued, monitored and 
analyzed by ASTRA® software (Wyatt Technology Corporation, USA). 
3.7 Methods in structural biology 
Strengths and weaknesses of different methods in structural biology were described in 
chapter 1.3. Here, protocols followed are described to conclude structural information from 
adequate experiments.  
3.7.1 X-ray crystallography 
The principles of X-ray crystallography are explained in more detail in chapter 1.3.1. 
Samples for protein crystallization required an excellent purity and were analyzed in terms 
of homogeneity and stability, as well. 
3.7.1.1 Protein crystallization  
In general, protein crystals were grown in vapor diffusion experiments. Regular screening 
was performed with the Honeybee 961 pipetting robot (Digilab®, Hopkinton, 
Massachusetts, USA), which transferred 60 µL of reservoir solution from a deep-well 
storage block to the reservoir chamber of an 96-3 Intelli-plate® (Art Robbins Instruments, 
Sunnyvale, California, USA) and dispensed 200 nL each of reservoir and protein solution 
into three sitting drop wells. The chambers were sealed and stored in a Rock Imager® 
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automated microscope (Formulatrix, Bedford, Massachusetts, USA), monitored and 
inspected over a period of 48 days.  
Additive screening was performed by prefilling the reservoir chamber manually with 96 
times 6 µL additive solution and 54 µL of a defined reservoir. The prefilled Intelli-Plate® 
was then further processed with the Honeybee.  
For seeding, a seed stock was prepared by crushing a single crystal in 50 µL of its reservoir 
solution. The suspension was further diluted when necessary. Crystallization plates were 
set up using the OryxNano pipetting robot (Douglas Instruments, East Garston, UK) in 
order to mix the protein solution with both, the reservoir and the seed stock.  
Detected crystals were fished using a micro-mesh or loop, attached to a pin holder, fixed 
to a magnetic cryo wand. If necessary, the crystals were transferred to a soaking solution. 
Before flash-freezing the crystals in LN2, the crystals were transferred to a reservoir 
solution, supplemented with sufficient amount of cryoprotectants, i.e., 10% (v/v) glycerol.  
3.7.1.2 Data collection, processing and interpretation 
Crystals were tested for diffraction using an in-house X-ray generator equipped with a Cu 
K-α rotating anode. Full and high-quality datasets were collected at the beamlines of 
various synchrotrons. SAD experiments were in general performed at a synchrotron 
source with a tunable wavelength. For SAD phasing, highly redundant data were collected 
with a relatively low dose per image. Data indexing, integration and scaling was done with 
the XDS and XSCALE software package (Kabsch, 2010 a). Initial phases were derived 
from single anomalous dispersion differences in diffraction data of crystals from SeMet-
labeled protein or NH4I-soaked crystals collected at the absorption edges of the 
corresponding elements. Heavy atom positions were identified with hkl2map (Pape et al., 
2004) and forwarded to phenix.phaser of the PHENIX software suite (Adams et al., 2010). 
Initial model generation was performed with phenix.autobuild (Terwilliger et al., 2007) and 
followed by manual model building of poorly defined regions in Coot (Emsley et al., 2010) 
from the CCP4 software suite (Winn et al., 2011). Further refinement involved alternating 
rounds of manual adjustments and optimization in phenix.refine (Afonine et al., 2012).  
3.7.2 NMR spectroscopy 
NMR spectroscopy was performed with the help of Junior-Prof. Dr. Alexander Marchanka 
from the Institute of Organic Chemistry at the Leibniz University of Hannover. 
Characteristics of NMR spectroscopy were described in chapter 1.3.2. Simple 1D 
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experiments provide information on the folding state of the protein. A folded, non-
aggregated protein shows sharp peaks over a wide range of chemical shifts. The signals 
range from 0 ppm to 3 ppm for methyl groups and aliphatic residues, from 3.5 to 5.5 ppm 
for Hα’s and up to 10 ppm for amine-associated, aromatic and backbone protons. Signals 
embedded in the ladder area give information on the tertiary structure and the folding state. 
A sample which provided a good 1D 1H-spectrum was further addressed by 15N-labelling 
and 15N-1H-HSQC, the so-called protein fingerprint (Cavanagh et al., 2007).  
High protein purity was in general essential for interpretable spectra and was achieved by 
application of highly selective Strep-Tactin® purification and a SEC polishing step. For 
liquid state NMR, the protein needed to be concentrated to approximately 20 mg/mL and 
delivered in a small volume of 600 µL. The salt concentration was kept below 300 mM 
NaCl.  
For an HSQC experiment, the protein was labelled with 15N, according to the protocol 
described in chapter 3.5.4, and purified to homogeneity.  
Samples for NMR were prepared freshly and freeze-thaw cycles were avoided. Samples 
were stored at 4°C and handed over promptly.  
3.7.3 Small angle X-ray scattering 
The sample purity and homogeneity are essential for measurements in batch mode, as 
the resulting signal will be a superimposition of all molecules dissolved. For this reason, 
the sample needed to be characterized in detail in terms of its stability and its behavior 
upon freeze and thaw cycles. A pure and homogeneous protein sample needed to be 
dialyzed o/n to enable background subtraction. Importantly, protein concentration after 
dialysis was avoided to circumvent possible aggregation. Instead, the samples were 
dialyzed at a high concentration and diluted to at least three working concentrations after 
dialysis. Typical working concentrations were between 20 mg/mL for small proteins, down 
to 1 mg/mL. A minimum sample volume of 50 µL was targeted. A buffer for background 
subtraction was provided in large excess.  
For SEC-SAXS, separable impurities were tolerable, but reproducible elution profiles of a 
distinct species needed to be assured. The sample amount to load for the SEC run again 
correlated with the protein size. To maintain good resolution properties, 50 µL sample 
volume were not exceeded. The sample concentration was at least 5 – 7 mg/mL.  
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3.7.4 Electron microscopy 
TEM was performed at the HZI with the help of Dr. Mathias Müsken from the Central 
Facility for Microscopy. Samples were delivered immediately after accomplishing the last 
purification step. Freeze-thaw cycles and high amounts of glycerol or salt were avoided.  
Carbon coated copper grids with a mesh size of 400 (EMS, Hatfield, Pennsylvania, USA), 
as well as self-produced carbon foils were used for sample immobilization. A diluted 
droplet of 50 µL of the sample was placed on a clean, repulsive surface, such as parafilm, 
and two droplets of water and one droplet of a 4% uranyl acetate (UAc) solution were 
placed next to it. For adsorbance, the carbon foil or the carbon-coated grid was put on top 
of the sample droplet. Adsorbance time ranged from 15 seconds to 1 minute. Afterwards, 
the foil/grid was removed and excess liquid was carefully removed by touching the corner 
of the grid with filter paper. Subsequently the grid was washed twice by dipping it onto the 
water droplets. Staining was performed by placing the grid on the UAc droplet for 1 minute. 
The grid was then dried and ready for inspection.  
Data collection was carried out at a LIBRA 120 electron microscope (Carl Zeiss AG, 
Oberkochen, Germany). Once an area suitable for data collection was found in the low 
magnification mode, the magnification was set to 20.000. Areas with a homogenous 
particle distribution were preferred. Images were taken, exported and converted to .mrc 
file format. Further processing was performed with the software package Relion.  
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4 Topic I: Architecture of the Clostridioides difficile 
proline reductase 
Besides rudimentary knowledge of the molecular weight and partial identification of the 
active site, detailed understanding of the assembly and the architecture or structures of 
subunits of the proline reductase are lacking. This study aims to fill these gaps. A variety 
of techniques addressing diverse perspectives was applied and combined, including 
homologous and heterologous protein expression as well as biophysical characterization 
of isolated targets. 
From the structural point of view, this task was split into a set of sub projects. Due to the 
assembly from rather small to medium-sized entities to the multimeric protein complex, 
versatile methods from the field of structural biology have been applied. The subunits PrdA 
and PrdB were addressed by X-ray crystallography. Due to its relatively small size of 23 
kDa, the selenocysteine-containing subunit PrdB could also be subjected to NMR. Due to 
a size of around 870 kDa (Kabisch et al., 1999), the complete complex is a predestined 
target for TEM and cryoEM.  
Heterologous production of recombinant PrdA and PrdB and affinity chromatography 
purification was performed to yield high amounts of unmatured protein. The interaction of 
both subunits was recovered and accurate size determination was performed by 
electrophoresis and scattering experiments. A similar set of techniques was applied to the 
natively purified, fully matured and completely assembled proline reductase complex after 
the purification protocol was modified to milder conditions.  
The following chapters summarize the experiments that were applied to gather structural 
information of the proline reductase.  
4.1 Proline reductase subunit PrdA 
PrdA is produced as a proprotein with 67.6 kDa and is subsequently cleaved by a 
selenocysteino/cysteino/-serinolysis (dependent on the C. difficile strain) between amino 
acids 420 and 421, resulting in the two subunits PrdAβ with 44.6 kDa and PrdAα with 
22.8 kDa. While the N-terminal subunit PrdAβ evolves as a regular C-terminus, the N-
terminus of the C-terminal subunit PrdAα matures to a modified pyruvyl group, which is 
essential for proline binding. The supposed function of the subunits during the reaction 
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cycle is shown in detail in chapter 1.1.4. Beside substrate binding and direct interaction 
with PrdB, further structure-function-relationships remain elusive. Here, the aim for 
detailed understanding of the proline reductase was set, which is why the gene prdA was 
cloned for recombinant protein production and characterization. 
4.1.1 Cloning of prdA 
Genes were amplified by PCR from gDNA of C. diffcile 630Δerm (van Eijk et al., 2015), 
provided by the DSMZ, Braunschweig. Correct restriction, insertion, ligation and 
transformation was reviewed by colony-PCR and sequencing. The detailed protocols are 
given in the chapters 3.4.3 to 3.4.7. As soon as correct cloning was verified, the purified 
DNA was transformed into E. coli expression strains and tested for expression. 
4.1.2 Production of PrdA 
Full length PrdA was produced in LB medium, following the protocol described in chapter 
3.5.6, induced with 50 µM IPTG at 20°C. The protein was purified in a two-step purification 
procedure using Ni-NTA and SEC (S200 16/60). The preparative SEC showed strong 
protein aggregation as indicated by a main peak eluting in the exclusion volume at 45 mL. 
A second peak at 72 mL shows a much lower signal that might correlate to the size of a 
PrdA dimer. The SDS-PAGE showed exclusively a single band slightly above the 66 kDa 
marker protein. Hence proteolytic maturation towards PrdAα (22 kDa) and -β subunits 
(45 kDa) did not occur autocatalytically. Interestingly, most proteins that carry a pyruvoyl 
group act as decarboxylating or reducing enzymes on amino acids or amino acid 
derivatives, as the proline reductase does (Jiang et al., 2013). As described by Ute Kabisch 
and Brit Bednarski, the serinolysis of recombinant PrdA does not occur spontaneously in 
vitro but requires a large amount of strong reducing agent (Kabisch et al., 1999; Bednarski 
et al., 2001). Other examples are known for which the proteolytic maturation appears 
autocatalytically (Gallaghert et al., 1992; Albert et al., 1998; Tolbert et al., 2003; Bale et 
al., 2010). However, it is considered that in vivo, C. difficile provides chaperones for 
reduction and induction of serinolysis, as it has been shown for other proteins (Trip et al., 
2011). Either way, it was suggested that a backbone oxygen, intrinsically present or 
provided by a chaperone, forms an oxyanion hole for stabilization of the intermediate 
oxyoxazolidine (Schmitzberger et al., 2003). Until today, only the L-aspartate-α-
decarboxylase has been crystallized as a pyruvoyl-dependent protein in its inactive, 
unmatured state. From this study one can derive that the overall structural conformation is 
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not affected by pyruvoyl formation. Yet, the direct environment shows reduced flexibility 
after maturation (Schmitzberger et al., 2003). Crystallization and other biophysical 
investigations of the purified full-length construct were not successful. The strong 
aggregation pointed towards misfolding of the protein. Nevertheless, the purified protein 
could be used to find truncation sites to break up the soluble agglomerates. Therefore, 
PrdA was subjected to limited proteolysis. 
4.1.3 Limited proteolysis of PrdA 
The soluble but aggregated protein was treated by limited proteolysis in order to determine 
boundaries for soluble PrdA-constructs. The aim was to find a soluble PrdA construct 
forming a defined oligomeric state. Hence PrdA was incubated with various protease and 
PrdA fragments from different time points were separated on SDS-PAGE. While no 
digestion with chymotrypsin, papain, endoproteinase glu-C, clostripain, bromelain and 
actinase E was observed, trypsin, subtilisin and proteinase K degraded the protein 
completely without generating any distinct band for further analysis. 
 
Figure 4.1: Limited proteolysis of PrdA. A) PrdA formed soluble aggregates and could not be used for bioanalytic 
analysis. Therefore, the protein solution was mixed with elastase and digested at 37°C. SDS-PAGE samples were 
taken after 5, 10, 15, 30 and 60 minutes. As the protein band corresponding to PrdA was digested and formed 
bands corresponding to lower molecular weight, the reaction was upscaled. B) The reaction product was 
applied to an analytical SEC (S200 10/30 increase) and a soluble species was isolated. The sample was 
transferred on a PVDF membrane by western blot and N-terminal sequencing identified the cleavage site A149 
of the N-terminus. 
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Other proteases like trypsin, subtilisin and proteinase K completely degraded the protein 
without generating distinct bands for further analysis. Pepsin, cleaving N-terminally of 
phenylalanines, shows a gradual proteolysis with many bands appearing. Due to difficult 
separation of the resulting bands and the mostly internally located phenylalanines, Pepsin 
was dismissed from the selection. However, limited proteolysis by elastase yielded two 
distinct bands with lower molecular weight (see figure 4.1). To determine the exact 
cleavage site of elastase, which is predicted to cleave adjacent to neutral amino acids, an 
upscaled batch of PrdA-elastase mix was prepared and subsequently analyzed by 
analytical SEC (S200 10/30) as depicted in figure 4.1. The composition for the single 
fractions collected was visualized by SDS-PAGE. Fraction 25, eluting at 13 mL, contains 
exclusively one digestion product with a slightly reduced MW compared to full length PrdA. 
This material was selected for N-terminal sequencing. The sample was applied to SDS-
PAGE and transferred onto a PVDF-membrane by WB. The transferred band was cut and 
analyzed by N-terminal sequencing. N-terminal sequencing clearly located the elastase 
cleavage site at position A149. According to bioinformatical predictions (PSIPRED, 
DISOPRED3) the elastase cleavage site is located in one of two stretches that are 
presumably highly flexible (compare figure 4.2). 
 
 
Figure 4.2: Disorder prediction for the N-terminal sequence stretch of PrdA. In the range from amino acid 80 to 
120 and 140 to 170, the protein is predicted to be highly flexible by PSIPRED DISOPRED3. The elastase cleavage 
site is located in the center of the second flexible region at A179.  
 
It has been described before that protein interaction sites are often formed by flexible 
regions that adopt a more rigid and stable conformation upon binding (Dunker et al., 2005). 
Hence, it appears likely that the flexible region 1 – 149 potentially represents an 
oligomerization site. As the cleavage site at A149 was found to lead to a soluble construct 
of PrdA with a defined oligomerization state, the truncated construct PrdA149-626 was cloned 
and expressed. 
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4.1.4 Production of N-terminally truncated PrdA 
In the following, N-terminally truncated versions of PrdA were cloned, expressed and 
purified by a two-step purification protocol using Ni-NTA and SEC (S200 26/600). PrdA149-
626 is the soluble construct that was identified by limited proteolysis. PrdA158-626 starts at the 
predicted helix6 and was additionally designed from the sequence-based SS prediction. 
Both constructs yielded soluble protein. This leads to the assumption that the 148 mostly 
flexible N-terminal residues cause the observed heavy agglomeration. In direct 
comparison, PrdA158-626 shows a non-symmetrical elution profile in SEC, whereas PrdA149-
626 elutes in one predominant symmetrical peak. Therefore, PrdA149-626 was used for further 
analysis.  
4.1.5 Thermal shift assay with PrdA 
A set of thermal shift assays for PrdA149-626 were performed to determine optimal buffer 
conditions for purification, storage and crystallization. The protein was mixed with 
SYPROOrange and the additives as described in chapter 3.6.1. As one can derive from 
figure 4.3, the protein boundaries identified from limited proteolysis and N-terminal 
sequencing (see chapter 3.5.13) led to a construct that is soluble, stable and therefore 
suitable for bioanalytical techniques. In the storage buffer PrdA149-626 shows a melting 
temperature of 51°C. The first derivative of the melting curve (see figure 4.3) possesses a 
symmetric minimum, which indicates that this construct forms one entity and partial 
denaturation of several subunits does not occur. 
 
Figure 4.3: Melting profiles for PrdA149-626. Diluting the sample with water serves as a reference. In direct 
comparison, 20% glycerol and 500 mM glutamate significantly stabilize the protein by increasing the melting 
temperature from 51°C to 56°C. On the other side, addition of 500 mM arginine led to complete diminishing of 
the fluorescence signal. Melting temperatures are given in table 4.1. 
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Addition of 20% glycerol showed a strong positive effect, which was exhibited by an 
increased melting temperature of 56°C. The same observation was made for the addition 
of 500 mM glutamate. Both chemicals can serve as protein stabilizers by shielding 
hydrophobic surface patches. Ionic interactions to positively charged surface residues are 
likely. However, upon addition of 500 mM arginine, a positively charged and chaotropic 
amino acid, PrdA149-626 does not show any melting signal, which indicates complete 
denaturation of the sample. Melting temperatures are given in table 4.1. 
 
Figure 4.4: EMBOSScharge analysis of PrdA. The sequence of PrdA was analyzed in terms of net charge over 
amino acid position. This plot shows abnormally low values for the sequence stretches 1 - 100 and 180 – 280. 
The local minima are framing a region of strong positive net charge for the amino acid positions 100 – 180.  
 
Considering that the net charge difference of glutamate and arginine might have played a 
major role in the observed difference in results, the sequence of PrdA was analyzed in 
terms of its charge over amino acid position. This analysis showed obvious commonalities 
between sequence-based flexibility analysis and net charge. The first stretch in the PrdA 
sequence shows a low net charge, as one can derive from figure 4.4. The termination of 
this glutamate rich region is accompanied by a high net charge in the stretch from amino 
acid position 100 to 180. In this region the elastase cleavage site A149 is located. This 
could signify that the removed domain is comprising an oligomerization site. Interestingly, 
the first stretch of negative net charge is followed by a second stretch that ranges from 
amino acid position 180 – 280. Observing the loss of structural order and considering that 
this second negatively charged stretch forms another interaction site, it can be 
hypothesized that this region represents another protein-protein interface. An interaction 
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between proteins with glutamate- and aspartate-rich regions has already been reported 
for the hirudin-thrombin-interaction (Sharp, 1996). 
In this case, addition of high concentrations of arginine could potentially disrupt ionic 
interactions in an interface and lead to denaturation of PrdA149-626. An important information 
for this hypothesis is the definition of the oligomerization state of this construct. 
 
Figure 4.5: Melting profiles for PrdA149-626. Comparison of melting curves after addition of KCl, chelators and 
reducing agents. PrdA149-626 does not show any significant stabilization or destabilization upon addition of 
KCl, DTT or TCEP. However, adding chelators such as EDTA and EGTA, the fluorescence signal is completely 
diminished. Melting temperatures are given in table 4.1. 
 
Further information can be extracted from figure 4.5, which shows that reducing agents 
such as DTT and TCEP do not affect protein stability, despite the fact that it has previously 
been shown that DTT can be used to induce proline reductase activity and serve as an 
electron donor (Kabisch et al., 1999). However, addition of chelating agents, such as EDTA 
and EGTA, led to complete extinction of the melting signal. This finding indicates that ions 
may play a critical role in protein stability. As soon as those ions were removed from 
PrdA149-626, the protein denatured. Calculated melting temperatures Tm are given in table 
4.1.  
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Table 4.1: Melting temperature for PrdA149-626. Melting temperatures were determined in a thermal shift assay 
applying the RUBIC Additive Screen (Hampton Research, Aliso Viejo, California, USA). Corresponding melting 
peaks are shown in figures 4.3 and 4.5. 
 
Additive Tm [°C] Additive Tm [°C] 
Control (water) 51 1 mM ZnCl2 42 
20 % glycerol 54 5 mM EDTA not detectable 
500 mM Glutamate 56 5 mM EGTA not detectable 
500 mM Arginine not detectable 5 mM DTT 50 
100 mM KCl 51 5 mM TCEP 51 
 
The presence of metal ions has been described to be essential for protein folding in many 
cases before. For instance, it was found that the intrinsically disordered protein 
Prothymosin-α requires zinc to establish protein-protein interactions. Interestingly, 
Prothymosin-α exhibits a glutamate-rich region, just as PrdA does in regions with 
significant low net charge (Garapati et al., 2018). It has also been described that zinc and 
other metal ions were bound by acidic binding motifs (Herrera et al., 2019). Indeed, it was 
observed that zinc plays a role in proline reductase melting behavior. However, in terms 
of addition of zinc, TSA results were inconsistent and varied from a positive effect of 
stabilization of the proline reductase supercomplex by ΔTm of 13°C (data not shown) to a 
destabilization by 9°C for PrdA149-626 (compare table 4.1). This suggests that the interaction 
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4.2 Proline reductase subunit PrdB 
PrdB is the 25.7 kDa subunit of the proline reductase complex that contains the active-site 
selenocystein-cystein, predicted to induce the reductive ring cleavage of D-proline. For 
PrdB, neither the structure nor protein interfaces to interaction partners are predictable.  
4.2.1 Cloning of prdBU151C 
The sequence of PrdB was amplified from the gDNA of C. difficile 630Δerm (van Eijk et 
al., 2015). As PrdB has a seleno-cystein at amino acid position 151, which is encoded by 
an alternative stop codon in E. coli expression strains, this position was mutated into a 
cysteine using PIPE cloning (prdBU151C). The mutated gene prdBU151C was subsequently 
cloned into different expression vectors. Success of cloning of the PrdBU151C mutant was 
monitored by agarose gel electrophoresis and DNA sequencing as described in chapters 
3.4.2 to 3.4.7. 
PrdB could be produced with both TEV cleavable N-terminal Strep-tag and C-terminal 
His6-tag. Either way, a large amount of pure PrdB could be isolated. The elution volume 
from a SEC (S75 16/60) suggests PrdB to be present as a monomer. 
4.2.2 Production of PrdBU151C 
PrdB could be expressed with both, a TEV cleavable N-terminal Strep-tag and C-terminal 
His6-tag. Either way, a large amount of pure PrdB could be yielded. The elution volume 
from a SEC (S75 16/60) suggests PrdB to be present as a monomer. 
4.2.3 Thermal shift assay with PrdBU151C 
For buffer optimization, PrdB was diluted to 1.5 mg/mL and mixed with SyproOrange and 
the stock solutions as described in chapter 3.6.2. In a first attempt, the melting temperature 
was determined for a variety of buffers, covering a range from 0 to 500 mM NaCl and a 
pH range from 4.0 to 10.5.  
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Figure 4.6: Thermal Shift Assay PrdBU151C. The melting temperature for the protein is shown in dependency of 
the salt concentration (blue, red, green, black) and the pH tested. In general, highest values for Tm were 
achieved with a pH between 7 and 8.5. Increasing the salt concentration, gradually led to an increased Tm.  
 
As can be derived from figure 4.6, the optimal pH for PrdBU151C ranges from 7.0 to 8.5. In 
this area the protein tolerates both, high and low salt concentrations. Interestingly, if the 
pH value drops below the theoretical pI of 5.7, there is a significant drop of Tm when high 
concentrations of NaCl are present. The effect is less pronounced for lower salt 
concentrations. The maximum melting temperature was 54°C.  
Subsequently, an additive screening was performed to identify other stabilizing 
compounds. Unsurprisingly, this experiment showed that glycerol stabilizes the protein, 
but no other stabilizing buffer components could be identified. 
4.2.4 NMR with PrdBU151C 
With a MW of 25.7 kDa, PrdBU151C is a suitable candidate to be addressed by NMR for 
structural determination. Collection and interpretation of the spectra was performed by 
Prof. Dr. Alexander Marchanka from the LU Hannover. 
For these measurements, the protein was expressed in a 2 L TB fermenter batch, which 
yielded approximately 40 mg of pure PrdBU151C. The protein was concentrated to 
20 mg/mL and dialyzed against 100 mM NaCl, 20 mM HEPES pH 8.5. The spectrum 
shown in figure 4.7 is characterized by sharp signals for N-H coupling with a chemical shift 
of approximately 6.5 – 9.5 ppm. The Cα-H coupling is shown with a shift of 3 - 5 ppm, while 
side chain protons rise in the region of 0 – 5 ppm.  
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Figure 4.7: 1D NMR spectrum of PrdBU151C. This first experiment shows sharp signal lines for characteristic 
couplings in proteins. Typical ranges for chemical shifts that occur frequently in proteins are marked by black 
bars.   
 
This first NMR experiment shows that PrdBU151C is a monomer and did not aggregate 
during the measurement, as the peaks are well resolved. This is a basic requirement for 
successful structure determination by NMR.  
Hence, PrdBU151C was labelled with 15N during another fermenter batch in M9MM. By 
replacing the natural abundant 14N with 15N, the signal for correlations is sharpened, as 
quadrupolar interactions that appear for 14N are erased. This way N-H correlations become 
interpretable. In a 2D HSQC, a folded, monodisperse protein typically shows a signal for 
each backbone N-H and additional signals for each N-H group present in sidechains. As 
asparagines and glutamines hold a primary amine group, each sidechain raises two peaks 
with the same shift for the 15N atom (110 - 115 ppm) and two shifts for the two protons 
(6 - 8 ppm). PrdBU151C possesses 9 Asn and 7 Gln, potentially leading to 32 additional 
signals in the mentioned region of the spectrum. The 15N that are incorporated into 
tryptophane’s indole ring resides in a chemical environment that differs from that of 
amines. Therefore, their chemical shifts differ strongly. Usually, signals for Trp can be 
found in a range of 125 - 125 ppm for 15N and 10 - 11 ppm for protons. As the PrdB 
sequence has only one Trp, there should be only one additional signal. With 241 backbone 
N-H pairs and described backbone couplings, PrdBU151C is expected to show 274 peaks in 
an HSQC protein fingerprint. However, this experiment showed more signals than 
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expected, with a plurality of weak signals scattered over a wide range of chemical shifts, 
attesting some structural inconsistencies, as one can see in figure 4.8. 
 
Figure 4.8: 2D NMR spectrum of PrdBU151C. The HSQC or protein fingerprint. The sample shows a well-defined 
behavior in terms of solubility and monodispersity, as the obtained peaks show sharp signals. However, the 
number of signals detected exceeds expectations.  
 
As the protein was tested at high purity, it can be excluded that the additional signals 
originate from impurities. Further, dimerization appears unlikely, as signals remain as 
sharp as before. This would not be the case for an oligomerizing or aggregating sample, 
which would show much broader peaks due to higher rotational correlation time, which 
enhances relaxation speed. Therefore, it was concluded that recombinant PrdB might 
possess different conformations. This assumption was investigated using CD 
spectroscopy and fluorescence-based melting temperature determination, both 
techniques capable to distinguish between different protein species.  
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4.2.5 CD spectroscopy with PrdBU151C 
Previous NMR experiments suggested that recombinant PrdBU151C might show several 
conformations. As this circumstance likely affects the SS content, CD spectroscopy was 
chosen to find further evidence. During SEC of PrdBU151C-His6, the main peak 
corresponding to PrdBU151C was flanked by a shoulder, indicating the presence of two 
species with variant radii of gyration. Careful fractionation of eluting species made 
comparable studies on early and late eluting material possible, although both species 
could not be separated completely. Collected samples were concentrated to 1 mg/mL and 
dialyzed against PrdB storage buffer before subjection to CD spectroscopy. Results are 
shown in figure 4.9. 
 
Figure 4.9: CD spectroscopy with PrdBU151C. The direct comparison of two spectra on PrdBU151C, corresponding 
to an early and late eluting species shows clear differences. The CD spectrum can be divided in several areas or 
interest, *1 marks the range from 190 to 240 nm, which gives information on the SS of the sample. From 250 
to 270 nm, phenylalanines contribute to the signal, indicated by *2. In the following range, *3 marks 270 to 
290 nm, where tyrosine signals can be found and finally *4 ranging from 280 to 300 nm describes tryptophane 
signals in a chiral environment. Folded PrdBU151C shows a clear signal with -4 mdeg at 290 nm. This signal cannot 
be found for the other PrdBU151C species.  
 
Comparison of the spectra for both species shows significant differences in secondary 
structure composition. SS elements give characteristic minima at 208 and 220 nm for α-
helices and at 215 nm for β-strands, which are differently pronounced. Additionally, 
comparison of the near UV range (250-300 nm) shows a change for signals induced by 
aromatic residues that are embedded in a chiral environment. The near UV CD signal is 
dependent on protein folding, rigidity and amino acid composition. PrdBU151C sequence 
analysis suggests that the signal difference at 290 nm arises from a changed environment 
for the only tryptophane that is present in PrdBU151C. As the signal giving tryptophane is 
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located at amino acid position 25, following immediately on a triple-proline-motif, an 
increased flexibility of the N-terminus could cause that observation.  
4.2.6  Intrinsic fluorescence thermal shift assay with PrdBU151C 
Previous experiments showed a difference for the CD signal of aromatic residues (Chapter 
4.2.5) as well as the presence of multiple conformations in NMR studies of PrdBU151C 
(Chapter 4.2.4). In the following intrinsic fluorescence thermal shift assay (intrinsic 
fluorescence TSA), a tryptophane fluorescence shift (350 nm → 330 nm) is caused by a 
change in the chemical environment of the sidechain. Typically, the change is part of an 
unfolding event and can therefore be used to calculate the Tm (Moon et al., 2011). Again, 
the two species of PrdBU151C, separated by SEC, were compared. The plotted ratios show 
a clear difference, as one can see in figure 4.10.  
 
 
Figure 4.10: Intrinsic fluorescence TSA with PrdBU151C. Two separated species of PrdBU151C are directly compared 
by melting the proteins and monitoring the ratio of fluorescence signals at 350 and 330 nm. For the folded 
PrdBU151C (black), a typical curve can be observed were the ratio increases upon denaturation. The unfolded 
PrdBU151C (red) shows an increased ratio from the very beginning of the experiment. The 1st derivatives of the 
melting profiles are represented as dashed lines (black and red). 
 
A high 350 nm/300 nm-ratio at the beginning of the experiment (red line) indicates that the 
tryptophane sidechain is already surrounded by a hydrophilic environment, whereas the 
curve of the second species (black line) shows a transition for the tryptophane residue, 
indicating translocation of the sidechain from a hydrophobic core to the hydrophilic solvent 
upon heat induced denaturation.  
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As the signal is based on Trp emission, this experiment confirms, that the Trp is directly 
affected by the conformational change of PrdBU151C. A closer look at the primary structure 
of PrdBU151C shows a triple-proline motif, followed by the only tryptophane present in 
PrdBU151C at position 25. This peculiar composition is likely to form disordered structures 
as predicted by sequence based structural disorder estimations (DISOPRED). So far, it is 
not clear whether both conformations are capable to interact with PrdA. 
 
Figure 4.11: N-terminal consensus sequence of PrdB. The sequence ranging from Val17 to Leu32 shows a 
conspicuous high number of prolines (red), presumably causing a high flexibility in this region. Furthermore, a 
tryptophane (green) is embedded in this area. It is remarkable that this residue represents the only tryptophane 
in the whole PrdB sequence.  
 
At present, the uncontrollability of conformational heterogeneity impedes biochemical and 
biophysical characterization of PrdBU151C. Therefore, understanding the cause for this 
heterogeneity is of critical importance. Clearly, structural elucidation of PrdBU151C by NMR 
is exclusively achievable after elimination of that behavior. It is likely that a mixture of 
conformational states prohibits crystallization of PrdBU151C and is the cause for poor 
reproducibility in PrdA-PrdB-interaction studies. Nevertheless, the intrinsic fluorescence 
TSA provides an opportunity to screen a large number of purified protein batches within a 
short time, making this goal achievable.  
Topic I: Architecture of the Clostridioides difficile proline reductase 
75 
 
4.3 Interaction of recombinant PrdA149-626 and PrdBU151C 
The isolation of a suitable fragment of PrdA (PrdA149-626, chapter 4.1.3) enabled 
experiments to further investigate the interaction between PrdB and PrdA. Both proteins, 
PrdA149-626 and PrdBU151C were expressed and purified separately, mixed in an equimolar 
ratio and subsequently characterized.  
4.3.1 SEC-MALS with PrdA149-626/PrdBU151C 
PrdA149-626 and PrdBU151C were characterized by SEC-MALS and tested for interaction. For 
each run, 8 nmol of protein sample were loaded. The injection volume was 44 µL. The 
mixture of PrdA149-626/PrdBU151C was set up using 34 µl of PrdA149-626 and 10 µl of 
PrdBU151C.  
 
Table 4.2: SEC-MALS experiments for PrdA and PrdB. Experiments were set up by mixing of PrdA149-626 and 
PrdBU151C in an equimolar ratio. The total injection volume was kept constant with 44 µL. The final 
concentration of injected sample was targeted to be 182 µM, resulting in an amount of 8 nM of protein for 





















PrdA149-626 52.5 12.4 235.6 34 0 10 420.6 182.1 
PrdBU151C 25.7 20.6 799.2 0 10 34 205.5 181.6 
PrdA149-626BU151C 78.2 14.2 182.0 34 10 0 626.1 182.0 
 
The SEC-MALS experiment was performed with a S200 10/30 increase column at a flow 
rate of 0.5 mL/min. Each injection had a volume of 44 µL. Data collection and analysis was 
performed using the ASTRA® software package, version Astra 7.3.2.19 (Wyatt 
Technology Corporation, USA). Determination of protein concentration is based on RI-
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Figure 4.12: SEC-MALS measurement of PrdA and PrdB. The chromatogram shows the refractive index (RI) of 
the complex PrdA149-626/PrdBU151C (black line), PrdA149-626 (red line) and PrdBU151C (blue line). The 
calculated molar masses of the different species are shown as dots (g/mol). The eluting species PrdA and PrdB 
are well separated and show a distinct elution volume. The mixed species PrdAB shows a shifted elution volume 
(14.7 min), compared to PrdA, indicating a protein-protein interaction.  
 
The chromatogram shows well-defined elution profiles for all species. After mixing 
PrdA149-626 and PrdBU151C, the elution is shifted towards higher MW, indicating a 
protein-protein interaction. The MW is calculated from the measured RI. Results are 
summarized in table 4.3.  
 
Table 4.3: SEC-MALS results for PrdA and PrdB. The interaction of PrdA149-626 and PrdBU151C was investigated by 
SEC-MALS. The recombinant samples were analysed as separately purified proteins and in-vitro mixed batches.  
 














PrdA 52.5 420.6 73.1 96.3 0.6 1.8 
PrdB 25.7 205.5 74.5 24.9 0.6 1.0 
PrdAB 78.2 626.1 71.2 139.4 0.6 1.8 
 
The calculated MW for PrdA149-626 is 96.3 kDa. With an expected MW for 52.5 kDa for a 
monomer, this result suggests PrdA149-626 is present as a dimer. PrdBU151C on the other 
hand elutes after 20.6 min and has a calculated MW of 24.9 kDa, which is consistent with 
a monomer with an expected size of 25.7 kDa. Mixing both proteins in equimolar amounts 
leads to a shift of the elution volume of the sample to 14.7 min. Additionally, a minor peak 
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for free PrdBU151C was observed. The main peak was determined to have a MW of 
139.4 kDa. The theoretical masses for the heterotetramer (PrdA149-626)2/(PrdBU151C)2 are 
156.4 kDa, while a heterotrimer (PrdA149-626)2/PrdBU151C adds up to 130.7 kDa. Although 
the determined mass of 139.4 kDa is closer to a heterotrimer, the complex is thought to 
be present as a heterotetramer, as the amount of free PrdBU151C was decreased to an 
extend that rules out a 2:1 complex. Further, the determined mass for the PrdA149-626 dimer 
is already settled 9% below the expected mass, which can be due to further terminal 
degradation or measuring inaccuracy. Assuming 96.3 kDa to be the true value for the MW 
of the PrdA149-626 dimer, a heterotetramer would result in a complex of 147.7 kDa, which is 
closer to the results as a heterotrimer. Also, gel band intensities on SDS-PAGES suggest 
a 2:2-ratio. Therefore, it can be concluded that PrdA149-626 and PrdBU151C form a hetero 
tetramer.  
4.3.2 SEC-SAXS with PrdA149-626/PrdBU151C 
Further, a SEC-SAXS experiment with a multi-detector setup was performed. The 
synchrotron SAXS data were collected at beamline P12 operated by EMBL Hamburg at 
the PETRA III storage ring at the DESY, Hamburg (Blanchet et al., 2015). The purified 
samples were shipped to the synchrotron in a shock-frozen state on dry ice. They were 
stored at -80°C and thawed when needed.  
To enhance complex formation PrdA149-626/PrdBU151C and PrdBU151C were crosslinked using 
15 mM DSSO. PrdA149-626 was not crosslinked, as the dimer reacted sensitively to the 
reagent with complex decomposition. The scattering was used to determine I0, Rg, the 
MW, the Porod volume and Dmax, as well as to generate an ab initio bead model of the 
proteins. Native PrdA149-626 was applied with 1.237 mg. PrdBU151C was crosslinked with 
15 mM DSSO and applied with 1.661 mg. PrdA149-626PrdBU151C was also crosslinked and 
applied with 1.64 mg. Scattering elution profiles and subtracted raw scattering is shown in 
figure 4.13.  
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Figure 4.13: SAXS measurement on PrdA and PrdB. Experimental results of the SAXS measurement, collected 
at P12 at DESY, Hamburg are shown A) The raw scattering intensities for each collected frame are shown for 
PrdA149-626 (red), PrdBU151C (blue) and in vitro mixed PrdA149-626PrdBU151C (black) complex. A set of frames were 
defined as sample and background scattering. Scattering profiles were merged and subtracted. B) Merged and 
subtracted scattering profiles for PrdA149-626 (red), PrdBU151C (blue) and the complex of PrdA149-626PrdBU151C 
(black). The scattering profiles proof a non-aggregated condition and were used for further analysis to 
determine particle specific values.  
 
The elution profile given in figure 4.13 shows that SEC separation was necessary to 
achieve high quality SAXS data. This way, aggregated material was removed and frames 
for further analysis could be selected. Merged and subtracted scattering profiles prove 
high data quality with significant signal up to relatively high scattering angles. As the 
curvature of the scattering profiles in the lowest angles up to s = 1 is convex, the samples 
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were proven to be non-aggregated. Further, the interpolated values for I0 correlate with the 
MW of the sample. The results indicate an interaction of PrdBU151C with PrdA149-626, as the 
scattering intensity at low scattering angles increases for PrdA149-626PrdBU151C. The ATSAS 
package (Version 2.8.4, 2018) was used for further analysis of particle specific characters. 
The data range selected for analysis was chosen with scattering angles as low as possible 
on the lower limit. At the higher scattering angle limit, data were used until the sRg reached 
a value of 1.3. In this range, the linear Guinier approximation is valid.  
 
Table 4.4: SEC-SAXS/MALS results for PrdA and PrdB. The measurement was collected at P12 at DESY, Hamburg. 
I0 and Rg were interpolated from the Guinier plot. Dmax and the Porod volume are determined from the 
distance distribution analysis. The MWSAXS is estimated by I0, the Porod volume and further scattering 
parameters. The MWMALS was estimated from a parallel MALS experiment.  
 






































The generation of ab initio 3D bead-models was performed by DAMMIF. Relevant 
parameters were chosen as shown in table 4.4. Several modelling approaches were 
started and compared. One important entity for data quality assessment is the Chi2 value. 
A value close to 1.0 indicates a good fit of the model to the experimental data. Models 
were generally generated by several repetitions. For PrdBU151C P1 symmetry was applied, 
as the protein is present as a monomer. As PrdA149-626 was found to be a dimer, P2 
symmetry was applied. For the complex of PrdA149-626PrdBU151C, P1 and P2 symmetries 
were tested and compared. Generated models were averaged with DAMAVER and refined 
with DAMMIN. The Chi2 values were 1.083 for PrdA149-626, 1.044 for PrdBU151C and 1.242 
for the PrdA149-626PrdBU151C complex. From the increase of I0, the interaction of PrdA149-626 
with PrdBU151C becomes intuitively visible. Calculated values such as the MW underline 
this observation. Finally, the ab initio bead model suggests a P2 symmetry-related 
interaction of the subunits, were PrdA149-626 provides a basis as a stable dimer with two 
distinct interaction sites to PrdBU151C. Hence, the resulting complex most likely possesses 
2:2 stoichiometry.  
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Figure 4.14: SEC-SAXS-Envelopes of PrdA and PrdB. Comparative SEC-SAXS experiments were performed with 
PrdBU151C, PrdA149-626 and the PrdA149-626PrdBU151C complex. A) The scattering profiles show the data range that 
have been applied for 3D ab initio modelling for PrdA149-626 (left), PrdBU151C (middle) and the PrdA149-626PrdBU151C 
complex (right). B) The distance distributions for analyzed species are given here. The shape of the distance 
distribution curve provides first ideas of the overall shape of the particles. The distance distribution for PrdA149-
626 (left) points towards an overall globular shape. PrdBU151C (middle) is much smaller than PrdA149-626 and is 
almost globular with an extension. The PrdA149-626PrdBU151C complex (right) shows a similar shape but is 
elongated in one direction, as the distance distribution runs out slowly. C) Merged and refined 3D ab initio bead 
models are shown in the surface mode. PrdA149-626 (red, left) has an irregular hexagonal shape. PrdBU151C (blue, 
middle) is described as a monomeric globular protein with a single extension. The complex PrdA149-626PrdBU151C 
(right, black) shows similarity to PrdA149-626 but it extended on two sides by appendices. 
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4.3.3 Cryo-EM with PrdA149-626/PrdBU151C  
The analysis of the complex PrdA149-626PrdBU151C by cryo-EM was performed by Deniz 
Urgular at the ThermoFisher Scientific laboratory in Eindoven, The Netherlands. PrdA149-
626 and PrdBU151C were purified separately and mixed in vitro as described before. The final 
concentration of PrdA149-626BU151C was 3.7 mg/mL. The samples were aliquoted, flash 
frozen in LN2 and shipped on dry ice and thawed for use. For screening purposes, 10 grids 
were prepared in dilution series from 2-fold to 40-fold dilution. The blotting procedure was 
performed with a Vitrobot at 4°C and a humidity of 95%. The blotting was optimized to be 
carried out with 6-7 seconds and blotting force 2. A first screening was performed at a 
Glacios 200kV electron microscope equipped with a Falcon 3 EC camera. The 
magnification was set to 150,000 x. 554 images were collected with a defocus of -2.5, -2, 
-1.5 and -1 nm from several grids. With 1:40 diluted sample, particles were separated well 
enough to start data acquisition on a 300 kV Titan Krios G4 microscope, equipped with a 
Falcon 4 camera and automated EPU workflow. The magnification was again set to 
150,000x and defocus was set to -2, -1.7, -1.4- -1.1 and -0.8 nm. Here 4133 micrographs 
were collected. Motion correction was applied and 405 images were sorted out due to a 
pixel drift of more than 50 px. Another 116 micrographs were sorted out after Ctf correction, 
as the resolution cut off was set to 4 Å. From 3612 micrographs, 1,497,349 particles were 
extracted and 985,620 were classified into only three 2D classes. These data were already 
sufficient to generate an ab initio model with 15 Å resolution. However, the particles were 
present in a single preferred orientation and hence the 2D classes showed the protein from 
one side only. Therefore, a second dataset was generated from a 1:160 dilution for 
acquisition of a dataset with a tilted specimen holder. The goniometer was tilted by 30° 
and another 1332 images were collected, from which 1323 remained after motion 
correction. Ctf estimation excluded 54 micrographs with a resolution < 4 Å. From the 
remaining 1269 micrographs, 570,490 particles were extracted and 426,695 of them were 
classified in eight 2D classes. Merging the data, further 2D classification and 3D refinement 
led to a 4.1 Å map from 872,193 particles. The Ctf estimation was refined and after 
masking and sharpening the map, a final map with 3.75 Å resolution was obtained 
(estimated by FSC1/2). However, the data shows a high degree of anisotropy, as the tilted 
dataset suffered from lower grid quality. As a consequence, merged data did not show 
significant improvements in map quality and density interpretation was not possible. Data 
processing is schematically summarized in figure 4.15. Results are shown in figure 4.16. 
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Figure 4.15: Cryo-EM workflow. The analysis of PrdA149-626PrdBU151C hetero tetramer by cryo-EM is shown. 
Datasets were collected with a Titan Krios Falcon 4 and processed with Relion. Nominal magnification was set 
to 150,000x. Pixel size is 0.65 Å. The dose rate is 4.35 e/px/sec with an exposure time of texp = 4.86 sec. Motion 
correction filtered the images with a cutoff of 50 px. Ctf-estimation was used to discard images with resolution 
worse than 4 Å. Automated particle picking was done by EPU. 2D classification showed preferred orientation 
of the particles, leading to anisotropy. An initial model was generated ab initio with a resolution of 15 Å. 
Anisotropy was meant to be addressed by collection of a tilted dataset. However, merging data was not 
sufficient to eliminate anisotropy. The final map has a spatial resolution of 3.75 Å along a two-fold rotation axis 
(estimated from FSC-1/2-value). The resolution in an orientation perpendicular to the rotation axis is lower.  
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Figure 4.16: Cryo-EM results. The map for PrdA149-626PrdBU151C, generated by Deniz Urgular (Thermo Fisher 
Scientific) after merging regular data with tilted data (compare figure 4.15) is shown. A) The map revealed a 
two-fold symmetry with a C2 rotation axis along the top view. The side view illustrates data anisotropy with a 
lower resolution due to preferred orientation of the molecules. The SAXS bead model of PrdA149-626PrdBU151C 
(see chapter 4.3.2) suggests a two-fold symmetry. B) A section from the top view showed density that was 
arranged in a linear manner, characteristically found for β-sheets. However, strong anisotropy did not allow 
clear statements of further structural elements or atomic details. C) The described pattern could be interpreted 
as a set of at least 4 β-strands, arranged in a parallel sheet. However, data anisotropy impedes accurate 
estimations of secondary structure composition. 
 
Direct comparison of the cryo-EM data to the results of SAXS measurements described 
above confirmed findings with respect to an applicable C2-symmetry of the PrdA149-
626PrdBU151C hetero-tetramer. Although the map quality was insufficient to detect the 
symmetry automatically by cryo-EM validation tools in Phenix (Afonine et al., 2018), visual 
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inspection allowed this interpretation (see figure 4.16A). In direct comparison to the SAXS 
bead model, the intact interaction of PrdBU151C and PrdA149-626 could be questioned. 
Comparing envelope shapes for the PrdA149-626 dimer to the PrdA149-626PrdBU151C tetramer 
in figure 4.14 suggests that the cryo EM map eventually shows a PrdA149-626 dimer. 
However, the data quality does not allow definite statements. Reinvestigation of the proline 
reductase subcomplex PrdA149-626PrdBU151C and its smaller subunits will hopefully lead to 
improved map quality and deliver deeper understanding of atomic details for this so far 
unknown complex. Further experiments will cover the analysis of the PrdA149-626 dimer, 
reanalysis of the PrdA149-626PrdBU151C tetramer and direct comparison to the same samples 
after crosslinking with DSSO, which should decrease the flexibility in the subcomplex 
further (Kastner et al., 2008; Stark, 2010; Adamus et al., 2019). Data anisotropy, resulting 
from only one preferred orientation in the EM grid, clearly represents the most important 
hurdle in sample preparation of the proline reductase subcomplex. It is hypothesized that 
this common phenomenon is caused by the thin layer of solvent, leading to molecular 
adsorption at the air-water interface (Chen et al., 2019). Collecting tilted datasets as it has 
been performed here, is only one of several means to overcome data anisotropy without 
applying changes to the environment of the sample. This technique is applied on a regular 
basis and well established (Zi Tan et al., 2017; Leber et al., 2018; Ghanim et al., 2019). 
However, in this study this approach was not successful, as reproducibility of high grid 
quality was not given. Another approach would be sample treatment that leads to a more 
randomized orientation. Examples are the addition of zwitter-ionic detergents, such as 
CHAPSO, or the use of grids with modified surfaces (Drulyte et al., 2018; Chen et al., 
2019; Wang et al., 2020). In conclusion, cryo-EM seems to be a valuable method to 
elucidate the architecture of C. difficiles proline reductase subcomplexes, although data 
finalization and map interpretation was not possible at the current state of research.  
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4.4 Proline reductase complex natively isolated from 
Clostridioides difficile 
The complete and untruncated complex of PrdAB was not accessible by recombinant 
protein production. Possibly, a Gram-positive expression system, such as Bacillus 
megaterium, could circumvent these difficulties and produce proteinogenic material with 
correct fold and maturation. Nevertheless, as this complex is unique for Clostridia, it 
remains unclear whether the native source supplies a specific chaperon system for correct 
complex assembly.  
Consequently, the complex of PrdAB had to be purified from its native source. In this study, 
Clostridioides difficile 630Δerm was cultivated in a proline-containing CDMM and 
harvested in the late exponential growth phase. 
4.4.1 Optimization of the existing purification protocol for the 
proline reductase complex 
The purification procedure for the proline reductase is based on the work of Kabisch et al. 
(Kabisch et al., 1999). As the protein complex was to be used for structural investigations 
and further biophysical measurements, an as gentle as possible protocol was sought. In 
order to achieve this, several changes had been applied to the previously published 
protocol to reduce the number of purification steps and to avoid an (NH4)2SO4 precipitation.  
One pellet from 1.6 L culture was resuspended in 40 mL lysis buffer. Upscaling is not 
recommended, as the following AC step does not have sufficient capacity to bind the entity 
of material, the proline reductase will consequently be removed from the column 
competitively. For direct precipitation of poorly soluble proteins immediately after cell lysis, 
40 mL of cold 2 M (NH4)2SO4 solution was added slowly under stirring, leaving the proline 
reductase complex in the soluble phase. Cell debris were removed. 
Hydrophobic interaction chromatography (HIC) was optimized with a HIC selection kit, 
identifying butyl sepharose (Butyl HP) as the affinity material with the highest specificity 
for the proline reductase complex.  
 
 




Figure 4.17: Summary improved purification of native proline reductase complex. A) Schematic workflow. Lysed 
cells were mixed with 1 M (NH4)2SO4 for precipitation of poorly soluble proteins and spun down by high 
performance centrifugation. The supernatant was split and applied to six different HIC materials for screening 
purposes. IEX chromatography was applied as an intermediate purification step. The target is polished by SEC. 
B) The cleared lysate was applied on a 5 mL Butyl HP column. The (NH4)2SO4  concentration was reduced from 
1 M to 0 M. Eluting material was analyzed by SDS-PAGE and pooled as indicated by the black box. C) A fine-
tuned KCL gradient was applied in the intermediate IEX step. Different species of proline reductase containing 
fractions were obtained and analyzed by SDS-PAGE. The latter species was pooled and kept for further 
purification. D) HIC-IEX-isolated proline reductase complex was polished by SEC. Last impurities were removed. 
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The IEX purification step, using MonoQ material, was optimized solely in salt gradient 
slope and step arrangements. An additional band was observed after IEX purification on 
the SDS-PAGE. This protein was identified to be the elongation factor G FusA. A direct 
interaction of FusA could not be confirmed by means of MST and TSA. Sequence based 
calculation of the theoretical pI shows a value of 4.91, which is close to the value for the 
proline reductase complex of 4.83. Hence, this protein might be an impurity that coelutes 
with the target. The final purification step was a SEC, using a Superose 6 16/100, 
equilibrated with PR SEC-MALS buffer, separating the PR complex from FusA. Results 
are summarized in figure 4.17. 
4.4.2 Thermal shift assay with the proline reductase complex 
In order to obtain robust protein complexes for TEM and cryo-EM, the buffer conditions for 
the proline reductase complex were revised. TSA provides a powerful tool to determine 
melting temperatures of proteins in a 96-well format. Therefore, purified proline reductase 
complex was addressed by TSA.  
In the first attempt, the pH optimum was determined as described in chapter 3.6.2. The 
calculated melting temperature was plotted against the pH value, as shown in figure 4.18. 
 
Figure 4.18: Determination pH optimum for the proline reductase complex. The TSA buffer screen was suitable 
to determine a pH dependent melting temperature. A range from pH 4 to pH 11.5 was tested by mixing the 
purified complex with different buffer substances. As a result, the ph range from 7 to 8 was found as a stability 
maximum with a Tm of 54°C. 
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The determined pH optimum was in the range of 7 to 8.5.  
Further, additive screening was performed to identify compounds that contribute to protein 
complex stability. No compounds could be identified that further increase the melting 
temperature. Addition of TCEP leads to a complete loss of melting signal. As a similar 
effect on PrdA149-626 was observed for EDTA and EGTA (compare chapter 4.1.5), it was 
contemplated that chelating agents affect complex stability. In fact, chemical features of 
TCEP do not only provide reducing properties, but also enable the molecule to act as a 
chelator. Indeed, studying the effect of EDTA and EGTA on the full proline reductase 




Figure 4.19: Melting profiles for proline reductase complex, chelators. Melting profile of the proline reductase 
complex. Addition of KCl and DTT does not affect protein stability. However, the supercomplex integrity is 
negatively affected by the addition of chelators, such as TCEP, EDTA and EGTA. 
 
Possibly, the proline reductase complex assembly is mediated by metal ions. Similar 
observations have been described before for various ions, such as zinc, copper or 
manganese (Stott et al., 1995; Sharp, 1996; Maret, 2012; Pace et al., 2014; Song et al., 
2014; Garapati et al., 2018). Hence, addition of strong chelators must be avoided in 
purification. Purification protocols were adjusted by using EDTA-free protease inhibitors. 
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4.4.3 GraFix and Blue native-PAGE 
The MW of the proline reductase complex has previously been estimated by Kabisch et 
al. using analytical SEC and a standard MW calibration (Kabisch et al., 1999). It was 
described as an 870 kDa complex, possibly representing a nonamer or decamer of trimers, 
which is in line with observations made in this study. However, as the MW estimation by 
SEC is dependent on the hydrodynamic radius and therefore on the shape of the particle, 
it usually provides relatively rough estimates only. In order to understand the architecture 
of the complex, an exact determination of the stoichiometry is required, and techniques 
that are more accurate were applied here. 
An alternative technique for MW determination is the Blue native (BN)-PAGE. This 
electrophoretic separation method does not contain denaturing or reducing agents. 
Instead, the charge required for mobility in the electric field is generated by mixing the 
protein with the anionic dye Coomassie blue G250. In many cases, Coomassie attaches 
to the surface of proteins by ionic interaction to arginines without inducing unfolding, hence 
allowing uniform mobility in an electric field. Here BN-PAGE was combined with the GraFix 
approach (Kastner et al., 2008; Stark, 2010) to stabilize the delicate complex. Here, this 
separation technique was established without crosslinkers and compared to results were 
the maximum concentration of glutar aldehyde (GA) as a crosslinker was set to 0.01 and 
0.1%. Elution profiles show high background absorption, which results from GA (compare 
figure 4.20 A). After the GraFix run, non-crosslinked proline reductase complex was 
analyzed by SDS-PAGE (figure 4.20 B). Crosslinked proline reductase complex was 
applied to the BN-PAGE with a separation range suitable for large complexes (figure 4.20 
C). 
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Figure 4.20: GraFix and BN-PAGE results for proline reductase complex. The complex was purified from 
C. difficile and analyzed in a native and crosslinked state. A) Comparative elution profiles of proline reductase 
supercomplex after gradient ultracentrifugation separation in a glycerol gradient from 15 – 35% glycerol. 
Applying 0.1% GA in the 35% glycerol phase results in three eluting species, from which two lie under one peak 
eluting after 500 seconds. The third species elutes later after almost 700 seconds (black). Decreasing the GA 
concentration by a factor of 10 leads to a retarded elution after 600 seconds. A broad peak is observed (grey). 
The control run without crosslinker shows a similar elution profile with a relatively broad peak and several 
eluting species (light gray). Time-based fractionation was applied with fractions of 100 seconds each. Fractions 
were applied to SDS-PAGE for the control and to BN-PAGE for crosslinked samples as indicated by bars in the 
corresponding colors. B) SDS-PAGE for the control separation of the proline reductase supercomplex without 
crosslinker. In fraction 6 to 10, all three subunits of the complex can be found (light grey). C) The BN-PAGE for 
samples crosslinked by 0.01% GA (grey) and 0.1% GA (black) are shown. For 0.01% GA, the elution profile is 
comparable to non-crosslinked proline reductase. Here a complex of approximately 400 kDa can be observed, 
which would correspond to a tetramer of trimers with a theoretical mass of 372 kDa. Applying higher 
concentrations of 0.1% GA, the elution profile shifts towards higher MW that is larger than 669 kDa. Precise 
MW determination is not possible here. The proline reductase complex forms three species with different 
migration depths, corresponding to three eluting species monitored in section A).  
 
The elution profiles recorded a shift in apparent MW for increasing concentrations of GA 
(see figure 4.20 A). Inspecting the SDS-PAGE for the control GraFix run in figure 4.20 B, 
one can see a good performance of separating proteins based on their size and a high 
purity of the proline reductase subcomplex. Supercomplex integrity cannot be judged from 
this SDS-PAGE, but the complex of PrdAα, PrdAβ and PrdB is maintained. Comparing the 
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elution profiles and gel patterns (Figure 4.20A and B) to those of crosslinked proline 
reductase complex (Figure 4.0 C), one can see a shift of MW from approximately 400 kDa 
to more than 800 kDa by increasing the GA concentration to 0.1%. The lower MW species 
of around 400 kDa is in line with early findings from Seto and Stadtman (Seto et al., 1976). 
However, this GA concentration-dependent mass-shift in combination with our previous 
findings, reported in this thesis, indicate that BN-PAGE is not an appropriate method to 
determine the MW, as the complex is easily losing its quaternary structure. It was shown 
in previous experiments that truncated PrdA149-626 is able to form stable dimers, while PrdB 
is present as a monomer (see also chapter 4.3). However, on the BN-PAGE these lower 
MW species of 90 kDa or 25 kDa were not observed, indicating, that although the 
supercomplex disintegrates during the electrophoresis, the PrdAB-subcomplex still 
persists. Instead, the decomposition of the PrdAB-supercomplex into 
PrdAB-heterohexamers seems to be the reason for observed results.  
4.4.4 In-situ dynamic light scattering 
Time-resolved in situ DLS experiments were performed with support from Arne Meyer (Xtal 
Concepts, Hamburg) and was used as a direct feedback for oligomerization, aggregation 
and radii calculations. The direct readout of particle conditions in various environments 
gives information on potential improvements in negative stain EM. For an accurate 
measurement, five repetitions at different concentrations ranging from 10 mg/mL to 
0.5 mg/mL of the proline reductase supercomplex were performed. The radius was 
determined to be 8.0 nm ± 1.3%. From this value the MW was calculated as 396.5 kDa ± 
3.0%, which again correlates with early findings from Seto and Stadtman (Seto et al., 
1976). Additionally, additive screening was performed to test the influence of previously 
identified additives on the oligomerization state directly (see chapter 4.4.2). PBS and 
HEPES buffers were tested in a range from pH 7 to 8 as a storage condition. Additionally, 
phosphor tungstate acid (PTA) as a negative stain reagent was tested in a pH range from 
5 to 7 and (NH4)2MoO4 at pH 7. Acetic acid and formic acid were tested at pH 4.3, 
mimicking the environment while staining with uranyl acetate (UAc) and uranyl formic acid 
(UFA). 
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Figure 4.21: Results of in situ DLS for the proline reductase complex. The protein solution was mixed in a 1:1 
ratio with different buffers (100 mM) and the scattering was observed over a period of 3 minutes. A sharp, 
defined signal that was stable over time was observed for buffer substances in the range of pH 7 to 8. For PTA, 
aggregation was observed, independent from the pH. Low pH buffers, mimicking negative stain conditions, such 
as acetate and formate show immediate heavy agglomeration. The dispersity for NH4Mo at pH 7 appears to be 
more conserved, compared to other staining methods. However, it was still negatively affected when 
comparing the signal to pure storage buffer conditions. Calculated radii and MW estimations are given in table 
4.5. 
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As has been observed before (chapter 4.4.2), the complex is most stable in the pH range 
of 7 to 8.5. In agreement to this, the DLS signal for those buffer conditions was stable over 
a longer period of time and showed neither disintegration, nor agglomeration for both, PBS 
and HEPES buffer systems. A different behavior can be seen for the sample HEPES pH 7, 
which might be elicited by improper sample treatment during the mixing procedure or 
placement under oil. In general, this observation attests high sample quality.  
 
Table 4.5: Results in-situ DLS on proline reductase complex. The data corresponds to the measurements 
depicted in figure 4.21. Calculated radii and MW estimations are given for samples mixed with storage buffers 
and negative stain reagents.  
 
Condition Radius (nm) MW (kDa) 
PBS pH 7.0 9.1 528.6 
PBS pH 7.5 8.4 431.7 
PBS pH 8.0 8.7 472.5 
HEPES pH 7.0 13.0 1185 
HEPES pH 7.5 8.8 489.2 
HEPES pH 8.0 9.1 527.4 
PTA pH 5.0 10.0 652.0 
PTA pH 6.0 10.2 674.9 
PTA pH 7.0 10.9 797.0 
Na-Acetate pH 4.3 aggregates 
Na-Formate pH 4.3 aggregates 
NH4Mo pH 7 9.9 630.8 
 
As described in chapter 4.4.2, the proline reductase complex is sensitive to low pH values. 
The in situ DLS measurements support this finding for conditions mimicking negative stain 
procedures, as heavy agglomeration was observed upon addition of acetic acid and formic 
acid at pH 4.3. This sensitivity must be considered before loading the sample onto a TEM 
grid. (NH4)2MoO4 at pH 7 seems to affect protein integrity to a lesser extent. Therefore, 
this agent can be considered a useful staining reagent, despite its low contrast in negative 
stain TEM.  
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Testing DTT and TCEP as reducing agents, it became clear that DTT has no influence on 
protein stability or integrity, as shown in figure 4.22. However, addition of TCEP leads to 
heavy agglomeration. Again, this is in agreement with the TSA results (compare chapter 
4.4.2). Due to high buffer concentrations, a pH drop is ruled out to cause this behavior. 
Calculated radii and MW estimations are summarized in table 5.5. 
 
Figure 4.22: Results of in-situ DLS for the proline reductase complex. After addition of different additives. D-
proline and DTT both did not show any effect on oligomerization of the complex. Addition of TCEP however, 
lead to immense aggregation of the proline reductase.  
 
As investigating the architecture of the complete complex is of priority, the effect of adding 
crosslinking agents was monitored by in-situ DLS with the aim to determine crosslinking 
conditions that stabilize the supercomplex.  
 
Figure 4.23: Results in situ DLS crosslinking experiments. The proline reductase complex was crosslinked with 
various concentrations of DSSO. The distance distribution of the proline reductase supercomplex gradually 
increases upon the addition of rising concentrations of the crosslinker DSSO. However, the obtained species do 
not seem to be monodisperse. 
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For this, the proline reductase was mixed with various concentrations of DSSO. The in-
situ DLS results for crosslinked proline reductase is shown in figure 4.23. 
Table 4.6: Results in-situ crosslinking experiments. Upon the addition of the crosslinker DSSO, the measured 
radius, as well as the estimated molecular weight gradually increases. 
 
Condition Radius (nm) MW (kDa) 
Control 8.4 431.6 
0.24 mM DSSO 8.5 451.5 
1.2 mM DSSO 9.4 571.7 
3.6 mM DSSO 9.8 618.2 
6.0 mM DSSO 10.5 725.1 
 
In analogy to the results of the BN-PAGE, crosslinking was introduced prior to 
measurement. Figure 4.23 shows an effect on scattering behavior, but the signal does not 
show a clear shift. At the same time, agglomeration was not observed, pointing towards a 
stabilization of a higher MW complex that is potentially present in native conditions. As one 
can see in table 4.6, both, the calculated radii, as well as the estimated MW rose with 
increasing crosslinker concentration, approaching values comparable to analytical SEC. 
This was encouraging to confidently use crosslinkers for exact size determination and 
negative stain TEM blotting. As the scattering did not shift completely to a distinct higher 
oligomeric MW species, but a fraction remained at the previous level of 8 nm, it appears 
likely, that the maximum concentration of 6 mM DSSO was not sufficient to link the 
complete amount of protein.  
4.4.5 SEC-MALS with the proline reductase complex 
SEC-MALS experiments on the proline reductase complex purified from C. difficile were 
performed with a Superose 6 10/30 increase column. The analysis was performed with the 
ASTRA® software (Wyatt Technology Corporation, USA). The complex was analyzed in 
terms of size and behavior upon crosslinking. Further, SEC-MALS was used to identify 
eluting species that are suitable for negative stain TEM grid preparation. As SEC-MALS is 
a robust method to determine MW’s, repetitive measurements with increasing 
concentration of the crosslinker DSSO were performed to determine conditions that lead 
to the highest level of crosslinking possible without the formation of aggregates. The first 
attempt of this experiment was set up with 1 mM DSSO to perform a proof of principle 
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experiment with 280 µg for both samples to enable an exact measurement and 
comparability. 
 
Figure 4.24: SEC-MALS comparison native and crosslinked proline reductase complex. Direct comparison of 
native (black) and crosslinked (red) proline reductase complex, purified from native source in a SEC-MALS 
experiment. Both samples show a distinct scattering peak. The native sample (black) has a calculated molecular 
weight of 794.2 kDa. After crosslinking the sample with 1 mM DSSO, the molecular weight shifted to 935.2 kDa. 
The elution volume is slightly shifted to a higher gyrical radius.  
 
In a direct comparison of native and crosslinked proline reductase (see figure 4.24) it was 
found that the elution volume slightly shifted to a higher hydrodynamic radius. At the same 
time, the MW shifted from 794.2 kDa to 935.2 kDa.  
As the crosslinker should neither alter the hydrodynamic radius that determines the elution 
volume from a SEC column nor the refractive index increment (dn/dc) used to calculate 
MW from scattering, these results point towards a stabilization of a decamer of PrdAB-
hetero-trimers. Unlike BN-PAGE and in situ DLS, SEC appears to be a gentler method to 
maintain the complete quaternary structure of the proline reductase supercomplex. 
However, there seems to be still dynamic disintegration and assembly on the column, 
which leads to an elution peak with higher elution volume and lower calculated MW from 
MALS. As one can see from the scattering profile, aggregates that are separated from the 
main species are formed to some extent. Considering that scattering of large aggregates 
has higher intensity, the amount of aggregate is considered as low. This is supported by a 
negligible UV signal for the elution peak that represents these aggregates. Although the 
maximal level of crosslinking was probably not reached, the peak fraction of the eluted 
complex was collected and used for negative stain TEM. At the same time, crosslinking 
was repeated with higher amounts of crosslinking agent and a more economical input of 
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proline reductase. Concentrations of DSSO tested in the range from 2 mM to 20 mM. The 
results are shown in figure 4.25. 
 
 
Figure 4.25: SEC-MALS results for increasing concentrations of crosslinker. The crosslinking agent DSSO (8 mM 
green, 10 mM blue, 15 mM black and 20 mM red) was applied to 50 µg of proline reductase complex each. The 
injected volumes and masses were kept constant. The elution volume did not change by increasing the 
crosslinker concentration. After adding 20 mM DSSO (red) to the proline reductase complex, the scattering signal 
was significantly decreased significantly. 
 
By comparing elution profiles for increasing crosslinker concentrations, the effect on the 
calculated radii and the MW was marginal for most concentrations of DSSO tested. For 
DSSO concentration below 15 mM, the content of aggregates persists at a low level, while 
concentrations above 15 mM DSSO seem to initiate agglomeration. Results are 
summarized in table 4.7. 
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Table 4.7: Summary of SEC-MALS results for increasing concentrations of crosslinker. The proline reductase 
supercomplex was mixed with different concentrations of DSSO. The native complex was addressed by MALS 
experiments with increasing crosslinker concentration.  
Sample calc. MW (kDa) Uncertainty (%) Oligo factor 
native 794.6 0.2 8.5 
1 mM DSSO 927.0 0.0 10.0 
2 mM DSSO 943.8 0.4 10.1 
3 mM DSSO 973.3 0.5 10.5 
4 mM DSSO 967.1 0.4 10.4 
8 mM DSSO 927.7 0.4 10.0 
10 mM DSSO 962.5 0.4 10.3 
15 mM DSSO 967.1 0.2 10.4 
20 mM DSSO 928.1 3.6 9.2 
Ø̅crosslinked 940.5 3.9 10.1 
 
The main species from the crosslinking with 15 mM DSSO was collected for negative stain 
TEM grid preparation. Comparisons of TEM micrographs of native and crosslinked proline 
reductase are given in chapter 4.4.7. Comparing the MW for native and crosslinked proline 
reductase supercomplex, it seems that the complex increased in size, regardless of the 
applied concentration of DSSO. This points towards a stabilization of a decameric 
supercomplex. Presumably, the supercomplex has a low stability and is present as a 
mixture of octamers and decamers when no crosslinker was applied. Crosslinking has 
been used widely for stabilization of delicate protein complexes (Schmidt et al., 2017; 
Rozbeský et al., 2018; Adamus et al., 2019; Chu et al., 2019) 
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4.4.6 SEC-SAXS with the proline reductase complex 
In analogy to SEC-MALS experiments, the proline reductase supercomplex was 
investigated with SEC-SAXS. SAXS data was collected at beamline P12 operated by 
EMBL Hamburg at the PETRA III storage ring (DESY, Hamburg, Germany). Beamline 
operation was supervised by Cy Jeffries (Blanchet et al., 2015). The supercomplex was 
crosslinked to support the complete quaternary structure, as dynamic arrangement and 
disruption of the supercomplex was derived from experiments performed by crosslink 
SEC-MALS. As expected, the scattering profile shows similarities to previous results with 
high MW aggregates, as shown in figure 4.26. Data analysis was performed with the 
ATSAS package (Franke et al., 2017). Scattering images for merging were selected based 
on a constant value for Rg, which was calculated with 9.8 nm to 9.6 nm over the images 
from 1189 to 1268. The background selection was done automatically by CHROMIXS. The 
scattering profile resulting from the subtraction of the background from the peak data was 
used for further analysis. Data analysis was used to calculate the MW, as Guinier analysis 
allows at low scattering angles from the scattering profile (Mylonas et al., 2007). The Rg 
was calculated in the Guinier range for the data points from 10 to 40. I0 was interpolated  
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Figure 4.26: Results SEC-SAXS for the proline reductase complex. The results are collected on natively purified 
and crosslinked proline reductase supercomplex. A) The raw scattering over frame number constitutes the 
elution profile of the complex. A sharp peak was separated from minor portions of aggregates and disintegrated 
complex. The background was defined in an early area of the elution. B) Subtraction of sample and background 
scattering curves resulted in this scattering profile. From the scattering intensity at low angles, I0 was derived. 
The versatile features of the curve point towards a complicated shape. C) For 3D bead model generation, 
scattering data was used to a certain scattering angle, as depicted here. The calculated curve fits the observed 
data to a high degree. D) The distance distribution unveils a number of features that were used to calculate a 
3D bead model with a Dmax of around 32.5 nm. E) The 3D bead model generated by assuming a 5-fold symmetry 
is shown. It was calculated with a Chi2 value of 1.183. 
 
with 76656.4 ± 69.2. Rg was calculated from the slope to be 10.01 ± 0.58 nm. This way 
the sRg limits were adjusted to 0.49 to 1.3. The calculated MW was 829.5 kDa to 
1237.5 kDa with a credibility of 92%. In comparison, the MW was determined by MALS 
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with 880 kDa (direct comparison to 940.5 kDa in independent SEC-MALS experiment). 
Results are summarized in table 4.8. 
Table 4.8: Results SAXS/MALS measurements for the proline reductase complex. The data is collected at 
beamline P12 at DESY, Hamburg. I0 and Rg were interpolated from the Guinier plot. Dmax and the Porod volume 
were determined with the distance distribution analysis. The MWSAXS was estimated by means of I0, the Porod 
volume and further scattering parameters. The MWMALS was estimated from a parallel MALS experiment.  
 



























The results for MW estimations correlate with previous observations made in this work 
(compare chapter GraFix and Blue native-PAGE 4.4.3, in situ DLS 4.4.4 and SEC-MALS 
4.4.5). However, exclusive MW-estimations are not suitable to prove a nonameric or 
decameric arrangement of the subunits here. The distance distribution is almost bell 
shaped but shows an overlap of two bell shaped curves. This indicates that the proline 
reductase particle has an overall globular shape featured with cavities and smaller as well 
as globular elements. The Guinier range was set to cover the data points 10 to 40 to cover 
the lowest scattering angle possible and not to exceed an sRg of 1.3. A set of 20 3D bead 
models was generated, predefining all possible and rational symmetries. The results were 
compared and assumption of a 5-fold symmetry led to the most credible results with a Chi2 
of 1.183. A 5-fold symmetry, as it is shown in figure 4.26, supports a decamer of 
PrdAB-hetero trimers. This would consist of five hexamers that have a 2-fold symmetry 
themselves, as it had been found in the chapters 4.3.2 and 4.3.3. Therefore, the SAXS-
results suggest that the proline reductase complex is a triacontamer. The models were 
used for later comparisons to negative stain TEM projections.  
4.4.7 Negative stain TEM with the proline reductase complex 
Due to the large size of the proline reductase complex, negative stain TEM as well as 
cryoEM are suitable techniques for structural investigations. Although high-resolution data 
of any proline reductase subunits are not yet available, our understanding of the exact 
stoichiometry and particle composition improved significantly by summarizing results from 
MALS, SAXS, in situ DLS and diverse crosslinking experiments. Also, complex stability  
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Figure 4.27: Comparative negative stain TEM data on the proline reductase supercomplex. A) IEX purified 
proline reductase is collected and plotted for negative stain TEM. The micrograph shows inhomogeneity and 
disintegration. B) A subsequent SEC isolation improves purity, as indicated by SDS-PAGE. However, the 
micrograph quality is not improved. C) Proline reductase is applied to GraFix, where the sample is crosslinked 
by GA, as it migrates into the glycerol gradient. The resulting micrograph shows improved size distribution of 
the particles. However, no clear preferred conformations can be observed. D) Crosslinking of the SEC-purified 
proline reductase with 15 mM DSSO and subsequent SEC-MALS analysis leads to micrographs, that are free of 
protein fragments. Also reoccurring patterns can be observed. Certain projections show a clear 5-fold-
symmetry. However, 2D-classification does not lead to evolution of higher resolution details. A first ab initio 3D 
model shows common patterns but is not refinable. All micrographs are prepared with 4% UAc staining.  Images 
are collected at HZI/ZEIM on a Carl Zeiss Libra 120 electron microscope.   
 
and reasons for protein disintegration became more transparent, so that treatment during 
grid preparation could iteratively be adjusted in parallel to ongoing experiments.  
The negative stain TEM grid preparation was performed by Mathias Müsken, HZI 
Braunschweig, Central Facility for Microscopy. Samples to be blotted on TEM grids were 
taken after preparative IEX, GraFix (GA supplemented density gradient centrifugation), 
SEC and after crosslink-SEC-MALS. The grid quality improved iteratively and final 
experiments allowed single particle picking, as one can see in figure 4.27. 
Non-crosslinked proline reductase did not lead to micrographs of sufficient quality. Figure 
4.27 A) and B) prove sample heterogeneity and disintegration. Fixation of the complex by 
GraFix (see figure 4.27 C) lead to micrographs where the size distribution of the particles 
seems to be improved. However, the images appear blurry and the particles do not seem 
to establish homogeneous conformations. Best results were achieved after crosslinking 
the proline reductase supercomplex with 15 mM DSSO for 30 minutes at RT and 
subsequent SEC-MALS isolation, as shown in figure 4.27 D). Eluting material was 
fractionated and subjected to negative staining immediately after collection. The 
micrographs prove the proline reductase supercomplex to be present as a high MW 
complex with more than 20 nm in size. This observation is in line with previous 
experiments, as discussed in the chapters 4.4.4 to 4.4.6. Moreover, it became obvious for 
certain projections that the proline reductase supercomplex assembles with a 5-fold 
symmetry, which is in agreement with SAXS-data as well (see chapter 4.4.6). However, 
particle homogeneity was considered as low, as 2D classes appeared diffuse and ab-initio 
3D reconstructions showed very low resolution. Possibly, a flexible linker region, 
connecting the central oligomerization domain with the five catalytic domains is 
responsible for the poor model quality. 
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4.4.8 Coevolution Analysis with the proline reductase complex 
Performed experiments showed that the proline reductase complex is assembled as a 
triacontamer. The three proteins, PrdAα, PrdAβ and PrdB form a hexamer that is referred 
to as subcomplex. The supercomplex is assembled from five subcomplexes, if the 
N-terminus of PrdAβ is present. To substantiate the observations made, sequence 
analysis was performed, including a HHBlits sequence alignment (Remmert et al., 2012) 
and subsequent GREMLIN analysis for the identification of coevolution clusters 
(Ovchinnikov et al., 2014). Coevolution occurs in protein-protein-interfaces that would lose 
their interaction ability if only one participating amino acid would undergo mutation. In order 
to maintain the functionality of the interface, the interacting amino acid eventually adopts 
with a second mutation, which is referred to as coevolution. 
Conservation of domains was illustrated using Jalview (Clamp et al., 2004). To make 
sequences of the proline reductase complex accessible for GREMLIN-analysis, it needed 
to be divided in sections, as the number of related and homologous proteins for the proline 
reductase is rather small. First results were generated for PrdA 1 - 200. Jackhmmer search 
aligned 120 sequences, from which 12 were removed due to a coverage below 75%. 
Therefore, an overall seq/len value of 0.6 was achieved, leading to potentially noisy data. 
For this reason, an analysis covering the whole length was not possible. In a first attempt, 
the first 200 amino acids were subjected for analysis, as shown in figure 4.28. The graph 
revealed that this sequence stretch holds three clusters with agglomerations of coevoluted 
residues. The N-terminal “Cluster I” for the residues 1 - 100 was accompanied by a high 
degree of sequence conservation. A further mentionable region was found in the range 
from amino acid position 110 to 125, showing coevolution to residues spanning a large 
stretch of the N-terminus. According to secondary structure prediction (Jones, 1999; 
Buchan et al., 2019), this stretch describes a 16 amino acid long β-strand, which possibly 
includes the whole N-terminal domain. The next “Cluster II” of coevoluted residues was 
found to range from amino acid position 170 to 200. This sequence stretch is already 
present in the truncated version of PrdA and presumably depicts the dimer-interface.  
For more reliable results and deeper analysis, the first 100 amino acids, which presumably 
depicting the decamer interface, were reused for another GREMLIN analysis (compare 
figure 4.29). Further, the PrdA sequence was truncated at the elastase cleavage site A149 
and the serinolysis cleavage site T420 for closer investigations. Here, the sequence of 
PrdB was added to the search for inter-protein interactions. Results are shown in figure 
4.30. 
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Figure 4.28: GREMLIN analysis for conservation and coevolution in PrdA1- 200. The darker and larger the blue 
dots are, the higher the degree in coevolution is. The plot displays residues in the sequence that show 
coevolution based on a BLAST search. This analysis allows predictions of interaction sites, even if the 3-
dimensional structure is unknown. For PrdA, the stretch of the first 100 amino acids shows a dense cluster of 
interacting amino acid positions. This area is also well conserved among homologs. Another interesting region 
is found from amino acid position 110 to 125, which is predicted as a long β-strand and shows coevolution to 
amino acids covering the first 100 N-terminal residues. Further, a sequence stretch starting with amino acid 
160 displays another cluster of coevoluted residues. 
 
The resubmission of the PrdA sequence 1 to 100 (see figure 4.29), covers a conserved 
domain with a high amount of coevoluted residues. In more detail, 18 pairs of amino acids 
were identified with a calculated coevolution probability of more than 75%. The amino acid 
pairs are given in table 4.9. The properties of involved residues include small and bulky 
amino acids, as well as acidic, basic, hydrophobic and aromatic residues. Despite the pair 
H11-D14 found with a probability of 96%, no potential ionic interactions have been found. 
The residues identified are predominantly hydrophobic, which are typically located in the 
hydrophobic core of a protein or in chaperone generated interfaces. 
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Figure 4.29: Detailed GREMLIN analysis of coevolution cluster I. The cluster I is located within the first 100 
amino acids of PrdA. Blue spot size and intensity represents the coevolution strength. This area shows a high 
number of residues that potentially interact, as visualized by red arrows. The prediction is based on a sequence 
comparison, with an E-value of 10-4, with 8 iterations and 50% coverage.  
 
The results for the GREMLIN analysis on the PrdA sequence ranging from amino acid 
position 1 to 100 illustrated in figure 4.29 are summarized in table 4.9. 
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Table 4.9: Summary GREMLIN coevolution analysis for PrdA. Coevoluted residues in the range of amino acid 
position 1 to 100. E-value 10-4, with 8 iterations and 50% coverage are shown.  
Pos1  Pos2 
Probabilit
y 
  Pos1  Pos2 Probability 
N 13   G 58 1.000  P 30   K 64 0.854 
C 18   F 22 0.988  A 63   G 82 0.843 
H 11   D 14 0.961  I 28   V 80 0.839 
I 3   I 57 0.957  T 4   T 7 0.834 
V 80   Y 83 0.885  F 22   N 32 0.821 
A 40   E 43 0.883  I 3   H 11 0.812 
Q 9   A 12 0.880  E 23   N 32 0.793 
I 3   T 7 0.875  D 14   I 57 0.762 
H 11   I 57 0.865  F 22   A 71 0.753 
 
Based on the conservation pattern and the density of coevoulting residues, the amino acid 
stretch M1 to Y83 is considered to depict the decamerization domain. Interestingly, this 
amino acid stretch is accompanied by a low net charge due to a high glutamate content 
(EMBOSS analysis, see figure 4.4) and is immediately followed by a flexible region 
(DISOPRED, see figure 4.2), which strengthens this hypothesis. 
The generation of P2-symmetrical subcomplexes was thought to be mediated by an amino 
acid stretch beginning at position A149 of the PrdA sequence (compare chapter 4.1). 
PrdA149-626 was further found to interact with PrdBU151C. Possible interfaces were again 
addressed by sequence submission to the GREMLIN server, as illustrated in figure 4.30. 
Due to low number of homologs, the sequence of PrdA needed to be C-terminally 
truncated to position T420. 
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Figure 4.30: Detailed GREMLIN analysis of coevolution cluster II. This cluster is found within amino acid positions 
N150 to T420 of PrdA and PrdB. Blue spot size and intensity represents the coevolution strength. The second 
cluster of coevolution is smaller than cluster I and is approximately restricted to the amino acid positions from 
N150 to E250. No coevolution was between PrdA N150 – T420 and PrdB was observed that would give detailed 
information on the interface. For PrdB only, some residues showing coevulution were identified that must be 
caused by intramolecular interactions. The prediction is based on a sequence comparison, with an E-value of 
10-4, with 8 iterations and 50% coverage. 
 
GREMLIN sequence analysis of PrdA identified an agglomeration of coevoluted residues, 
referred to as “Cluster II”. However, in comparison to Cluster I, the sequence conservation 
is lower. Hence, prediction accuracy suffers and only two pairs of coevoluted residues 
show a probability above 50%, which are the pairs I181/I193 and F187/I224. Further, no 
significant coevolution between PrdA149-420 and PrdB was detected. As a consequence, 
PrdA/PrdB-interaction is herewith predicted to be realized in the PrdAα subunit. In analogy 
to Cluster I, cooccurrence of flexible regions (compare figure 4.2) and glutamate rich region 
(compare figure 4.4) was observed, again confirming previously suggestions that 
glutamate bound ions are needed for complex integrity. 
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4.5 Summary - proline reductase complex 
Putting together observations made on full length PrdA (see chapter 4.1), certain 
peculiarities become clearer that partially explain occurring difficulties. This is true for 
sample handling and poor behavior of both, PrdA and the proline reductase supercomplex. 
Some sequence stretches in PrdA can now be classified as domains with different 
functions. Removing the N-terminal domain ranging roughly from AA M1 to V148, as it was 
found by limited proteolysis (compare chapter 4.1.3), the remaining AA A149 – N626 are 
still able to form a homo dimer of PrdA149-626, exhibiting a C2-symmetry. However, proline 
reductase supercomplex formation is prevented and previously observed agglomeration 
was diminished. Therefore, this N-terminal domain can be referred as a decamerization 
domain. It is distinguishable from the remaining PrdA by a high content of glutamines in 
the range of AA 1 to 100 and therefore shows strong local negative charges due to 
deprotonation, as visualized by EMBOSS (compare figure 4.4). Indications for ion-
mediated oligomerization were found in a TSA experiment, where tremendous 
destabilization of PrdA149-626 by chelating agents like EDTA, EGTA and TCEP was 
observed. Again, glutamines can be found in protein-protein interfaces and might be 
essential for ion-binding and oligomer formation (Krebs, 1967; Stott et al., 1995; Sharp, 
1996; Jeong et al., 2002; Pace et al., 2014; Garapati et al., 2018). The transition from 
negative to neutral charge is accompanied by a confidence of flexibility and protein binding 
prediction in the range of AA V80 – V120 (compare figure 4.2). Subsequent sequential 
analysis of this N-terminal stretch confirms the hypothesis of an oligomerization domain 
by identification of coevoluted residues (compare figures 4.28-30). This complicated 
architecture likely causes poor sample quality for recombinant PrdA production. Possible 
solutions could be the transfer to a Gram-positive expression system, such as Bacillus 
megaterium or coexpression from the whole prd-operon. Such an approach has been 
shown to be valid for protein complex production and in some cases even lead to 
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Figure 4.31: Conclusions proline reductase supercomplex. All experiments performed draw a coherent image 
of the C. difficile proline reductase supercomplex, which is summarized here. Limited proteolysis circumvented 
formation of soluble PrdA aggregates. The interaction to PrdBU151C was maintained.  
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The second domain of PrdA is referred to as PrdD-like domain, due to its sequence 
similarity to PrdD from AA E167 to T420 with 41.1% identity. PrdD is another protein 
encoded in the prd-operon with yet unknown function. The PrdD-like domain starts with 
the first positively charged section of PrdA from AA A149 - F180, followed by a second, 
large negatively charged region, again promoted by a high content of glutamines in the 
range of AA F180 – E250. Putatively, this stretch of PrdA is involved in dimer formation. 
Combining experimental results and sequence analysis, the dimerization domain is 
thought to cover the amino acid region from position A149 to T267. The remaining stretch 
ranging from G268 to T420 cannot be annotated to a function yet. Present data does not 
suggest a role in oligomerization or protein-protein-interaction. One may only hypothesize 
a role in proteolytic maturation or enzymatic activity, as this domain concludes with the 
serinolysis cleavage site. 
The following domain in PrdA (I422 to V575) will be referred to as PrdE-like domain, as it 
shares 44.5% identity and 67.1% similarity with PrdE and covers more than 150 amino 
acids. The PrdE-like domain carries the N-terminal pyruvyl group in mature PrdA. This 
domain holds the only sequence motif that can be used for sequence based structural 
prediction by Phyre2. The two most promising results depict asparaginases, that adopt an 
α/β-fold (Lubkowski et al., 1996; Sanches et al., 2003). Interestingly, those hits turn over 
amino acids, which was also found to depict a characteristic property of 
pyruvoyl-dependent enzymes. Both properties are true for the proline reductase (Ekstrom 
et al., 2001; Schmitzberger et al., 2003; Tolbert et al., 2003; Andreesen, 2004; Bale et al., 
2010; Trip et al., 2011; Jiang et al., 2013). Further this domain is thought to hold the PrdB-
interaction-site, since none of the other domains investigated showed indications for an 
interaction with PrdB.  
For PrdB itself, a concrete basis for structural elucidation was created. Still, despite 
partially promising results in gained sample amount and quality, reproducibility in batch 
generation could not be achieved. Therefore, no data suitable for structural elucidation of 
PrdB could be collected by X-ray crystallography or NMR spectroscopy. Most likely, 
obstruction was caused by an N-terminal amino acid stretch with high flexibility and 
multiple structural conformations. It was found by combination of CD spectroscopy, 
tryptophane fluorescence emission shift spectroscopy and NMR spectroscopy that PrdB 
adopts at least two distinguishable conformations, which are only insufficiently separable 
by SEC. The biological relevance of those species remains elusive. The problem must be 
addressed not only by means of purification, but probably also by testing various 
expression conditions. Tryptophane fluorescence emission shift spectroscopy provides a 
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rapid and robust method to validate folding states of recombinant PrdB. Eliminating the 
source of this complication is essential for further studies and structural elucidation of 
PrdB. Most promising attempts are given with NMR spectroscopy, which was proven to 
work in principle on PrdB (see figure 4.7). Once the sample shows homogeneity and 
chemical shifts could be annotated, the interaction sites to PrdA can be easily determined.  
One milestone in C. difficile’s proline reductase related research was passed by validating 
cryo-EM as a method suitable for data generation on the subcomplex of truncated PrdA 
and PrdB. This complex could be produced recombinantly in high amounts and good 
purity. It has been proven to be stable and was monodisperse in solution. Characterization 
of the complex was addressed by SEC-MALS, SEC-SAXS and cryo-EM, drawing a 
consistent image of a rather rigid heterotetramer, which exhibits a C2-symmetry with 
154 kDa. Future experiments will include repetition of cryo-EM data acquisition at different 
specimen tilting angles and addition of detergent or other compounds to native and 
crosslinked PrdA149-626PrdBU151C to overcome preferred particle orientation as observed in 
chapter 4.3.3 (Scheres, 2016; Zi Tan et al., 2017; Drulyte et al., 2018; Chen et al., 2019). 
This approach will hopefully lead to isotropic resolution of the subcomplex by cryo-EM 
single particle analysis. Potentially the map could be reconstructed to a resolution of more 
than 4 Å, as it had been observed to be true for the projection along the C2-symmetry axis. 
Additionally, further truncation versions of PrdA are under investigation to promote 
crystallization.  
Natively purified proline reductase complex has been accessible before and purification 
protocols were refined in order to improve sample homogeneity and stability (Seto et al., 
1976; Kabisch et al., 1999). The PrdAαβB-supercomplex was known to be present as a 
high MW assembly, lately described as a decamer or nonamer of trimers. However, 
structural assembly and details were elusive and had not been addressed for a longer 
period. With occurrence of new process resins, exhibiting improved binding properties, 
revisiting the formerly used HIC material has been a promising approach. Indeed, testing 
various resins lead to identification of a Butyl-HP resin, which had the highest affinity for 
the mature proline reductase complex among all resins tested, when 1 M (NH4)2SO4 was 
present in the buffer. As a consequence, precipitation of the complex became obsolete. 
The obtained protein mixture could easily be purified by MonoQ IEX, resulting in an almost 
pure sample after pH and salt gradient optimization. The remaining impurity, the elongation 
factor G FusA, could effectively be removed by SEC, using Superose 6 material. 
Combination of different bioanalytical approaches lead to the conclusion that the 
subcomplex of PrdAαβPrdB shows a high stability. However, the supercomplex assembly 
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depicts a flexible and dynamic process, which is not controllable by optimization of 
purification procedures or buffer composition. Instead, reliable stabilization was achieved 
by crosslinking the supercomplex with 15 mM DSSO, an amine-reactive, monofunctional 
crosslinker with a linker distance of approximately 10 Å. The stabilized sample could finally 
be addressed by SEC-SAXS, SEC-MALS and negative stain TEM, suggesting that the 
supercomplex is a pentamer of hexamers. Structural investigations on the supercomplex 
by native cryo-EM were not successful, as the complex showed heavy disintegration.  Low 
resolution negative stain TEM was optimized and the C5-symmetry was visually recorded. 
Application of the optimized crosslinking procedure for cryo-EM grid preparation could 
potentially lead to successful data collection and processing. However, due to observed 
flexibility it is likely that resulting maps will suffer from poor resolution. Still, even a low-
resolution map will be helpful for map fitting of the PrdA149-626BU151C subcomplex to 
correctly localize enzymatically active subcomplexes in the context of the supercomplex 
structure. Urgent questions are the orientation of catalytic centers within the subcomplex 
and possible effects on reactivity, as well as the exact orientation of the catalytically active 
domains towards each other in reduced and oxidized forms. Simultaneously, the 
decameric core complex, presumably mirroring the C5-symmetry, will be defined as a 
target for structural investigations. Structural information of the decamerization domain 
could potentially shed light on the relationship of oligomerization and biological function of 
the proline reductase complex. 
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5 Topic II: Structure of the Phospholipase PlaA from 
Legionella pneumophila 
Purified Strep-PlaA was provided by MSc Miriam Hiller from the Robert Koch Institute, 
Wernigerode. The material was subjected to a SEC polishing step and crystallization. 
Crystallization optimization, co-crystallization and soaking experiments were conducted to 
elucidate the determined structure of PlaA. 
5.1 Crystal structure of PlaA 
The purified protein was polished by gel filtration using a S200 10/30 Increase column, 
pre-equilibrated with PlaA SEC buffer. After SDS-PAGE, the fractions containing the main 
peak were pooled and concentrated to 8 mg/mL before subjection to crystallization, as 
shown in figure 5.1. 
 
 
Figure 5.1: SEC polishing of PlaA. A) The provided 
protein was purified by size exclusion 
chromatography, using a S200 10/30 Increase column. 
The fractions marked with a blue bar were collected 
and analyzed by SDS-PAGE. B) The SDS-PAGE of 
collected fractions shows one single band 
corresponding to PlaA. Fractions containing PlaA were 
pooled and concentrated to 8 mg/mL for 
crystallization experiments. 
Initial screening using a JCSG+ screen led to small crystals from several conditions 
containing PEG in different sizes. Therefore, optimization was performed with the aim to 
enhance crystal size. However, no high-quality crystals were achieved. It was 
hypothesized that crystallization in initial screens was successful due to the presence of 
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smaller PEG degradation products. Therefore, further optimization was performed by 
mimicking PEG degradation. This was achieved by addition of small PEG’s, i.e., ethylene 
glycol, PEG200, PEG 1K and Tacsimate, a mixture of organic acids adjusted to different 
pH-values. This approach was successful and crystallization behavior improved. 
Interestingly, the addition of the PlaA substrate lysophosphocholine (LPC) (16:0) made the 
presence of smaller PEG’s and Tacsimate unnecessary for crystallization.  
 
Figure 5.2: Structure determination of PlaA. A) Crystals grew in a condition containing 14.7% (w/v) PEG3350, 
1% (w/v) PEG 1K, 0.5% (w/v) PEG200, 8.9% (v/v) Tacsimate pH 5 and 200 mM NH4I, 1 mM CaCl2 and 1 mM 
MgCl2. B) After phase determination, seven iodine atoms were placed in the ASU with the parameters 
81.81/81.81/68.17/90/90/90. The green electron density shows the anomalous difference map at σ = 1. C) One 
molecule of PlaA was placed in the ASU. D) The topology diagram shows the arrangement of SS elements as a 
2-dimensional projection. The active site and termini are highlighted in white boxes. The fivefold central β-
sheet is surrounded by a set of α-helices. The lid is defined as the stretch between a cysteine bridge ranging 
from C243 to C272 and is present in a closed conformation. Helix α11 depicts the prominent element of the lid, 
covering the active site effectively.  
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For iodine phasing, PlaA crystals were grown in 14.7% (w/v) PEG3350, 1% (w/v) PEG 1K, 
0.5% (w/v) PEG200, 8.9% (v/v) Tacsimate pH 5 and 200 mM NH4I, 1 mM CaCl2 and 1 mM 
MgCl2. The crystal was fished and soaked in a solution of 10% w/w 1,2-butandiol, 16% 
(w/v) PEG3350, 6% (v/v) Tacsimate pH 5 and 920 mM NH4I. Two datasets with a detector 
shift (distance 140  mM and 135 mM) were collected at the SLS, Villigen, Switzerland 
(Bingel-Erlenmeyer et al., 2011). The energy was set to the lowest energy possible of 
7.000 keV (corresponding to wavelength λ = 1.771196 Å), exploiting the f’/f’’ difference 
arising from the L-I-absorption edge of iodine (5.1881 keV, 2.3898 Å). Both DS were 
collected with an oscillation range of 0.1° and 360° in total. The DS were processed on 
site by XDSGO and merged with XSCALE (Kabsch, 2010 a). Phases were determined 
with a strong anomalous signal up to 2.50 Å resolution and an overall 20-fold multiplicity 
by hkl2map and the SHELX-package (Pape et al., 2004). The FOM was determined to be 
0.779, indicating a successful phasing procedure. Subsequently, an initial poly-alanine 
model was generated, which was used later as a reference model. Seven iodine atoms in 
total could be positioned in the map.  
 
 
Figure 5.3: Ligand coordination in the active 
site of PlaA. After refinement, additional 
density was found in the center of PlaA, 
filling the space in a hydrophobic pocket in 
proximity to the active site. Due to small 
PEGs in the crystallization condition, this 
density was considered to arise from PEG 
(n = 3) 
 
The observed behavior in crystallization already suggested that smaller PEG molecules 
are essential for crystallization of PlaA. Indeed, after refining the model, additional electron 
density was found in the center of the protein, as shown in figure 5.3. Due to its elongated 
shape, it was interpreted to arise from short PEG molecules. As the coordinated PEG was 
located in a hydrophobic channel in close proximity to the active site, a mimicking 
mechanism was assumed. The PEG degradation product shows similarity to a long chain 
fatty acid, one of the reaction products of LPC hydrolysis. 
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Table 5.1.: Data collection and refinement statistics PlaA. Two datasets are collected from a PlaA crystal. Data 
collection was performed at the SLS at low energy to record f’-f’’-differences remote from Iodine L-I absorption 
edge. In between the datasets the detector distance was shifted from 140 mM to 135 mM. Datasets were merged 
by XSCALE and phases were determined by hkl2map. Refinement was performed using phenix.refine. Statistics for 
the highest-resolution shell are shown in parentheses. 
 










Wavelength [λ] 1.771 1.771  
Resolution range 
[Å] 
49.3 - 2.3 (2.4 - 2.3) 49.3 - 2.4 (2.5 – 2.4) 10.3 – 2.3 (2.4 – 2.3) 
Space group P 3 (143) P 31 2 1 (150) P 31 2 1 (150) 
Unit cell a/b/c [Å] 







Total reflections 226470 (33141) 217967 (33848) 444207 (19394) 
Unique reflections 22580 (3631) 21455 (3469) 22580 (1691) 
Multiplicity 10.0 (9.1) 10.2 (9.8) 19.7 (11.5) 
Completeness [%] 100.00 (99.90) 100.00 (99.9) 100.00 (99.7) 
Mean I/sigma(I) 11.21 (1.15) 11.20 (1.19) 15.78 (1.17) 
R-meas 17.3 (157.8) 17.6 (159.7) 16.6 (179.0) 







Reflections refinement  42349 (3515) 
Reflections R-free   2115 (173) 
R-work   0.21 (0.49) 
R-free   0.23 (0.50) 
Number non-hydrogen atoms  2455 
  macromolecules   2287 
  ligands   15 
  solvent   153 
Protein residues   290 
RMS(bonds)   0.01 
RMS(angles)   1.19 
Ramachandran favored [%]  96.18 
Ramachandran allowed [%]  3.12 
Ramachandran outliers [%]  0.69 
Rotamer outliers (%)  5.24 
Clashscore   16.27 
Average B-factor   32.29 
  macromolecules   31.77 
  ligands   65.49 
  solvent   36.78 
 
The presence of additional density in the protein core and the necessity of PEG for PlaA 
crystallization suggested that ligand addition played a key role in successful crystallization. 
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As a substrate bound ligand structure was desired to unveil reaction mechanisms, the 
substrate LPC (16:0) was added to an inactive mutant of PlaA and crystallization was 
optimized. In this experiment, any PEG was avoided to prevent competitive insertion of 
PEG molecules in the active site. In detail, a high-resolution structure of PlaA was achieved 
by adding 500 µM LPC (16:0) to a 7 mg/mL PlaA solution. The crystallization condition 
was 2.2 M (NH4)2SO4 and 0.2 M NH4-acetate. The previously experimentally determined 
structure of PlaA served as a MR search model. The structure is shown in figure 5.4. 
Statistics are summarized in table 5.2.  
 
Figure 5.4: Crystal structure of PlaA in complex with palmitic acid. A) A single crystal grew upon addition of 
500 µM LPC (16:0) from a 7 mg/mL protein solution in a crystallization condition containing 2.2 M (NH4)2SO4 
and 0.2 M NH4-acetate. Data was collected at DESY P11 and phases were determined by MR with a previously 
generated model. B) The high-resolution structure of PlaA shows the same structure compared to the 
experimentally determined model (RMSD = 0.122 over 1817 atoms). C) The lid of PlaA was found in a closed 
conformation. The helix α11 efficiently shields the substrate tunnel from the solvent. The ProA cleavage site 
for maturation of PlaA is depicted in red. The stabilizing cysteine bridge Cys243 - Cys272 is shown as yellow 
stick-model. D) Palmitic acid was found as a ligand bound to PlaA, occupying a hydrophobic channel. The 
carboxyl group was found in close proximity to the mutated active site Ser30, Asn278, His282.  
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Interestingly, despite of using the inactive mutant PlaAD278N for crystallization, the substrate 
LPC (16:0) reacted to palmitic acid and, presumably, glycerol-3-phosphocholine (G3P). 
This might be possible from residual activity or autohydrolysis of the compound. The 
substrate and G3P were not found to be present in the structure. However, the reaction 
product palmitic acid was clearly located in the hydrophobic binding tunnel. The carboxyl 
group was pointing towards the active site, indicating a correct and not a random insertion 
of the reaction product. 
Table 5.2: Data collection and refinement statistics PlaA, ligand structure. A high-resolution dataset is collected 
from a PlaA crystal after co-crystallization with the substrate LPC (16:0). Data collection was performed at DESY 
P11 at a wavelength of 1 Å. Statistics for the highest-resolution shell are shown in parentheses. 
 
Data collection Refinement 
Wavelength [Å] 1.000 Reflections used in refinement 
46400 
(4574) 
Resolution range [Å] 41.4 - 1.4 (1.5 - 1.4) Reflections used for R-free 2386 (257) 
Space group P 31 2 1 (150) R-work 0.17 (0.26) 
Unit cell a/b/c [Å] 82.85/82.85/68.60 R-free 0.20 (0.27) 
Unit cell α/β/γ [°] 90/90/120 
Number of non-hydrogen 
atoms 
2592 
Total reflections 855868 (136795)   macromolecules 2314 
Unique reflections 45174 (8501)   ligands 84 
Multiplicity    solvent 194 
Completeness (%) 99.99 (98.80) Protein residues 290 
Mean I/sigma(I) 29.4 (1.65) RMS (bonds) 0.01 
Wilson B-factor 16.58 RMS (angles) 1.28 
R-meas (%) 6.1 (150.2) Ramachandran favored (%) 97.20 
CC1/2 100.0 (65.4) Ramachandran allowed (%) 2.80 
  Ramachandran outliers (%) 0.00 
  Rotamer outliers (%) 5.98 
  Clashscore 18.34 
  Average B-factor 24.30 
    macromolecules 22.76 
    ligands 45.88 
    solvent 33.27 
 
PlaA is a canonical GDSL hydrolase with an α/β-hydrolase fold (Flieger et al., 2004), as 
confirmed by crystallization and experimental phasing, shown in figure 5.2. The core 
β-sheet consists of 5 β-strands and is surrounded by a set of α-helices. The structure 
unveiled a lid domain, ranging from C243 to C272. This lid was found in a closed 
conformation, as structural comparisons proved (Jeong et al., 2002; Secundo et al., 2004; 
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Schleberger et al., 2007; Khan et al., 2017). Interestingly, it is stabilized by a disulfide bond 
located at its boundaries. The proteolytic cleavage site is known to be present in an amino 
acid stretch at the C-terminal end of the lid (Lang et al., 2017). The access to the active 
site and the hydrophobic binding pocket is effectively shielded by α-helix α11. Hence, it 
appears likely, that proteolytic maturation and activation of PlaA by ProA induces high 
flexibility in the lid structure and enables access of substrates to the active site. 
Considering the lid to be flexible upon maturation, substrate binding is not explained 
entirely yet. Insertion of the long hydrophobic C16 chain through a small whole is 
energetically unlikely. Hence, an opening mechanism is considered, that opens the 
hydrophobic binding tunnel laterally. This could easily be achieved by removing the C-
terminal helix α12, as demonstrated in figure 5.5. Considering α12 to be flexible explains 
how the substrate binding event could be thermodynamically enabled.  
Another feature of PlaA can now be described by the generated structure. If unmatured, 
PlaA shows an activity towards an alternative substrate, cholesteryl palmitate. While the 
biological relevance remains unclear, potential binding motifs on the surface of PlaA could 
be identified as shown in figure 5.6. However, co-crystallization with this substrate failed, 
as those hydrophobic surface residues are involved in crystal contact formation. 
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Figure 5.5: Ligand coordination in PlaA. A) Considering the C-terminus and α12 to be flexible before ligand 
binding, the hydrophobic binding tunnel becomes solvent accessible. This flexibility appears to be necessary for 
ligand insertion. B) The bound product appears in close proximity to the active site. However, in case of opening 
the entry site, the residues Asn278 and His282 are considered to be present in a disordered state as well. C) A 
water molecule is tightly coordinated by the backbone nitrogen of Ser30 and Gly86. The catalytic triad describes 
the proton subtraction by Asn278 from His282. The generated electron delocalization induces electron transfer 
from His282 to Ser30 and hydrolysis of the substrate. The water molecule is most likely to be bound in the 
oxyanion hole after successful subtraction of the electrons. 
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Figure 5.6: Atomic details of putative cholesteryl palmitate binding site. The aromatic residues Tyr40, Tyr82, 
Phe84, Phe99 and Phe100 are located on the surface of PlaA and depict potential binding sites for the ring 
system typically found in cholesteryl derivatives. The side chains are located in close proximity to the lid domain.  
 
Assuming increased flexibility of the lid domain upon cleavage at position 266, a structural 
rearrangement depicts the most likely reason for activity induction towards the natural 
substrate LPC (16:0). Simultaneously, the same structural rearrangement could potentially 
diminish cholesteryl palmitate activity by sterical blocking of the surface located aromatic 
sidechains.  
Together our data describe the relation of proteolytic maturation, activation and substrate 
specificity of PlaA. Upon secretion by the type II secretion system (T2SS), the metallo 
protease ProA (Hales et al., 1999; Truchan et al., 2017) cleaves the PlaA backbone in the 
range of the amino acids S260-L270, preferably at E266-L267 (Lang et al., 2017). The 
cleavage presumably brings a high degree of flexibility to the lid, which is structurally 
defined to cover the amino acid range surrounded by the disulfide bond C243 to C273. At 
the same time, the disulfide bond stabilizes the residual structural integrity of PlaA.  
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6 Topic II: Structure of the Phospholipase PlaB from 
Legionella pneumophila 
To decipher the molecular basis for PlaB’s unusual activation mechanism (compare 
chapter 1.2.4) and to gain insight into determinants of membrane association, the crystal 
structure of PlaB has been determined and corroborated the importance of structural 
elements by mutational analysis. This allowed identification of sequence motifs required 
for proper localization of PlaB and, interestingly, a NAD(H)-mediated tetramerization 
mechanism that controls activity and hence is suited to protect L. pneumophila from self-
inflicted lysis.  
6.1 Recombinant protein production of PlaBD203N 
All expressed constructs were generated and provided by Dr. Katja Kuhle and Dr. Wiebke 
Michel from the Robert Koch Institute, Wernigerode. PlaBD203N, the PlaB version that 
carries a mutation in the active site was used for crystallization, was purified with an 
N-terminal Strep-tag and polished by SEC as shown in figure 6.1. 
 
Figure 6.1: SEC on PlaBD20N. Strep-tagged PlaB was expressed in E. coli BL21 cells. Cell lysate was applied on an 
8 mL Strep-Tactin column and eluted. Pooled material was applied polished by SEC (S200 10/30 increase). 
Fractions were analyzed by SDS-PAGE. The main peak was pooled and further used for crystallization. M: 
Marker, P: cell pellet, L: cell lysate, FT: Strep-Tactin flowthrough, E: Strep-Tactin elution, 1-4: SEC fractions. 
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The purified protein was addressed by several biophysical techniques and subjected to 
crystallization. 
6.2 Thermal shift assay with PlaBD203N 
In order to improve crystallization properties and diffraction quality, the buffer suitability for 
PlaB was addressed by a TSA. Buffer screening did not lead to any further improvement 
of the melting temperature. However, additive screening showed interesting alterations in 
the melting behavior upon addition of certain chemicals. The TSA assays were performed 
by mixing 5 µL protein solution at 2 mg/mL with 5 µL SYPRO® Orange (1:50 diluted from 
provided 5000x stock solution, Invitrogen, USA), 5 µL of 8-fold buffer (1200 mM NaCl and 
400 mM Tris pH 8), and 35 µL RUBIC Additive Screen (Molecular Dimensions, USA) in a 
96-well plate. Data was collected with a C1000 Touch™ Thermal Cycler, equipped with a 
CFX96™ Real-Time System from 4°C to 95°C in 1°C increments. TSA data was analyzed 
with the software BIO-RAD CFX96 Manager 3.1 (BIO-RAD, USA). 
 
 
Figure 6.2: Thermal shift assay with PlaBD203N. The results showed interesting behavior when nicotinic acid or 
NAD was added to the protein. Upon dilution with water, PlaB exhibits a broad melting signal starting at 35°C, 
ranging up to 58°C with a minimum at 47°C and a barely visible shoulder at approximately 40°C. When nicotinic 
acid was added to the protein, the two minima become more distinct. However, when NADH was added to 
PlaB, the minimum at 40°C is strongly reduced. At the same time, addition of NADH lead to a tremendous shift 
of melting signal towards the higher temperature melting minimum. The previously observed shoulder was 
almost completely diminished.  
 
The curves in figure 6.2 show how the addition of nicotinic acid or NADH altered the melting 
behavior of PlaB. While the melting profile showed a flat curve with a minimum at 47°C 













  Water, Tm = 47°C
  5mM Nicotinic acid, Tm = 48°C
  1mM NADH, 1mM MgCl2, Tm = 49°C
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melting curve towards the species with the higher melting temperature. The shoulder on 
the other hand was drastically reduced. This indicated that addition of those chemicals 
lead to a more homogeneous sample (Chari et al., 2015). Based on general 
understanding, improvements not only of the melting temperature but also peak symmetry, 
leads to improved crystallization behavior (Boivin et al., 2013; Chari et al., 2015). 
Consequently, addition of the NAD+-derivative SNAD was a strategy followed in the 
process of structural investigation. 
6.3 Crystallization of PlaBD203N 
Extensive efforts were required to obtain high-quality crystals from PlaB. Most crystals 
suffered from strong anisotropic diffraction and streaky, overlapping reflections. Initial 
crystallization conditions were identified with the vapor diffusion method in sitting drops 
consisting of 200 nL protein solution at a concentration of 1 mg/mL to 6 mg/mL mixed with 
the same volume of precipitant and equilibrated against 60 µL reservoir at 20°C. 
Precipitants yielding crystals were optimized in grid and random screens. Microseeding 
experiments were performed with an OryxNano liquid dispenser (Douglas Instruments, 
UK), using 100 nL seed stock of native PlaB crystals broken up in 500 µL of the 
corresponding reservoir and 300 nL SeMet PlaB at 4 mg/mL mixed with 200 nL precipitant 
solution. At later stages, crystals were further optimized by pre-incubating the protein with 
1 mM thio-nicotinamidedinucleotide (SNAD). Crystallization conditions used in this study 
are summarized in table 6.1. 
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Table 6.1: Crystallization conditions for PlaBD203N. All batches were polished with PlaB SEC buffer. After extensive 
screening, crystals of highest quality were identified experimentally and selected for data collection. As 
crystallization was hampered by unknown reasons at first, seeding from a rod-shaped crystal, grown within 150 
days from Oswald ripening, was applied. The seed stock was used to generate a single rod-shaped crystal from 
seleno-L-methionine derivatized PlaBD203N to solve the phase problem by experimental SAD-phasing. Another 
dataset was collected from crystals grown in an environment containing 1 mM thio-nicotinamidedinucleotide. 
Those crystals showed improved diffraction properties. 
 
Crystal Seed stock generation Experimental phasing, P21 SNAD addition, P1 
Buffer 100 mM HEPES pH 7 - - 100 mM Tris pH 8.5 
Salt 18.9 mM LiSO4 77.8 mM  NaSNC 18.9 mM LiSO4 
Polymer 8.89% w/v PEG mME 5k 5.44% v/v PEG400 - - 
Alcohol - - 1.67% v/v Glycerol 9.22% v/v 2-Propanol 
Additive 5% v/v Tacsimate 
pH7 








 Crystal developed by Oswald 
ripening within 150 days. 
Generation of seed stock 
Seleno-L-methionine 
derivatized crystal, used for 
experimental phasing. 
Generated from seed stock. 
Crystals grown after addition 
of 1 mM SNAD, enhanced 
diffraction qualities. 
 
Diffraction data collection proceeded with crystals obtained with precipitation conditions 
consisting of 100 mM Tris pH 8.5, 8.33% (v/v) glycerol, 10.8% (v/v) 2-propanol (native 
PlaB) and 77.8 mM NaSCN, 1.67% (v/v) glycerol, 5.44% (v/v) PEG400, 11.6% (v/v) 2-
Propanol and 4.11% (v/v) Tacsimate (SeMet PlaB). After fishing, crystals were 
cryoprotected by washing in mother liquor supplemented with 
10 % (v/v) (2R,3R)-(−)-2,3-butandiole before flash-cooling in liquid nitrogen. Diffraction 
data were collected on beamlines P11 (PETRAIII, DESY Hamburg, Germany) and PXIII 
(SLS, Paul Scherrer Institute, Villigen, Switzerland (Bingel-Erlenmeyer et al., 2011)). 
Indexing, integration and scaling was achieved with XDS and XSCALE (Kabsch, 2010 a;  
b), as summarized in table 6.2. The structure was finally determined at 2.5 Å resolution by 
single-wavelength anomalous dispersion experiment on a seleno-L-methionine labeled 
crystal obtained by seeding, collected at the K-absorption edge of selenium. This crystal 
belonged to space group P21 and the asymmetric unit contained four chains that arrange 
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as a tetramer best described as a dimer of dimers. Heavy atom positions were identified 
with hkl2map (Pape et al., 2004) and forwarded to phenix.phaser (McCoy et al., 2007) of 
the PHENIX software suite (Adams et al., 2010). Initial model generation was performed 
with phenix.autobuild (Terwilliger et al., 2007) and supplemented by manual model 
building of poorly defined regions in Coot (Emsley et al., 2010) from the CCP4 software 
suite (Winn et al., 2011). Further refinement involved alternating rounds of manual 
adjustments and optimization in phenix.refine (Afonine et al., 2012). Model statistics are 
provided in table 6.2. High R-values are due to detected tNCS. The generated structure 
was further used as a MR model for another dataset, which was collected from a crystal 
that grew upon the addition of 1 mM SNAD. This crystal belonged to spacegroup P1 and 
showed good isotropy and well-defined peaks. No tNCS was detected for the data from 
cocrystallization with SNAD. Statistics are summarized in table 6.2 
6.4 Crystal structure of PlaBD203N 
PlaB crystallized in a tetrameric arrangement build from two identical dimers A and A’, as 
shown in figure 6.3. The PlaB monomer consists of two domains. An N-terminal domain 
(NTD) comprises a common α/β-hydrolase fold (ABH) (David et al., 1992; Schrag et al., 
1997; Suplatov et al., 2012; Rauwerdink et al., 2015; Mindrebo et al., 2016), also found in 
other phospholipases (Rauwerdink et al., 2015). The internal β-sheet consists of 6 parallel 
β-strands (β2-β1-β3-β4-β5-β8 in the order of structural succession), antiparallelly 
complemented by β18 from a second PlaB molecule, forming a dimer bridging. The 
β-sheet is surrounded by a set of 17 α-helices (α1 to α17) representing the full ABH. The 
active site was determined previously as S85/D203/H251 (Bender et al., 2009) and was 
now structurally confirmed. It is embedded in the loops between the secondary structure 
elements β3-α5, α13-α14 and β8-α15 respectively. A lid structure (G127-G144; α8-α9), 
often found for proteins with an ABH (Tiesinga et al., 2007; Khan et al., 2017; Zhao et al., 
2017), was found in a closed conformation. The NTD is followed by a unique C-terminal 
domain (CTD), starting at aa position Y325. It is terminated by the amino acid stretch R446 
to D474 (in the following designated as hook). The CTD forms a bilobed β-sandwich that 
is complemented by intrusion of the non-canonical element β6/β7 from the NTD. 
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Figure 6.3: The crystal structure of PlaBD203N. The tetrameric arrangement is depicted as a dimer of dimers. 
Monomers of dimer A are shown in a color gradient on the upper left and in grey on the upper right half. The 
dimer interface is mainly established by a C-terminal amino acid stretch, referred to as hook (red) that is 
attached to a second PlaB molecule. The second dimer is shown in the lower half of the image. 
 
The hook extends the CTD and links two monomers to a dimer by interaction to the NTD 
of a second PlaB molecule and complements the ABH. The dimer interface was classified 
as stable by PISA-analysis with an energy gain of approximately -30 kcal/mol (Krissinel et 
al., 2007). Cation-π-interaction partners at the surface of the CTD decorate the tetramer 
interface and face each other in the center of the oligomer.  
DALI search (Holm et al., 2016) resulted in a set of proteins which have a similar structure 
for the NTD from Bacillus ssp., Geobacillus spp., or Streptomyces, (1JI3 (Tyndall et al., 
2002), 1KU0 (Jeong et al., 2002), 2DSN (Matsumara et al., 2008), 2Z5G (Matsumara et 
al., 2008), 3UMJ (Basri et al., 2012), 4X6U (Dror et al., 2015), 5H6B (Zhao et al., 2017)). 
None of those showed the secondary structure elements β6/β7, α17 and β9/β10 or the 
Topic II: Structure of the Phospholipase PlaB from Legionella pneumophila 
129 
CTD. Still it is a common feature of enzymes that the ABH is combined with a second 
domain for delivery of specific properties (Hopfner et al., 1998; Bashton et al., 2007).  
Table 6.2: Data collection and refinement statistics PlaBD203N. A SeMet derivatized crystal with spacegroup P21 was 
used for experimental phase determination in a SAD experiment. The generated model was further used as partial 
model for another dataset generated from a crystal after addition of 1 mM thio-nicotinamidedinucleotide in 
spacegroup P1.  
  
SeMet structure Native structure 
Data collection 
  
Space group P21 (4) P1 (1) 
Cell dimensions   
  
    a, b, c (Å) 75.8, 170.6, 93.5 75.8, 90.7, 92.8 
    a, b, g  () 90.0, 92.9, 90.0 78.4, 90.2, 75.4 
Wavelength (Å) 0.9795 1.0004 
Resolution range (Å) 50.0 - 2.5 (2.6 – 2.5) 47.02 – 2.0 (2.1 – 2.0) 
Rmeas 22.5 (80.5) 18.5 (101.8) 
I / sI 6.26 (2.12) 4.37 (1.04) 
Completeness (%) 99.5 (99.7) 92.9 (83.0) 
Redundancy 6.91 (6.99) 1.76 (1.48) 
   
Refinement 
  
Resolution (Å) 2.5 2.0 
No. reflections 81358 157093 
Rwork / Rfree 0.27/0.32 0.22/0.27 
No. atoms 16220 16341 
    Protein 15101 14916 
    Ligand/ion 229 424 
    Water 890 1001 
B-factors 
  
    Protein 33 22 
    Ligand/ion 30 22 
R.m.s deviations 
  
    Bond lengths (Å) 0.01 0.01 
    Bond angles () 1.25 1.23 
 
The NTD has two non-canonical β-sheets (β6/β7, S216-R237 and β9/β10, K308-I321) and 
a non-canonical α-helix (α 17, R285-N305) which are exclusively found in PlaB from other 
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Legionella species but were absent in PlaB-like proteins from other organisms as identified 
by BLAST search, as shown in figure 6.4. 
 
Figure 6.4: BLAST analysis of PlaB. Among close relatives of L. pneumophila, the non-canonical feature 
β9/β10(highlighted in yellow) is conserve and shows the characteristic cation-π-pattern. Homologs from other 
lung pathogens, such as Pseudomonas aeruginosa show a close overall homology to PlaB, however they lack 




Figure 6.5: Structural architecture of PlaB. PlaB is divided in two domains, the N-terminal phospholipase domain 
(NTD, blue) and the C-terminal β-sandwich domain (CTD, red). The dimer (color gradient for monomer a and 
grey for monomer a’, left) is shown. The active site is buried under a lid in closed conformation. The non-
canonical sheet β6/β7 protrudes from the NTD and complements the CTD. The CTD evolves to a hook-like 
structure, that depicts the dimer interface. The topology diagram of a PlaB monomer (color gradient, right) 
exemplifies the α/β-hydrolase fold with the internal β-sheet (β2/β1/β3/β4/β5/β8 in the order of structural 
succession) and surrounding helices. The strand β18 is part of the hook-like dimer interface and complements 
the β-sheet in an antiparallel manner. The lid accommodates α8 and α9. The active site is depicted as red stars 
 
A PlaB mutant single point mutation (S129A) from previous studies which turns out to be 
located in the lid structure showed reduced activity towards phosphatidyl choline (PC) but 
not phosphatidyl glycerol (PG) pointing towards its function in substrate recognition 
(Bender et al., 2009). Further surface exposed residues located in the lid structure were 
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identified by structural investigations (S129, R130, R133). Mutations of these positions 
were addressed in subsequent experiments. 
 
 
Figure 6.6: Lid structure of PlaB. The molecule has a lid 
structure, which is present in a closed conformation. 
It ranges from G127 to G144, covering α8 and α9. It 
effectively shields the active site S85, D203, H251 
from the solvent. The non-canonical THSTG-Motif, 
used for classification of PlaB as the first member of a 
novel lipase family is shown, enclosing S85. Residues 
that were mutated for further analysis are labelled in 
blue.  
 
The active site served for classification of PlaB as the first and so far, only member of a 
novel phospholipase family. No further phospholipases carry the THSTG-motif with the 
serine in the active site (Bender et al., 2009). The active site was effectively shielded from 
the solvent by a lid domain, found in a closed conformation. The lid domain was structurally 
determined to reach from amino acid position G127 to G144 and includes α8 and α9. In 




Figure 6.7: Non-canonical features of PlaB. The non-
canonical structural feature β9/β10 (yellow) 
protrudes from the NTD. It is decorated with cation-π 
characters. Due to the antiparallel arrangement, a 
deletion mutant was generated. Also, the aromatic 
sidechains (highlighted in blue) were mutated to 
aspartates for further functional analysis. 
Careful inspection of the non-canonical element β9/β10 reveals suspicious aa decoration 
with aromatic and cationic sidechains, as shown in figure 6.7. The exact role was 
addressed by PlaB versions lacking the π-character were subsequently characterized in 
terms of activity and localization.  
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The C-terminal domain (CTD) is shown in figure 6.8. This bilobed β-sandwich (upper lobe: 
β6-β7 intruded from NTD, β11-β13-β14-β17 and lower lobe: β12-β15-β16) shows an 
alternating, antiparallel/parallel/antiparallel composition in the upper lobe and antiparallel 
composition in the lower lobe. Inverse structural search for similar folds using DALI did not 
lead to any similar structure known, indicating that this C-terminal β-sandwich domain 
describes a novel fold (Holm et al., 2016; Holm, 2019).  
 
 
Figure 6.8: The sheet β6/β7 of PlaB (shown in 
green) protrudes from the NTD into the CTD 
(orange and red), which is a bilobed 
β-sandwich build from 7 β-strands, which are 
complemented by the β-sheet β6/β7.  
 
 
Looking into closer detail, the CTD shows a high number of aromatic sidechains that are 
located in the tetramer interface. The exact function of those residues could not be clarified 
by generation of PlaB mutants. However, a role in membrane interaction seemed to be 
likely, as cationic arginine sidechains complement typical phospholipid interaction sites. 
Unpublished data shows that C-terminal truncation of PlaB did not affect membrane 
translocation until β12/β13 was deleted. Indeed, β12/β13 has a set of cation-π-interaction 
partners located on their surface, as shown in figure 6.9. This observation emphasizes a 
role of those residues in membrane translocation. However, further and more detailed 
investigations are needed to describe the exact role of the single residues. 
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Figure 6.9: The C-terminal domain of PlaB is 
highly decorated with aromatic and cationic 
residues. Y343 and Y346 are located in β12, 
while F362, F363, R366 and R368 are found in 
β13. Y378 may play a role in a cation-π-
interface and is found in β14.  
In chapter 6.2 the influence of nicotinic acid and NAD+ on the melting behavior of PlaB was 
described. Consequently, crystallization of PlaB with 1 mM of the NAD+-derivative SNAD 
was performed as described in chapter 6.3. Crystallographic data quality was indeed 
improved by SNAD addition and tNCS was diminished. Inspection of the protein structure 
did not reveal any conformational changes upon SNAD addition. However, strong 
additional electron density could be observed in the tetramer interface, which was 
identified to originate from eight SNAD-molecules coordinated in the interface of the 
tetramer. This finding confirms the stabilization of a well-defined species, in this case the 
tetramer, by increasing TSA melting curve symmetry (Chari et al., 2015).  
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Figure 6.10: PlaB dimer in complex with SNAD. In the upper left is monomer A in a color gradient. In the upper 
right is monomer A´ in grey. Upon SNAD addition, uninterpreted fo-fc density emerged that was located in the 
tetramer interface (green mesh, σ = 3.0). The density was interpreted to originate from added SNAD. Four 
molecules are shown in the interface of monomer A and A’ (black carbons, blue nitrogens, red oxygens, orange 
phosphorus, yellow sulfurs). The interactions involve β9/β10 (yellow), a loop region and helix α13 (green), the 
lid (cyan) and β12/β13 located in the CTD (orange). 
 
 
The localization of SNAD in the tetramer interface by binding and stabilization of diverse 
structural elements suggested that a close cross-play of oligomerization, inhibition and 
localization of PlaB exists. Given that activity was known to be inhibited by tetramerization, 
the reverse conclusion that tetramer-promoting nucleotides inhibit PlaB activity was 
addressed by measuring activity of PlaB version in absence and presence of nucleotides.  
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6.5 PlaB activity assays 
Mutant generation and activity assays were performed by Dr. Wiebke Michel, Dr. Christina 
Lang and Christian Galisch. Structure guided mutagenesis was performed to shed light on 
the mode of oligomerization and activity. Bacterial lysates of E. coli BL21 producing PlaB 
or PlaB mutants were incubated with dipalmitoylphosphatidylcholine (PC), 
dipalmitoylphosphatidylglycerol (PG), 1-monopalmitoyl-lysophosphatidylcholine (LPC), 
and 1-monopalmitoyl-lysophosphatidylglycerol (LPG) (Avanti Polar Lipids, Inc.). The 
release of fatty acids was determined using NEFA-HR(2) Assay (Wako Fujifilm) as 
described previously (Bender et al., 2009). Figure 6.11 shows the activity of the PlaB 
versions towards the different substrates.  
 
 
Figure 6.11: PlaB mutant activity assays. 
Activity assays performed with cell lysates 
with wildtype PlaB or different PlaB mutants 
(WT, inactive mutant D203N, Δβ6/β7 and 
Δhook) after adding the substrates PG, PC and 
LPC. PlaB WT showed activity towards all 
substrates. The mutants show no activity. 
Error bars indicate standard deviations (SD). 
Statistical analysis was performed using 
two-tailed, unpaired students t-test, relating 
PlaB WT to PlaB mutants. * p < 0.02 (N=3). 
 
PlaB versions D203N, Δβ6/β7 and Δhook did not show any residual enzymatic activity. 
D203N served as a negative control with a mutation silencing PlaB activity, as described 
before (Bender et al., 2009; Kuhle et al., 2014). Deletion of β6/β7 showed the same 
reduction and emphasizes the importance of this unique element. Presumably, β6/β7 
serves as an anchor, holding the CTD in a certain orientation relative towards the NTD 
and therewith enables PlaB to form homodimers, mediated by the hook structure. 
Consequently, hook deletion led to comparable results. This confirms the previously 
observed importance of the CTD and parts thereof for catalytic activity (Bender et al., 2009; 
Kuhle et al., 2014). 
Previously, a single point mutant S129A was under investigation (Bender et al., 2009). 
With the presented crystal structure, we can confirm the changed substrate specificity is 
based on the residue’s role in substrate recognition. While activity against 
phosphatidylglycerols was slightly but significantly reduced, phosphatidylcholines could 
not be turned over any more. This points towards substrate recognition of the positively 
charged choline by interaction with the hydroxyl group of S129. Structural analysis 
unveiled an exposed position of S129 in the lid structure. The sidechains of R130 and 
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R133 were also identified to present charged and surface exposed residues and were 
selected for structure guided mutagenesis. Results are shown in figure 6.12.  
 
Figure 6.12: PlaB activity assays, lid 
domain. Activity assays performed 
with cell lysates for PlaB versions 
(WT, inactive mutant D203N and lid 
mutations S129A, R130A and R133A, 
as well as a triple mutant). The color 
code refers to the lid as structural 
element to be mutated (compare 
figure 6.6). The S129A version lost 
activity towards cholesterol carrying 
PC. R130A and R133A show slightly 
reduced overall activity. The triple 
mutant lost activity towards all 
substrates tested. Error bars indicate 
SD. Statistical analysis was 
performed using two-tailed, 
unpaired students t-test, relating 
PlaB WT to PlaB versions. * p < 0.02 
(N=3). 
 
The S129A mutant could not efficiently hydrolyze PC. Further, single point mutations in 
the lid structure (R130A, R133A) showed reduced activity for all substrates tested, pointing 
towards a more common role in substrate recognition. Mutation of the cluster 
S129A/R130A/R133A showed no remaining activity. These experiments underline the 
relevance of the amino acids in the lid for substrate recognition, as already described in 
different studies (Holmquist et al., 1995; Secundo et al., 2004; Schleberger et al., 2007; 
Khan et al., 2017). Interestingly, R130 exhibits an ionic interaction to a coordinated SNAD 
molecule in the tetramer interface. Presumably, this mechanism ensures that the lid 
domain remains in a closed conformation as long as the PlaB tetramer is present.  
Another structural element of particular interest is β9/β10, as this non-canonical element 
showed a high degree of surface-exposed cationic and aromatic side chains, typically 
found in membrane interacting protein regions (Matsumara et al., 2008; Bale et al., 2010; 
Grauffel et al., 2013). Therefore, a Δβ9/β10 deletion mutant and a F310D/F316D/Y320D 
triple mutant were generated and tested on their activity, as shown in figure 6.13. Both 
versions showed reduced activities for all substrates tested.  
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Figure 6.13: PlaB activity assays, β9/β10. 
Activity assays performed on purified protein 
samples for PlaB versions (WT, inactive mutant 
D203N, Δβ9/β10 and F310D/F316D/Y320D). 
Error bars indicate SD. Statistical analysis was 
performed using two-tailed, unpaired 
students t-test, relating PlaB WT to PlaB 
versions. * p < 0.02 (N=3). 
Both PlaB versions showed a similar pattern in activity reduction, indicating that the 
aromatic side chains participate in the turnover of the substrates. The residues were 
mutated to aspartates instead of alanines, as the negatively charged side chains of the 
acid groups were meant to interact with neighboring arginines and to diminish the aromatic 
character at the same time. In β9/β10, different types of interactions are involved in the 
binding of SNAD molecules that promote tetramerization. Y320 shows a typical interaction 
of its hydroxyl group with the heteroaromatic pyridine ring system of the SNAD molecule, 
which is also coordinated by Y192 from the other side via π-stacking. Especially this 
binding site is likely causing an effect in melting behavior for nicotinic acid (compare 
chapter 6.2), which is mimicking the nicotinamide group of NAD(H). 
As β9/β10 contributes to SNAD coordination and the tetramer interface, the enzymatic 
activities of PlaB versions were compared in presence of excess NAD+ or NADH, 
respectively. Results are shown in figure 6.14.  
 
 
Figure 6.14: PlaB activity 
assays, nucleotide 
substitution. Activity assays 
performed with purified 
protein samples of PlaB 
versions (WT, D203N, 
Δβ9/β10 and 
F310D/F316D/Y320D) with 
and without 1 mM NAD+ and 
NAD(H) respectively. Error 
bars indicate SD. Statistical 
analysis was performed using 
two-tailed, unpaired students 
t-test, relating PlaB versions 
without supplemented 
nucleotides to PlaB versions 
with 1 mM NAD+ and NAD(H), 
respectively. * p < 0.02 (N=3). 
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This experiment showed a strong reduction in PlaB WT activity upon addition of NAD+ or 
NAD(H), presumably due to enhanced oligomerization mediated inhibition. The activities 
of PlaB versions Δβ9/β10 and F310D/F316D/Y320D were in general reduced compared 
to the WT. The oligomerization state in dependency of nucleotide presence was addressed 
by SEC-MALS experiments.  
6.6 SEC-MALS with PlaB 
PlaB was described to show concentration dependent oligomerization, accompanied by 
enzymatic inhibition. At low concentrations in the range below 10 nM, the protein was 
present in an active form with a MW corresponding to a dimer. At 1 μM, PlaB was strongly 
inhibited and present as a tetramer (Kuhle et al., 2014). During protein purification 
dedicated to crystallization experiments, only high concentrations of PlaB were handled. 
Therefore, almost exclusively tetrameric protein was observed during polishing SEC, as 
one can see in figure 6.15.  
 
 
Figure 6.15: SEC-MALS results for PlaBD203N. Here, 10 mg of PlaBD203N were applied in parallel runs on a GE ÄKTA 
system to monitor the absorption at 280 nm and 260 nm and the light scattering on a Wyatt SEC-MALS system. 
The elution profiles were aligned and superimposed. The tetramer was determined with a mass of 228 kDa 
(13.4 – 14.8 mL). Interestingly, the A260/A280 ratio increases to more than 0.9, indicating nucleotide binding. This 
was not true for dimeric (118 kDa, 16.1 – 17.4 ml) and monomeric (62 kDa, 17.4 – 18.3 mL) species that were 
present in minor fractions. Here, the ratio numbered to 0.7. 
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For the tetramer an increased ratio for the absorptions at 260 nm and 280 nm was 
observed, pointing towards nucleotide binding of the tetramer, as it could be suggested 
from structural inspections (see figure 6.10) and enzymatic inhibition assays (see figure 
6.14). This observation was only partly true for dimeric and monomeric species, that were 
present to much lesser extent. However, as the crystal structure unveiled β9/β10 as a non-
canonical feature, present only in close PlaB homologes, structure guided mutagenesis 
was applied to deepen understanding of the exact function. From the model, involvement 
in tetramerization, NAD+-coordination and membrane association could be derived 
already. As the sheet is of antiparallel nature, a deletion mutant could be generated. The 
deletion mutant, as well as the triple mutant F310D/F316D/Y320D showed a similarly and 
significantly reduced activity towards all substrates tested (see figure 6.13). In another 
experiment,  the inhibitory properties of the nucleotides NAD+ and NADH were observed 
for the PlaB WT but also for PlaB versions affecting β9/β10. Consequently, the oligomeric 
state of PlaB β9/β10 versions investigated by SEC-MALS, as summarized in figure 6.16. 
 
 
Figure 6.16: SEC-MALS results for PlaB mutants. SEC-MALS showed concentration dependent oligomerization 
of PlaB WT (black). PlaB is present almost exclusively as a tetramer (120 µg), as a mixture of tetramers and 
dimers (60 µg) or exclusively as dimer (30 µg). PlaB mutants Δβ9/β10 and F310D/F316D/Y320D tested on their 
oligomerization were applied with the same amounts. The mutants showed exclusive dimer formation, 
independent from the applied amount.  
 
Various amounts of protein were applied to monitor the oligomerization state in 
dependency of the local concentration of PlaB. As one can see from figure 6.16, the PlaB 
WT (black) showed a concentration-dependent behavior. The tetramer with a MW of 
216.4 kDa was found when 120 µg of PlaB were injected. Here, the local PlaB 
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concentration at the peak was determined to be 1.94 µM. Injection of 60 µg showed 
strongly reduced light scattering signal for a tetramer/dimer mixture with a calculated mixed 
mass of 173.3 kDa. Here, a second dimer peak was observed, resulting in a MW of 
117.6 kDa. The local PlaB peak concentrations were determined to be 0.41 µM and 
0.12 µM, respectively. The injection of 30 µg of PlaB only resulted in PlaB dimers with a 
calculated MW of 118.7 kDa and a peak concentration of 0.17 µM. These results are in 
line with observations made before, that showed PlaB in an inactive tetrameric state at a 
concentration above 1 µM (Kuhle et al., 2014). The β9/β10 and F310D/F310D/Y320D PlaB 
mutants on the other hand did not exhibit concentration-dependent oligomerization. 
Instead, regardless of the the amount of protein sample applied, exclusively dimers were 
observed. Local PlaB peak concentrations were determined with 1.02 µM, 0.57 µM and 
0.26 µM for Δβ9/β10 (yellow) and 2.77  µM, 1.34  µM and 0.81 µM for 
F310D/F310D/Y320D (blue). Results are summarized in table 6.3. Activity assays have 
shown inhibition upon addition of 1 mM NAD(H) (compare figure 6.14). As activity was 
linked to oligomerization, the question was addressed, whether the presence of 1 mM 
NAD+ affects tetramerization. Therefore, the SEC-MALS system was equilibrated with 
SEC-MALS buffer, supplemented with NAD+. The resulting chromatograms are 
summarized in figure 6.17. 
 
Figure 6.17: SEC-MALS results for PlaB mutants, supplemented with nucleotides. SEC-MALS experiments on 
PlaB WT (black, 60 µg, 30 µg and 15 µg), and structure guided mutants (PlaB Δβ9/β10, yellow and 
F319D/F312D/Y320D, blue) were exclusively present as tetramers after addition of 1 mM NAD+ to the SEC 
buffer. All species were almost exclusively present as tetramers, regardless of applied amounts of protein 
(60 µg, 30 µg and 15 µg) and PlaB version.  
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Indeed, addition of 1 mM NAD+ promoted PlaB tetramerization, as it had been predicted 
from structural and biochemical data gathered before. Interestingly, the concentration 
dependency for PlaB WT (black) was lost and exclusively tetramers with a MW of 225.1 
kDa ± 1.2% were observed. The local PlaB peak concentrations were determined to be 
1.12 µM, 0.44 µM and 0.24 µM. The β9/β10 mutants showed slightly differing elution 
volumes, indicating changes in the gyrical radius of the tetramer, but calculated masses 
were almost identical to the WT with 221.6 kDa ± 3.9% and 222.3 kDa ± 2.2%, 
respectively. The local PlaB peak concentrations for the mutants were determined with 
0.48 µM, 0.20 µM and 0.09 µM for Δβ9/β10 and 1.52 µM, 0.51 µM and 0.37 µM for 
F310D/F316D/Y320D. Results are summarized in table 6.3. 
Direct comparison of SEC-MALS experiments of PlaB WT and β9/β10 versions with and 
without supplemented NAD+, complement the figure drawn before. It can be concluded 
that concentration dependent tetramerization occurred when no nucleotide was 
supplemented. Concentrations of PlaB of approximately 2 µM were able to bind copurified 
nucleotides with a higher efficiency, compared to lower concentrations. The results confirm 
previous studies (Kuhle et al., 2014). The β9/β10 versions lost their ability to hold 
copurified nucleotides and were present as dimers. Still, they had the ability to form 
tetramers, when NAD+ was present in large excess.  
 
Table 6.3: Summary SEC-MALS results for PlaB variants. Results for the WT, Δβ9/β10 and F310D/F316D/Y320D 
and effect of NAD+ on tetramerization are shown. In absence of NAD+, PlaB WT forms concentration dependent 
tetramers and dimers. Δβ9/β10 and F310D/F316D/Y320D were exclusively found as dimers. Upon addition of 







regular SEC buffer applied 
amount 
[µg] 
SEC buffer + 1 mM NAD+ 
Dimer Tetramer Tetramer 






 120 - 216.4 / 1.94 60 228.3 / 1.12 
60 117.6 / 0.12 173.3 / 0.41 30 225.3 / 0.44 
30 118.7 / 0.17 - 15 221.8 / 0.24 











 120 107.8 / 1.02 - 60 217.5 / 0.48 
60 111.0 / 0.44 - 30 213.6 / 0.20 
30 106.3 / 0.24 - 15 233.7 / 0.09 






















 120 110.2 / 2.77 - 60 218.7 / 1.52 
60 113.1 / 1.34 - 30 219.1 / 0.51 
30 112.2 / 0.81 - 15 229.2 / 0.37 
mean MW 111.8 ± 1.1% - mean MW 222.3 ± 2.2% 
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Structural interpretation of the PlaB oligomer interfaces by PISA showed interesting 
properties. The hook was found to stabilize the dimer with 29.8 kcal/mol and the dimer was 
classified as a stable complex. For the tetramer, the conditions are more complex. When 
SNAD was included in the calculations, the tetramer was calculated to be stabilized by 
45 kcal/mol. However, when SNAD was removed from the model structure, almost no 
remaining energy gain was predicted for the tetramerization (Krissinel et al., 2007). This 
suggests, that the PlaB dimer is the catalytically active form of PlaB. The non-canonical 
β9/β10 sheet seems to be a multifunctional element that promotes nucleotide dependent 
oligomerization and plays an additional role in enzymatic activity, regardless of the 
oligomeric state. The inhibition in the tetrameric state arises from nucleotide binding, as 
SNAD was found to lock the lid in its closed conformation by ionic interaction. 
6.7 Cell fractionation and PlaB localization 
Despite several years of research, the translocation mechanism of PlaB to the outer 
membrane remains unclear. Deletion mutants suggest that the transport must be ensured 
either by an unknown export machinery or by an auto transport process. It has been found 
that transport of C-terminal truncated PlaB was unaffected until β12/β13 was deleted. 
However, deletion of β12/β13 lead to abrupt loss of export ability (data not published). 
Inspection of the crystal structure showed that explicitly those strands show a set of 
cation-π-interaction sites and tightly interact with coordinated SNAD molecules. Beside 
those located in β12/β13, further aromatic and cationic sidechains were observed to be 
surface exposed in the CTD. Those residues have been selected for structure guided 
mutagenesis. To prevent the denaturation of PlaB versions upon modification, target 
amino acids were selected carefully and the direct environment was taken into account.  
Cloning and cell fractionation were performed by Dr. Wiebke Michel at the RKI, 
Wernigerode. The separation of the inner and outer membranes of E. coli BL21 carrying 
different vectors was performed with changes according to Roy & Isberg (Filip et al., 1973; 
Roy et al., 1997). Results for subcellular fractionation are summarized in figure 6.18. 
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Figure 6.18: Western blot analysis on PlaB variants. WB was performed using an anti-Strep-tag antibody. It 
shows localization of strep-tagged PlaB versions after subcellular fractionation. A) PlaB versions with mutations 
in the active site, the lid domain, the noncanonical elements β6/β7 and β9/β10 as well as the hook domain 
were analysed with respect to their localization. All versions were soluble. In contrast to any other version, 
deletion of β9/β10 and modification in this element lead to the presence of PlaB at the inner membrane. B) 
PlaB version that carried modifications in the CTD did not show any striking difference in membrane localization. 
C) Culture supernatant was tested on PlaB presence. When modifications affected β9/β10, PlaB was 
additionally found in the culture supernatant. TC: total content, SC: soluble content, C: cytosol, M: membrane, 
IM: inner membrane, OM: outer membrane, L: culture lysate, S: culture supernatant. 
 
Fractions were analyzed by means of Western blotting, detecting PlaB (StrepMAB-Classic, 
HRP conjugate, Iba), the outer membrane control protein OmpA (antibody kindly provided 
by Prof. Prasadaro Nemani (Prasadarao et al., 1996), the inner membrane control protein 
LepB (antibody kindly provided by Prof. Heinje (De Buck et al., 2007, 2008; Vranckx et al., 
2007) and the cytosolic control protein DnaK (Enzo Life Sciences). 
Comparing the presence of PlaB in the different subcellular fractions as shown in figure 
6.18, one can see presence of soluble protein, presumably possible by PlaB tetramer 
formation. Changes in the amount of detected soluble PlaB could potentially arise from 
higher expression levels, enabling a higher fraction to form tetramers. All versions tested 
were also present in the membrane fraction. However, more detailed analysis and 
separate examinations showed that PlaB was originally present only at the outer 
membrane. Changes were observed when β9/β10 was affected by mutagenesis. For those 
versions, PlaB was also found at the inner membrane. The same versions did also show 
reduced ability to bind to the OM, as PlaB could be detected in the cell culture supernatant. 
Once more independent experiments emphasize the importance of β9/β10 for PlaB 
specific characteristics, such as concentration dependent tetramerization and even 
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membrane translocation and interaction. Contrary to expectations, mutation of the 
aromatic residues in β12/β13 (Y343L/R368/R373A and F362A/F363A/Y378D) did not 
show any effect on PlaB localization. However, PlaB version in which the two neighbored 
tyrosins Y415D and Y416D were mutated exhibit a similar localization pattern to PlaB 
Δβ9/β10. The tyrosins interact with R44 and R447 and are located directly in the transition 
area of CTD and hook domain. The exact role of those residues in transportation, activity 
and oligomerization still needs to be elaborated.  
6.8 Summary - Phospholipase PlaB 
To unravel the molecular basis for enzyme oligomerization, inhibition and localization, the 
crystal structure of PlaB was generated in its tetrameric form. The PlaB tetramer is a dimer 
of identical dimers. The monomer consists of an N-terminal phospholipase domain with an 
ABH-fold augmented by two non-canonical β-sheets, β6/β7 and β9/β10. The CTD reveals 
a novel fold displaying a bilobed β-sandwich with a hook structure that is required for 
dimerization and complementation of the N-terminal phospholipase domain in the 
neighboring molecule. Unexpectedly, we observed additional electron density in the 
dimer/dimer-interface, suggesting that the bound nucleotides stabilize the tetramer and 
hence lead to inactivation of the enzyme. The density was interpreted to arise from 
NAD(H). Indeed, addition of NAD+, NADH or SNAD, an NAD+ analogs to PlaB, led to 
increased melting, enhanced crystallization, reduced activity and promoted 
tetramerization. The deletion of β9/β10, which acts as a nucleotide interaction site, altered 
oligomerization, activity profiles and localization, pointing towards a multifunctional role of 
this non-canonical element. Observations made were summarized in figure 6.19. 
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Figure 6.19: Summary of results for PlaB. 
NAD(H) plays a critical role in β9/β10-
mediated and concentration dependent 
oligomerization and activity regulation. In the 
presence of NAD(H), the tetramer is stabilized 
by approximately 45 kcal/mol, which results in 
exclusive tetramer formation when 
nucleotides are present in excess. This is even 
true for the Δβ9/β10 mutant. High 
concentrations of intracellular NAD(H) 
mediate tetramer formation of PlaB and thus 
inhibits the lipolytic activity. Upon 
translocation into a nucleotide-free 
environment, PlaB tetramers dissociate 
concentration dependently into dimers, as the 
tetramer interface is now only stabilized by 
3 kcal/mol, which is considered as an unstable 
interface. The importance of β9/β10 for the 
tetramerization was shown, as mutants were 
exclusively present as dimers, when 
nucleotides were absent. Upon decomposition 
of the tetramer, β9/β10 becomes accessible 
for membrane association, which will gain 
approximately 40 kcal/mol for two dimers 
with two β9/β10-elements each upon 
insertion. Therefore, dimers will associate to 
the outer membrane of L. pneumophila and 
will be presented as the active form. NAD(H) is 
shown as green spheres. Unclear binding of 
NAD(H) at PlaB dimers is shown as light green 
sphere with dashed contour. An accessible 
catalytic centre is illustrated as yellow star. The 
restricted activity for the Δβ9/β10 version is 
illustrated as orange star.  
 
 
Together, these data reveal a novel ligand-mediated oligomerization-dependent inhibition 
mechanism that likely protects L. pneumophila from self-inflicted damage by PlaB until the 
enzyme is exported to the bacterial surface. PlaB forms tetramers, build from two dimers 
and is activated by tetramer deoligomerization. Unexpectedly, we found that inactive 
tetramers are stabilized by NAD(H) molecules bound to the dimer/dimer interface. Since 
the cytosolic concentration of NAD(H) is in the millimolar range whereas it drops to zero 
outside of the cell, we propose that this unprecedented NAD(H)-dependent oligomerization 
mechanism protects L. pneumophila from damage until PlaB is exported.  
The dimer on the other hand was found to be stabilized by 29.8 kcal/mol, independently 
from nucleotide concentrations, which was considered as stable. The antiparallel 
complementation of the sheet at β2 by β-strand β18 from a second PlaB molecule is a 





This thesis covered several distinct projects. Firstly, the proline reductase complex, a 
central metabolic key player in the nosocomial pathogen C. difficile, was addressed and 
the assembly of a hetero-triacontamer and its subunits PrdAα/β and PrdB were studied. 
Secondly, the crystal structures of the two phospholipases PlaA and PlaB, important 
virulence factors from the airborne L. pneumophila, were determined that extend our 
current understanding of their mode of action. Although the pathogens included in this 
thesis were highly divergent, experienced complications in capturing concrete protein 
oligomerization states were alike.  
For the proline reductase supercomplex, the N-terminal section of PrdA provides a 
complicated decamerization platform of unknown architecture. This is introducing high 
flexibility and a dynamic oligomerization equilibrium paired with a large molecular weight, 
making protein crystallization for structural elucidation inaccessible. The interaction of 
PrdA and PrdB is preserved, when PrdA is N-terminally truncated. The natively purified 
proline reductase complex demanded chemical crosslinking and could successfully be 
visualized at low resolution. Combination of results from various techniques showed a 
complicated assembly from 30 subunits into a supercomplex of 970 kDa and 30 nm in 
diameter, exhibiting a 5-fold symmetry. For detailed understanding however, a more 
comprehensive structural characterization, providing higher resolution, will be necessary. 
After all, the feasibility of different techniques in structural biology generated encouraging 
results for different sets of subunits. Cryo-EM on PrdA149-626PrdBU151C resulted in an 
anisotropic map with local resolution of approximately 4 Å. Negative stain TEM on the 
triacontameric proline reductase supercomplex has shown good particle distribution and 
repetitive patterns in picked particles, however, class averaging suffered from low 
resolution due to high intrinsic flexibility. Last, NMR spectroscopy on PrdBU151C was shown 
to provide chemical shifts of high resolution but PrdBU151C was present in a mixture of at 
least two species with different conformations. Therefore, reproducible sample preparation 
needs to be improved. This could possibly be achieved by discovery of unknown cofactors 
involved in oligomerization or alteration of the chemical environment. The presented 
results provide a robust ground for ongoing studies. In the future, a major focus should be 
set on identification of possible cofactor binding and purification reproducibility. 
Conceivable methods for cofactor analysis are MS after protein denaturation and cofactor 
release for organic molecules or ICP-MS for ions.  
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The second project in this thesis was the structural elucidation of the phospholipases PlaA 
and PlaB from L. pneumophila. PlaA depicts a compact and mostly rigid 34 kDa monomer 
resulting in protein crystals of high quality. Structural elucidation based on experimental 
phase determination by iodine soaking was successful and confirmed sequence-based 
models, as well as previous knowledge about a common ABH-fold and the active site 
location. New insights were gained with respect to the change of substrate specificity upon 
ProA-mediated PlaA maturation. It has been found that a 29 amino acid long sequence, 
framed by a cysteine bridge, serves as a lid domain, which shields the active site from the 
solvent. At the same time, a putative binding site for the cholesterol moiety of the 
alternative substrate cholesterol palmitate was identified to be accessible on the surface 
of PlaA. Proteolytic maturation of the lid domain might be responsible for induced flexibility 
in the ABH-fold. This allows binding of the actual substrate LPC (16:0) and covering the 
cholesterol palmitate binding site, finally triggering PLA activity. The structure will help to 
generate structure guided PlaA versions, which will potentially provide deeper 
understanding of binding modes and substrate specificities. Until now, co-crystallization of 
PlaA with the enzymatic product palmitic acid was highly beneficial. However, co-
crystallization with substrates such as LPC (16:0) and cholesterol palmitate was not 
successful.  
PlaB was characterized by a complicated oligomerization behavior, possibly arising from 
a domain without sequence-based structural models. Concentration dependent 
oligomerization had been reported before. Diverging results in batch purifications provoked 
poor reproducibility in crystallization and mostly, collected datasets suffered from strong 
crystallographic defects, such as tNCS. However, it was found that, contrary to existent 
understanding, PlaB tetramerization was not solely concentration dependent but rather 
nucleotide mediated. Supplementation of NAD+ mediated concentration independent 
tetramer formation and hence improved crystallization of the PlaB tetramer. The crystal 
structure of a PlaB dimer of dimers explains the importance of the C-terminal domain, 
exhibiting a novel fold and in particular the 15 C-terminal amino acids are necessary for 
dimerization and activity. This short sequence, referred to as hook, serves as a tight and 
stable dimer interface and complements the ABH-fold of the second PlaB molecule. 
Tetramerization is based on a more complicated cross play of nucleotides and surface-
exposed cation-π-interaction sites. One particular, multifunctional element was identified, 
the antiparallel β-strand β9/β10, which is involved in enzymatic activity, nucleotide binding, 
tetramerization and membrane association. Additional cation-π-characters in the tetramer 
interface might contribute to the unique use of up to eight molecules of nucleotides for 
oligomerization, as future experiments will clarify. Bound nucleotides were responsible for 
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enzymatic inhibition that was accompanying tetramerization, as ionic interactions between 
the PlaB lid domain and a nucleotide presumably stabilized the lid in its closed 
conformation. This hypothesis requires more detailed investigation, still. But the influence 
of surface exposed charged sidechains in the lid domain on substrate recognition and 
turnover could unambiguously be monitored already. The enigmatic mechanism of PlaB 
export lacks complete understanding, still. However, unpublished data paired with 
structural inspections suggest that beside β9/β10, also β12/β13 may play a critical role in 
transmembrane transport. Altogether, structural determination of PlaB uncovered the 
architecture of the C-terminal domain with a novel fold and clearly improved understanding 
of dimerization dependent activity and tetramerization induced inhibition. It is suggested 
that for the purpose of self-protection, intracellular PlaB may be present as an inactive 
tetramer due to a high level of nucleotides. Upon membrane translocation, the tetrameric 
state is transformed to an active and thereby cytotoxic dimeric state, accompanied by 
nucleotide removal. This results in the exposure of PlaB on the bacterial surface of 
L. pneumophila. Until now, no comparable mode of regulation has been reported (Afonine 
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Table S1: Complete list of primers used in the projects presented in this thesis. Primer short names are provided 







↔ RE Sequence Tm 
[°C] 
MD001 PrdA M1 fw NdeI GGAATTCCATATGTCAATAACTTTAGAAACAGCTCAA
G 
66 
MD002 PrdA I422 fw NdeI GGAATTCCATATGATAGGACCTGCATCAAAAGAAATG 66 
MD003 PrdB M1 fw NdeI GGAATTCCATATGAGCCTTACAACAGTACAAGGAC 66 
MD007 PrdA T420 rv BamHI CGGGATCCttaGTTAATACCATTACAGCTCCATC 64 
MD008 PrdA N626 rv BamHI CGGGATCCTTAGTTTTCGTCTTTTTCGTATATTTC 68 
MD009 PrdB V241 rv BamHI CGGGATCCTTAAACGTGAGCTTTATATTCGTATG 68 
MD014 PrdB U151C rv 
 
CAAGTACCGCAGCCAGCTGTC 68 
MD016 PrdB U151C fw 
 
GACAGCTGGCTGCGGTACTTG 68 
MD020 PrdA M1 fw NotI AAGGAAAAAAGCGGCCGCTCAATAACTTTAGAAACAG
CTCAAG 
 
MD021 PrdA T420 rv KpnI GGGGTACCttaGTTAATACCATTACAGCTCCATC 
 
MD022 PrdA P164 fw NdeI tttcagggccatatgGGAATTCCATATGCCAAAAGTT
GAAGAAAAGAAAC 
58 
MD023 PrdA T420 rv XhoI ttagcagccggatccctcgagttaAGTTAATGCATGG
ATACCACC 
60 
MD024 PrdA I422 fw NdeI tttcagggccatatgGGAATTCCATATGATAGGACCT
GCATCAAAAGAA 
60 
MD025 PrdA V573 rv XhoI ttagcagccggatccctcgagttaTACACCTTCTATA
GCATTTTTAAG 
60 
MD026 PrdA A149 fw NdeI GGAATTCCATATGGCAAACGTTGCTGCTCCAGTG 68 
MD027 PrdA A158 fw NdeI GGAATTCCATATGGCAGCAGCAGAAGTAGCTCC 64 
MD028 PrdB M1 fw NotI ATAAGAATGCGGCCGCATGAGCCTTACAACAGTACAA
GGAC  
 
MD029 PrdB V241 rv KpnI GGGGTACCTTAAACGTGAGCTTTATATTCGTATG 
 
MD030 PrdB V241 rv KpnI GGGGTACCAACGTGAGCTTTATATTCGTATGGTA 
 





MD032 PrdA G198 fw NotI ATAAGAATGCGGCCGCATGGGAACTACTTTATACATC
AGAAAC 
64 
MD033 PrdA N626 rv KpnI GGGGTACCTTAGTTTTCGTCTTTTTCGTATATTTC 
 
MD038 PrdB V241 rv BamHI CGGGATCCTTAAACGTGAGCTTTATATTCGTATG 68 
MD039 PrdB I223 rv BamHI CGGGATCCTTATATTGCAACTAATTGCTCTAATGTAT 66 
MD040 PrdB S11 fw NotI AAGGAAAAAAGCGGCCGCATGTCTGAAATATTCGTTC
CAATAACAC 
66 
MD041 PrdB V22 fw NotI AAGGAAAAAAGCGGCCGCATGGTTTGGACTCCTGTAA
CTAAAG 
64 
MD042 PrdA E622 rv BamHI CGGGATCCTTATTCGTATATTTCTCTTCTCTTC 64 
MD043 PrdA E161A fw 
 
GTGCAGCAGCAGCAGTAGCTCCAAAAG 86 
MD044 PrdA E161A rv 
 
CTTTTGGAGCTACTGCTGCTGCTGCAC 86 
MD045 PrdA E355A fw 
 
GAAGAAGTAATAGCGCAATACAGAAGAG 78 
MD046 PrdA E355A rv 
 
CTCTTCTGTATTGCGCTATTACTTCTTC 78 
MD047 PrdB M1 fw NotI AGCCTTACAACAGTACAAGGAC  
 
















































MD78 PrdB E29 fw NotI ATAAGAATGCGGCCGCATGGAATTAAAAGATATGACT
ATAGC 
 
MD79 PrdB M33 fw NotI ATAAGAATGCGGCCGCATGACTATAGCTTTAGCTACA
GCAG 
 






Table S3: Percent identity matrix for a multiple sequence alignment of PlaB Legionella pneumophila str Corby generated by Clustal2.1. The identity for different Legionella does not 





























































































































































































































































































































































































































































































































































































































































































































































































































































CAD92451.1 phospholipase B 
[Legionella pneumophila str. Corby] 
100.00 98.10 88.61 88.82 88.82 87.76 86.92 86.92 85.23 83.76 79.75 79.11 45.98 44.93 44.57 25.85 24.47 23.88 
2 
WP 014841714.1 hypothetical protein 
[Legionella pneumophila] 
98.10 100.00 88.19 88.82 88.61 87.34 86.50 86.50 85.23 83.76 79.32 78.90 45.76 44.71 43.65 25.37 24.24 23.40 
3 
WP 058515395.1 hypothetical protein 
[Legionella santicrucis] 
88.61 88.19 100.00 88.19 91.98 95.99 93.46 90.72 85.44 85.86 81.65 81.43 45.31 44.71 43.42 43.76 25.18 25.53 
4 
WP 058483282 1 hypothetical protein 
[Legionella spiritensis] 
88.82 88.82 88.19 100.00 89.87 87.97 86.29 88.40 86.71 85.02 79.32 79.11 46.43 45.59 44.34 25.37 25.88 24.82 
5 
WP 045094542.1 hypothetical protein 
[Legionella fallonii] 
88.82 88.61 91.98 89.87 100.00 92.19 90.08 92.19 86.08 87.34 81.65 81.65 45.98 46.04 43.65 43.76 25.18 24.82 
6 
WP 058463789.1 hypothetical protein 
[Legionella cincinnatiensis] 
87.76 87.34 95.99 87.97 92.19 100.00 93.04 90.93 85.23 85.23 82.28 81.65 45.31 45.81 43.42 25.85 24.47 25.30 
7 
WP 019234277 1 hypothetical protein 
[Legionella anisa] 
86.92 86.50 93.46 86.29 90.08 93.04 100.00 89.24 85.02 84.60 81.86 81.43 45.31 44.05 43.88 43.82 24.00 43.64 
8 
WP 143869021.1 phospholipase 
[Legionella israelensis] 
86.92 86.50 90.72 88.40 92.19 90.93 89.24 100.00 85.86 85.86 82.07 81.86 45.76 45.15 43.88 25.85 24.71 25.30 
9 
WP 131795480.1 phospholipase 
[Fluoribacter gormanii] 
85.23 85.23 85.44 86.71 86.08 85.23 85.02 85.86 100.00 84.39 79.11 78.48 44.87 45.37 42.73 25.61 24.71 43.79 
10 
WP 018577989.1 hypothetical protein 
[Legionella shakespearei] 
83.76 83.76 85.86 85.02 87.34 85.23 84.60 85.86 84.39 100.00 81.43 82.07 46.43 44.71 44.34 25.61 25.41 24.82 
11 
WP 108292309.1 phospholipase 
[Legionella taurinensis] 
79.75 79.32 81.65 79.32 81.65 82.28 81.86 82.07 79.11 81.43 100.00 95.57 44.87 45.37 42.73 24.88 25.18 24.82 
12 
WP 058532019.1 hypothetical protein 
[Legionella rubrilucens] 
79.11 78.90 81.43 79.11 81.65 81.65 81.43 81.86 78.48 82.07 95.57 100.00 45.98 44.71 43.42 43.82 25.41 24.35 
13 
WP 011768684 1 hypothetical protein 
[Psychromonas ingrahamii] 
45.98 45.76 45.31 46.43 45.98 45.31 45.31 45.76 44.87 46.43 44.87 45.98 100.00 46.75 44.19 25.75 23.84 25.43 
14 
WP 027722894 1 hypothetical protein 
[Desulfovibrio zosterae] 
44.93 44.71 44.71 45.59 46.04 45.81 44.05 45.15 45.37 44.71 45.37 44.71 46.75 100.00 47.97 26.55 24.76 25.55 
15 
WP 012153585 1 phospholipase 
[Shewanella pealeana] 
44.57 43.65 43.42 44.34 43.65 43.42 43.88 43.88 42.73 44.34 42.73 43.42 44.19 47.97 100.00 27.78 25.93 26.00 
16 
WP 053813721 1 hypothetical protein 
[Pseudomonas aeruginosa] 
25.85 25.37 43.76 25.37 43.76 25.85 43.82 25.85 25.61 25.61 24.88 43.82 25.75 26.55 27.78 100.00 28.87 45.50 
17 
WP 012676954 1 hypothetical protein 
[Persephonella marina] 
24.47 24.24 25.18 25.88 25.18 24.47 24.00 24.71 24.71 25.41 25.18 25.41 23.84 24.76 25.93 28.87 100.00 34.78 
18 
WP 007152182 1 hypothetical protein 
[Marinobacter algicola] 
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